10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
	EXCHANGE ACT OF 1934

For the quarterly period ended March 30, 2013

Or

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
	EXCHANGE ACT OF 1934

For the transition period from _____ to _____                    

Commission file number: 001-14330

_____________________________________________ 

POLYMER GROUP, INC.

(Exact name of registrant as specified in its charter)

_____________________________________________ 

Delaware	57-1003983
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
9335 Harris Corners Parkway, Suite 300 Charlotte, North Carolina 28269	(704) 697-5100
(Address of principal executive offices)	(Registrant's telephone number, including area code)

____________________________________________ 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ¨    No  ý *

* The registrant is a voluntary filer of reports required to be filed by certain companies under Section 13 or 15(d) of the Securities Exchange Act of 1934 and has filed all reports that would have been required to have been filed by the registrant during the preceding 12 months had it been subject to such filing requirements during the entirety of such period.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	x  (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  ý

Number of common shares outstanding at May 3, 2013: 1,000. There is no public trading of the registrant's shares.

POLYMER GROUP, INC.

FORM 10-Q

INDEX

	Page
PART I. FINANCIAL INFORMATION	3
Item 1. Financial Statements	3
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	28
Item 3. Quantitative and Qualitative Disclosures About Market Risk	40
Item 4. Controls and Procedures	42
PART II. OTHER INFORMATION	42
Item 1. Legal Proceedings	42
Item 1A. Risk Factors	42
Item 4. Mine Safety Disclosure	42
Item 5. Other Information	42
Item 6. Exhibits	43
Signatures	44

2

PART I — FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

POLYMER GROUP, INC.

CONSOLIDATED BALANCE SHEETS

	(Unaudited)
In thousands, except share data	March 30, 2013			December 29, 2012
ASSETS
Current assets:
Cash and cash equivalents	$	74,627		$	97,879
Accounts receivable, net	139,848			131,569
Inventories, net	96,892			94,964
Deferred income taxes	3,806			3,832
Other current assets	40,078			33,414
Total current assets	355,251			361,658
Property, plant and equipment, net of accumulated depreciation of $119,170 and $106,134, respectively	477,958			479,169
Goodwill	80,712			80,608
Intangible assets, net	73,637			75,663
Deferred income taxes	1,222			945
Other noncurrent assets	24,855			24,026
Total assets	$	1,013,635		$	1,022,069
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings	$	1,411		$	813
Accounts payable and accrued liabilities	193,176			196,905
Income taxes payable	3,716			3,841
Deferred income taxes	479			479
Current portion of long-term debt	21,463			19,477
Total current liabilities	220,245			221,515
Long-term debt	583,199			579,399
Deferred income taxes	33,045			33,181
Other noncurrent liabilities	47,611			48,772
Total liabilities	884,100			882,867
Commitments and contingencies
Shareholders’ equity:
Common stock — 1,000 shares issued and outstanding	—			—
Additional paid-in capital	256,416			256,180
Retained earnings (deficit)	(108,436		)	(102,209		)
Accumulated other comprehensive income (loss)	(18,445		)	(14,769		)
Total shareholders' equity	129,535			139,202
Total liabilities and shareholders' equity	$	1,013,635		$	1,022,069

See accompanying Notes to Consolidated Financial Statements.

3

POLYMER GROUP, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Net sales	$	287,082		$	295,171
Cost of goods sold	(241,216		)	(241,984		)
Gross profit	45,866			53,187
Selling, general and administrative expenses	(34,342		)	(34,131		)
Special charges, net	(1,804		)	(2,419		)
Other operating, net	(340		)	361
Operating income (loss)	9,380			16,998
Other income (expense):
Interest expense	(12,084		)	(12,848		)
Foreign currency and other, net	(1,420		)	62
Income (loss) before income taxes	(4,124		)	4,212
Income tax (provision) benefit	(2,103		)	(4,477		)
Net income (loss)	$	(6,227	)	$	(265	)
Other comprehensive income (loss):
Currency translation	$	(3,772	)	$	4,823
Employee postretirement benefits, net of tax	96			—
Other comprehensive income (loss)	(3,676		)	4,823
Comprehensive income (loss)	$	(9,903	)	$	4,558

See accompanying Notes to Consolidated Financial Statements.

4

POLYMER GROUP, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(UNAUDITED)

In thousands	Common Stock			Additional Paid-in Capital		Retained Deficit			Accumulated Other Comprehensive Income (Loss)			Total Equity
	Shares	Amount
Balance — December 29, 2012	1	$	—	$	256,180	$	(102,209	)	$	(14,769	)	$	139,202
Net income (loss)	—	—		—		(6,227		)	—			(6,227		)
Share-based compensation	—	—		236		—			—			236
Employee benefit plans, net of tax	—	—		—		—			96			96
Currency translation	—	—		—		—			(3,772		)	(3,772		)
Balance — March 30, 2013	1	$	—	$	256,416	$	(108,436	)	$	(18,445	)	$	129,535

See accompanying Notes to Consolidated Financial Statements.

5

POLYMER GROUP, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Operating activities:
Net income (loss)	$	(6,227	)	$	(265	)
Adjustments for non-cash transactions:
Deferred income taxes	(28		)	—
Depreciation and amortization expense	16,152			15,852
(Gain) loss on financial instruments	—			(147		)
(Gain) loss on sale of assets, net	67			(6		)
Non-cash compensation	236			204
Changes in operating assets and liabilities:
Accounts receivable	(9,884		)	428
Inventories	(3,246		)	5,756
Other current assets	(6,364		)	(2,883		)
Accounts payable and accrued liabilities	(3,534		)	(2,381		)
Other, net	(1,883		)	3,056
Net cash provided by (used in) operating activities	(14,711		)	19,614
Investing activities:
Purchases of property, plant and equipment	(14,317		)	(13,312		)
Proceeds from sale of assets	11			1,657
Acquisition of intangibles and other	(53		)	(56		)
Net cash provided by (used in) investing activities	(14,359		)	(11,711		)
Financing activities:
Proceeds from long-term borrowings	6,666			24
Proceeds from short-term borrowings	1,446			1,441
Repayment of long-term borrowings	(912		)	(940		)
Repayment of short-term borrowings	(848		)	(2,072		)
Net cash provided by (used in) financing activities	6,352			(1,547		)
Effect of exchange rate changes on cash	(534		)	523
Net change in cash and cash equivalents	(23,252		)	6,879
Cash and cash equivalents - beginning of period	97,879			72,742
Cash and cash equivalents - end of period	$	74,627		$	79,621
Supplemental disclosures of cash flow information:
Cash payments for interest	$	22,300		$	23,537
Cash payments (receipts) for taxes, net	$	3,435		$	2,720

See accompanying Notes to Consolidated Financial Statements.

6

POLYMER GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1.  Description of Business

Polymer Group, Inc. (“Polymer” or “PGI”), a Delaware corporation, and its consolidated subsidiaries (the “Company”) is a leading global innovator, manufacturer and marketer of engineered materials, primarily focused on the production of nonwoven products. The Company has one of the largest global platforms in the industry, with a total of 13 manufacturing and converting facilities located in 9 countries throughout the world. The Company operates through 4 reportable segments, with the main sources of revenue being the sales of primary and intermediate products to the hygiene, healthcare, wipes and industrial markets.

Note 2.  Basis of Presentation

The accompanying consolidated financial statements reflect the consolidated operations of the Company and have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) as defined by the Financial Accounting Standards Board (“FASB”) within the FASB Accounting Standards Codification (“ASC”). In the opinion of management, the accompanying consolidated financial statements contain all adjustments, which include normal recurring adjustments, necessary to present fairly the consolidated results for the periods presented. The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Polymer Group, Inc. Annual Report on Form 10-K for the year ended December 29, 2012.

On January 28, 2011, pursuant to an Agreement and Plan of Merger, dated as of October 4, 2010, the Company was acquired by affiliates of the Blackstone Group (“Blackstone”), along with certain members of the Company's management (the "Merger"), for an aggregate purchase price valued at $403.5 million. As a result, the Company became a privately-held company. The Merger was financed by $560.0 million in aggregate principal of debt financing as well as common equity capital. In addition, the Company repaid its existing outstanding debt. Although the Company continues to operate as the same legal entity subsequent to the Merger and related change in control, a new entity was created for accounting purposes as of January 28, 2011. As a result, the purchase price was allocated to assets acquired and liabilities assumed based on their estimated fair market values at the date of acquisition. Under the guidance of the Securities and Exchange Commission ("SEC") Staff Accounting Bulletin Topic 5J, “New Basis of Accounting Required in Certain Circumstances,” push-down accounting is required when such transactions result in an entity being substantially wholly-owned. Therefore, the basis in shares of common stock of the Company has been "pushed down" to the Company from Scorpio Holdings Corporation, a Delaware corporation ("Holdings") that owns 100% of the issued and outstanding stock of Scorpio Acquisition Corporation, a Delaware corporation ("Parent") that owns 100% of the issued and outstanding common stock of the Company.

The Company's fiscal year is based on a 52 week period ending on the Saturday closest to each December 31. Therefore, the financial results of 53-week fiscal years, and the associated 14-week quarters, will not be comparable to the prior and subsequent 52-week fiscal years and the associated quarters having only 13 weeks. The three months ended March 30, 2013 and March 31, 2012 each contain operating results for 13 weeks.

Note 3. Recent Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update No. 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income" ("ASU 2013-02"), which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, ASU 2013-02 requires an entity to present, either on the face of the income statement or in the notes to the financial statements, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income in the financial statements. ASU 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012. The adoption of this guidance concerns disclosure only and did not have an impact on the Company's financial results. See Note 11 for additional information.

Note 4.  Accounts Receivable Factoring Agreements

In the ordinary course of business, the Company may utilize accounts receivable factoring agreements with third-party financial institutions in order to accelerate its cash collections from product sales. In addition, these agreements provide the

7

Company with the ability to limit credit exposure to potential bad debts, better management of costs relate to collections as well as enable customers to extend their credit terms. These agreements involve the ownership transfer of eligible trade accounts receivable, without recourse or discount, to a third party financial institution in exchange for cash.

The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheet. Receivables are considered sold when they are transferred beyond the reach of the Company and its creditors, the purchaser has the right to pledge or exchange the receivables, and the Company has surrendered control over the transferred receivables. In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold. Amounts due from financial institutions are recorded with Other current assets in the Consolidated Balance Sheet.

The Company has a U.S. based program where certain U.S. based receivables are sold to an unrelated third-party financial institution. Under the current terms of the U.S. agreement, the maximum amount of outstanding advances at any one time is $20.0 million, which limitation is subject to change based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. In addition, the Company's subsidiaries in Mexico, Colombia, Spain and the Netherlands have entered into factoring agreements to sell certain receivables to unrelated third-party financial institutions. Under the terms of the non-U.S. agreements, the maximum amount of outstanding advances at any one time is $49.7 million, which limitation is subject to change based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold.

The following is a summary of receivables sold to the third-party financial institutions that existed at the following balance sheet dates:

In thousands	March 30, 2013		December 29, 2012
Trade receivables sold to financial institutions	$	54,844	$	48,767
Amounts received from financial institutions	47,314		41,937
Amounts due from financial institutions	$	7,530	$	6,830

The Company sold $101.8 million and $88.8 million of receivables under the terms of the factoring agreements during the three months ended March 30, 2013 and March 31, 2012, respectively. The increase is primarily related to the inclusion of the Netherlands, which entered into a factoring agreement in March 2012. The Company pays a factoring fee associated with the sale of receivables based on the dollar of the receivables sold. Amounts incurred were $0.3 million and $0.3 million during the three months ended March 30, 2013 and March 31, 2012, respectively.

Note 5.  Inventories, Net

At March 30, 2013 and December 29, 2012, the major classes of inventory were as follows:

In thousands	March 30, 2013		December 29, 2012
Raw materials and supplies	$	42,438	$	41,070
Work in process	14,493		14,299
Finished goods	39,961		39,595
Total	$	96,892	$	94,964

Inventories are stated at the lower of cost, determined on the first-in, first-out ("FIFO") method, or fair market value. The Company performs periodic assessments to determine the existence of obsolete, slow-moving and non-saleable inventories and records necessary provisions to reduce such inventories to net realizable value. Reserve balances, primarily related to obsolete and slow-moving inventories, were $3.1 million and $3.3 million at March 30, 2013 and December 29, 2012, respectively.

Note 6. Intangible Assets

Indefinite-lived intangible assets are tested and reviewed annually for impairment during the fourth quarter or whenever there is a significant change in events or circumstances that indicate that the fair value of the asset may be less than the carrying amount of the asset. All other intangible assets with finite useful lives are being amortized on a straight-line basis over their estimated useful lives.

8

The following table sets forth the gross amount and accumulated amortization of the Company's intangible assets at March 30, 2013 and December 29, 2012:

In thousands	March 30, 2013			December 29, 2012
Technology	$	31,900		$	31,900
Customer relationships	16,896			16,869
Loan acquisition costs	19,472			19,472
Other	498			446
Total gross finite-lived intangible assets	68,766			68,687
Accumulated amortization	(18,629		)	(16,524		)
Total net finite-lived intangible assets	50,137			52,163
Tradenames (indefinite-lived)	23,500			23,500
Total	$	73,637		$	75,663

As of March 30, 2013, the Company had recorded intangible assets of $73.6 million. Included in this amount are loan acquisition costs incurred in association with the Merger. These expenditures represent the cost of obtaining financings that are capitalized in the balance sheet and amortized over the term of the loans to which such costs relate.

Amortization of intangible assets was $2.1 million and $2.1 million for the three months ended March 30, 2013 and March 31, 2012, respectively, of which $0.6 million and $0.7 million were charged to Interest expense, respectively, related to the amortization of loan acquisition costs. Estimated amortization expense on existing intangible assets for each of the next five years, including fiscal year 2013, is expected to approximate $8 million in 2013, $7 million in 2014, $7 million in 2015, $7 million in 2016 and $7 million in 2017.

Note 7.  Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consist of the following:

In thousands	March 30, 2013		December 29, 2012
Accounts payable to vendors	$	135,308	$	127,969
Accrued salaries, wages, incentive compensation and other fringe benefits	23,344		21,759
Accrued interest	7,821		18,630
Other accrued expenses	26,703		28,547
Total	$	193,176	$	196,905

Note 8.  Debt

The following table presents the Company's long-term debt at March 30, 2013 and December 29, 2012:

In thousands	March 30, 2013			December 29, 2012
Senior Secured Notes	$	560,000		$	560,000
ABL Facility	—			—
Argentine Facility	10,842			11,674
China credit facilities:
China Credit Facility — Healthcare	15,981			15,981
China Credit Facility — Hygiene	17,642			10,977
Capital lease obligations	197			244
Total debt	604,662			598,876
Less: Current maturities	(21,463		)	(19,477		)
Total long-term debt	$	583,199		$	579,399

9

The fair value of the Company's long-term debt was $649.0 million at March 30, 2013 and $640.0 million at December 29, 2012. The fair value of long-term debt is based upon quoted market prices in inactive markets or on available rates for debt with similar terms and maturities (Level 2).

Senior Secured Notes

In connection with the Merger, the Company issued $560.0 million of 7.75% Senior Secured Notes on January 28, 2011. The notes are due in 2019 and are fully and unconditionally guaranteed, jointly and severally on a senior secured basis, by each of the Polymer Group's wholly-owned domestic subsidiaries. Interest on the notes is paid semi-annually on February 1 and August 1.

The agreement governing the Senior Secured Notes, among other restrictions, limits the Company's ability and the ability of the Company's restricted subsidiaries to: (i) incur or guarantee additional debt or issue disqualified stock or preferred stock; (ii) pay dividends and make other distributions on, or redeem or repurchase, capital stock; (iii) make certain investments; (iv) repurchase stock; (v) incur certain liens; (vi) enter into transactions with affiliates; (vii) merge or consolidate; (viii) enter into agreements that restrict the ability of subsidiaries to make dividends or other payments to Polymer Group, Inc.; (ix) designate restricted subsidiaries as unrestricted subsidiaries; and (x) transfer or sell assets. However, subject to certain exceptions, the indenture permits the Company and its restricted subsidiaries to incur additional indebtedness, including senior indebtedness and secured indebtedness. The indenture also does not limit the amount of additional indebtedness that Parent or its parent entities may incur.

Under the agreement governing the Senior Secured Notes and under the credit agreement governing the senior secured asset-based revolving credit facility, the Company's ability to engage in activities such as incurring additional indebtedness, making investments, refinancing certain indebtedness, paying dividends and entering into certain merger transactions is governed, in part, by the Company's ability to satisfy tests based on Adjusted EBITDA as defined in the indenture.

ABL Facility

In connection with the Merger, the Company entered into a senior secured asset-based revolving credit facility (the "ABL Facility") to provide for borrowings not to exceed $50.0 million, subject to borrowing base availability. The ABL Facility provides borrowing capacity available for letters of credit and borrowings on a same-day basis. The ABL Facility is comprised of (i) a revolving tranche of up to $42.5 million (“Tranche 1”) and (ii) a first-in, last out revolving tranche of up to $7.5 million (“Tranche 2”). Provided that no default or event of default was then existing or would arise therefrom, the Company had the option to request that the ABL Facility be increased by an amount not to exceed $20.0 million, subject to certain rights of the administrative agent, swing line lender and issuing banks with respect to the lenders providing commitments for such increase. The facility was set to expire on January 28, 2015.

On October 5, 2012, the Company entered into an amended and restated ABL Facility. The amended and restated facility extended the maturity date to October 5, 2016 as well as made certain pricing and other changes to the original agreement. The Company maintained the option to request that the ABL Facility be increased by an amount not to exceed $20.0 million, subject to certain rights of the administrative agent, swing line lender and issuing banks with respect to the lenders providing commitments for such increase. As of March 30, 2013, the Company had no outstanding borrowings under the ABL Facility. Borrowing base availability was $29.6 million, however, outstanding letters of credit in the aggregate amount of $11.0 million left $18.6 million available for additional borrowings. The aforementioned letters of credit were primarily provided to certain administrative service providers and financial institutions. None of these letters of credit had been drawn on as of March 30, 2013.

Based on current borrowing base availability, the borrowings under the ABL Facility will bear interest at a rate per annum equal to, at our option, either (A) Adjusted London Interbank Offered Rate (“LIBOR”) (adjusted for statutory reserve requirements) plus (i) 2.00% in the case of Tranche 1 or (ii) 4.00% in the case of Tranche 2; or (B) the higher of (a) the administrative agent's Prime Rate and (b) the federal funds effective rate plus 0.5% (“ABR”) plus (x) 1.00% in the case of Tranche 1 or (y) 3.00% in the case of the Tranche 2.

The ABL Facility contains certain customary representations and warranties, affirmative covenants and events of default, including among other things payment defaults, breach of representations and warranties, covenant defaults, cross-defaults and cross acceleration to certain indebtedness, bankruptcy and insolvency defaults, certain events under ERISA, certain monetary judgment defaults, invalidity of guarantees or security interests, and change of control. If such an event of default occurs, the lenders under the ABL Facility would be entitled to take various actions, including the acceleration of amounts due under the ABL Facility and all actions permitted to be taken by a secured creditor.

10

Argentine Facility

In January 2007, the Company's subsidiary in Argentina entered into an arrangement with banking institutions in Argentina in order to finance the installation of a new spunmelt line at its facility near Buenos Aires, Argentina. The maximum borrowings available under the facility, excluding any interest added to principal, were 33.5 million Argentine pesos with respect to an Argentine peso-denominated loan and $26.5 million with respect to a U.S. dollar-denominated loan. The loans are secured by pledges covering (i) the subsidiary's existing equipment lines; (ii) the outstanding stock of the subsidiary; and (iii) the new machinery and equipment being purchased, as well as a trust assignment agreement related to a portion of receivables due from certain major customers of the subsidiary.

The interest rate applicable to borrowings under these term loans is based on LIBOR plus 290 basis points for the U.S. dollar-denominated loan and Buenos Aires Interbanking Offered Rate plus 475 basis points for the Argentine peso-denominated loan. Principal and interest payments began in July 2008 with the loans maturing as follows: annual amounts of $3.5 million beginning in 2011 and continuing through 2015, and the remaining $1.7 million in 2016.

In connection with the Merger, the Company repaid and terminated the Argentine peso-denominated loan. In addition, the U.S. denominated loan was adjusted to reflect its fair value as of the date of the Merger. As a result, the Company recorded a contra-liability in Long-term debt and will amortize the balance over the remaining life of the facility. At March 30, 2013, the face amount of the outstanding indebtedness under the U.S. dollar-denominated loan was $11.2 million, with a carrying amount of $10.8 million and a weighted average interest rate of 3.19%.

China Credit Facility — Healthcare

In the third quarter of 2010, the Company's subsidiary in China entered into a three-year U.S. dollar denominated construction loan agreement (the “Healthcare Facility”) with a banking institution in China to finance a portion of the installation of the new spunmelt line at its manufacturing facility in Suzhou, China. The three-year term of the agreement began with the date of the first draw down on the Healthcare Facility, which occurred in fourth quarter of 2010. The interest rate applicable to borrowings is based on three-month LIBOR plus an amount to be determined at the time of funding based on the lender's internal head office lending rate (400 basis points at the time the credit agreement was executed), but in no event would the interest rate be less than 1-year LIBOR plus 250 points.

The maximum borrowings available under the facility, excluding any interest added to principal, were $20.0 million. The Company repaid $4.0 million of the principal balance in the fourth quarter of 2012. As a result, the outstanding balance under the Healthcare Facility was $16.0 million at December 29, 2012, with a weighted average interest rate of 5.44%. As of March 30, 2013, the outstanding balance under the Healthcare Facility was $16.0 million with a weighted-average interest rate of 5.42%. The outstanding balance is scheduled to be repaid during 2013 using a combination of existing cash balances and cash generated from operations.

China Credit Facility — Hygiene

On July 1, 2012, the Company's subsidiary in China entered into a three-year U.S. dollar denominated construction loan agreement (the “Hygiene Facility”) with a banking institution in China to finance a portion of the installation of a new spunmelt line at its manufacturing facility in Suzhou, China. The interest rate applicable to borrowings under the Hygiene Facility is based on three-month LIBOR plus an amount to be determined at the time of funding based on the lender's internal head office lending rate (520 basis points at the time the credit agreement was executed).

The maximum borrowings available under the facility, excluding any interest added to principal, were $25.0 million. As of December 29, 2012, the outstanding balance under the Hygiene Facility was $11.0 million with a weighted-average interest rate of 5.51%. As of March 30, 2013, the outstanding balance under the Hygiene Facility was $17.6 million with a weighted average interest rate of 5.48%. In addition, the Company had $9.4 million of outstanding letters of credit that expired during the three months ended March 30, 2013. The Company's first payment on the outstanding principal is due in late 2013.

Other Indebtedness

The Company periodically enters into short-term credit facilities in order to finance various liquidity requirements. At March 30, 2013, outstanding amounts related to such facilities were $1.4 million, which are being used to finance insurance premium payments. The weighted average interest rate on these borrowings was 2.44%. At December 29, 2012, amounts outstanding under these facilities was $0.8 million at a weighted average interest rate of 2.46%. Borrowings are included in Short-term borrowings in the Consolidated Balance Sheets.

11

The Company also has documentary letters of credit not associated with the ABL Facility, Healthcare Facility or the Hygiene Facility. These letters of credit were primarily provided to certain raw material vendors and amounted to $5.9 million and $6.9 million at March 30, 2013 and December 29, 2012, respectively. None of these letters of credit have been drawn upon.

Note 9.  Derivative Instruments

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. These fluctuations can increase the cost of financing, investing and operating the business. The Company uses derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes.

All derivatives are recognized on the Consolidated Balance Sheet at their fair value as either assets or liabilities. On the date the derivative contract is entered into, the Company designates the derivative as (1) a hedge of the fair value of a recognized asset or liability (fair value hedge), (2) a hedge of a forecasted transaction or the variability of cash flow to be paid (cash flow hedge), or (3) an undesignated instrument. Changes in the fair value of a derivative that is designated as a fair value hedge and determined to be highly effective are recorded in current earnings, along with the gain or loss on the recognized hedged asset or liability that is attributable to the hedged risk. Changes in the fair value of a derivative that is designated as a cash flow hedge and considered highly effective are recorded in Accumulated other comprehensive income (loss) until they are reclassified to earnings in the same period or periods during which the hedged transaction affects earnings. Changes in the fair value of undesignated derivative instruments and the ineffective portion of designated derivative instruments are reported in current earnings.

The Company formally documents all relationships between hedging instruments and hedged items, as well as the risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives that are designated as fair value hedges to specific assets and liabilities on the Consolidated Balance Sheet and linking cash flow hedges to specific forecasted transactions or variability of cash flow to be paid.

The Company also formally assesses, both at the hedge's inception and on an ongoing basis, whether the designated derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flow of hedged items. When a derivative is determined not to be highly effective as a hedge or the underlying hedged transaction is no longer probable, hedge accounting is discontinued prospectively, in accordance with current accounting standards.

The following table presents the fair values of the Company's derivative instruments included within Accounts payable and accrued expenses on the Consolidated Balance Sheets as of March 30, 2013 and December 29, 2012:

	As of March 30, 2013					As of December 29, 2012
In thousands	Notional		Fair Value			Notional		Fair Value
Designated hedges:
Hygiene contracts	$	12,779	$	(1,309	)	$	22,554	$	(1,248	)
Undesignated hedges:
Healthcare contracts	—		—			—		—
Total	$	12,779	$	(1,309	)	$	22,554	$	(1,248	)

Hygiene Contracts

On June 30, 2011, the Company entered into a series of foreign exchange forward contracts with a third-party financial institution used to minimize foreign exchange risk on certain future cash commitments related to the new hygiene line under construction in China (the "Hygiene Contracts"). The contracts allow the Company to purchase fixed amount of Euros on specified future dates, coinciding with the payment amounts and dates of equipment purchase contracts. The Hygiene Contracts qualify for hedge accounting treatment and are considered a fair value hedge; therefore, changes in the fair value of each contract is recorded in Foreign currency and other, net along with the gain or loss on the recognized hedged asset or liability that is attributable to the hedged risk. Since inception, the Company amended the equipment purchase contract on the hygiene line to which the Hygiene Contracts are linked. However, the Company modified the notional amounts of the Hygiene Contracts to synchronize with the underlying updated contract payments. As a result, the Hygiene Contracts remain highly effective and continue to qualify for hedge accounting treatment.

Healthcare Contracts

In January 2011, the Company entered into a series of foreign exchange forward contracts with a third-party financial institution used to minimize foreign exchange risk on certain future cash commitments related to the new healthcare line under

12

construction in China (the "Healthcare Contracts"). The contracts allowed the Company to purchase fixed amount of Euros on specified future dates, coinciding with the payment amounts and dates of equipment purchase contracts. The Healthcare Contracts qualified for hedge accounting treatment and were considered a fair value hedge; therefore, changes in the fair value of each contract was recorded in Foreign currency and other, net along with the gain or loss on the recognized hedged asset or liability that was attributable to the hedged risk.

In July 2011, the Company completed commercial acceptance of the new healthcare line under construction in China and recorded a liability for the remaining balance due. As a result, the Company removed the hedge designation of the Healthcare Contracts and will continue to recognize changes in the fair value of the contracts in current earnings as an undesignated hedge. However, changes in the fair value of the hedged asset that is attributable to the hedged risk has been capitalized in the cost base of the healthcare line and no longer recognized in current earnings. During the first quarter of 2012, the Company remitted the final payment on the healthcare line and simultaneously fulfilled its obligations under the Healthcare Contracts.

The following table represents the amount of (gain) or loss associated with derivatives designated as hedges affecting Foreign currency and other, net in the Consolidated Statement of Operations:

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Designated hedges:
Hygiene contracts	61		(1,226		)
Undesignated hedges:
Healthcare contracts	—		(147		)
Total	$	61	$	(1,373	)

Gains and losses associated with the Company's designated fair value hedges are materially offset within Foreign currency and other, net by the changes in the fair value of the underlying transactions. However, once the hedge is undesignated, the fair value of the underlying transaction is no longer recognized in earnings.

Note 10.  Fair Value of Financial Instruments

The accounting standard for fair value measurements establishes a framework for measuring fair value that is based on the inputs market participants use to determine the fair value of an asset or liability and establishes a fair value hierarchy to prioritize those inputs. The fair value hierarchy is comprised of three levels that are described below:

Level 1 — Inputs based on quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs other than Level 1 quoted prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 — Unobservable inputs based on little or no market activity and that are significant to the fair value of the assets and liabilities, therefore requiring an entity to develop its own assumptions.

The fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions regarding what a third party would use in pricing an asset or liability based on the best information available under the circumstances. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The following tables present the fair value and hierarchy levels for the Company's assets and liabilities, which are measured at fair value on a recurring basis as of the following periods:

13

In thousands	Level 1		Level 2			Level 3		March 30, 2013
Assets
Firm commitment	$	—	$	1,309		$	—	$	1,309
Liabilities
Hygiene contracts	—		(1,309		)	—		(1,309		)

In thousands	Level 1		Level 2			Level 3		December 29, 2012
Assets
Firm commitment	$	—	$	1,248		$	—	$	1,248
Liabilities
Hygiene contracts	—		(1,248		)	—		(1,248		)

ASC 820 "Fair Value Measurements and Disclosures" (ASC 820) defines fair value as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company determines fair value of its financial assets and liabilities using the following methodologies:

• Firm Commitment — Assets recognized associated with an unrecognized firm commitment to purchase equipment. The fair value of the assets is based upon indicative price information obtained from a third-party financial institution that is the counterparty to the transaction.

• Derivative instruments — These instruments consist of foreign forward exchange contracts. The fair value is based upon indicative price information obtained from a third-party financial institution that is the counterparty to the transaction.

The fair values of cash and cash equivalents, accounts receivable, inventories, short-term borrowings and accounts payable and accrued liabilities approximate their carrying values due to the short-term nature of these instruments. The methodologies used by the Company to determine the fair value of its financial assets and liabilities at March 30, 2013 are the same as those used at December 29, 2012. As a result, there have been no transfers between Level 1 and Level 2 categories.

Level 2 to Level 1 assets -no

Level 1 to Level 2 liabilities - no

Level 2 to Level 1 liabilities - no

Note 11.  Pension and Postretirement Benefit Plans

The Company and its subsidiaries sponsor multiple defined benefit plans that cover certain employees. Postretirement benefit plans, other than pensions, provide healthcare benefits for certain eligible employees. Benefits are primarily based on years of service and the employee’s compensation.

Pension Plans

The Company has both funded and unfunded pension benefit plans. It is the Company’s policy to fund such plans in accordance with applicable laws and regulations in order to ensure adequate funds are available in the plans to make benefit payments to plan participants and beneficiaries when required.

The components of the Company's pension related costs for the following periods are as follows:

14

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Service cost	$	844		$	510
Interest cost	1,391			1,442
Return on plan assets	(1,884		)	(1,616		)
Curtailment / settlement (gain) loss	—			—
Net amortization of:
Transition costs and other	88			(16		)
Net periodic benefit cost	$	439		$	320

During the fourth quarter of 2012, the Company completed the liquidation of two pension plans related to its former Dominion Textile, Inc. business in Canada. All pension benefits legally owed to plan participants were fully paid from plan assets by the end of 2012. Excess plan assets left in the trust after all participants were paid was $0.3 million and is reported within Other current assets in the Company's Consolidated Balance Sheet at December 29, 2012. The surplus was received by the Company in the first quarter of 2013. As a result of the liquidation of these plans during 2012, the Company recognized a settlement loss of $0.8 million within Special charges, net in the Company's Consolidated Statement of Operations.

The Company’s practice is to fund amounts for its qualified pension plans at least sufficient to meet the minimum requirements set forth in applicable employee benefit laws and local tax laws. In addition, the Company manages these plans to ensure that all present and future benefit obligations are met as they come due. During the three months ended March 30, 2013, employer contributions totaled $1.7 million. Full year contributions are expected to approximate $5.3 million.

Postretirement Plans

The Company sponsors several non-U.S. postretirement plans that provide healthcare benefits to cover certain eligible employees. These plans have no plan assets, but instead are funded by the Company on a pay-as-you-go basis in the form of direct benefit payments.

The components of the Company's postretirement related costs for the following periods are as follows:

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Service cost	$	15	$	18
Interest cost	46		54
Curtailment / settlement (gain) loss	—		—
Net amortization of:
Transition costs and other	9		6
Net periodic benefit cost	$	70	$	78

For the three months ended March 30, 2013 and March 31, 2012, reclassifications out of accumulated other comprehensive income (loss) totaled $0.1 million and less than $0.1 million, respectively. These amounts related to net actuarial gains/losses included in the computation of net periodic benefit cost for both pension and postretirement benefit plans.

Defined Contribution Plans

The Company sponsors several defined contribution plans through its domestic subsidiaries covering employees who meet certain service requirements.  The Company makes matching contributions to the plans based upon a percentage of the employee's contribution in the case of its 401(k) plans and makes safe harbor contributions based on the employee's eligibility to participate in the plan.  In the case of the non-qualified Executive Retirement Plan, the Company does not make any contributions.

Note 12.  Income Taxes

The Company accounts for its provision for income taxes in accordance with ASC 740, "Income Taxes," which requires an estimate of the annual effective tax rate for the full year to be applied to the respective interim period, taking into account year-to-date amounts and projected results for the full year. For the three months ended March 30, 2013, the combination of the

15

Company's income tax provision and recorded loss from operations before income taxes resulted in a negative 51.0% effective tax rate for the period. For the three months ended March 31, 2012, the effective tax rate was 106.3%. The effective tax rate for the three months ended March 30, 2013 is different than the Company's statutory tax rate primarily due to losses in certain jurisdictions for which no income tax benefits are anticipated, foreign withholding taxes for which tax credits are not anticipated, changes in the amounts of tax uncertainties and foreign taxes calculated at statutory rates different than the U.S. statutory rate.

Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax reporting purposes and (b) operating loss and tax credit carryforwards. A valuation allowance is recorded when, based on the weight of the evidence, it is more likely than not that some portion, or all, of the deferred tax asset will not be realized. The realization of the deferred tax asset depends on the ability to generate sufficient taxable income of the appropriate character in the future and in the appropriate taxing jurisdiction. At March 30, 2013, the Company has a net deferred tax liability of $28.5 million.

At March 30, 2013, the Company had unrecognized tax benefits of $24.2 million, of which $11.4 million relates to accrued interest and penalties. These amounts are included within Other noncurrent liabilities within the accompanying consolidated balance sheet. The total amount of unrecognized tax benefits that, if recognized, would affect the Company's effective tax rate is $24.2 million as of March 30, 2013. Included in the balance as of March 30, 2013 is $4.2 million related to tax positions for which it is reasonably possible that the total amounts could significantly change during the next twelve months. This amount is comprised of items which relate to the lapse of statute of limitations or the settlement of issues. The Company recognizes interest and/or penalties related to income taxes as a component of income tax expense.

Management judgment is required in determining tax provisions and evaluating tax positions. Although management believes its tax positions and related provisions reflected in the consolidated financial statements are fully supportable, it recognizes that these tax positions and related provisions may be challenged by various tax authorities. These tax positions and related provisions are reviewed on an ongoing basis and are adjusted as additional facts and information become available, including progress on tax audits, changes in interpretations of tax laws, developments in case law and closing of statute of limitations. The Company’s tax provision includes the impact of recording reserves and any changes thereto.

The major jurisdictions where the Company files income tax returns include the United States, Canada, China, the Netherlands, France, Germany, Spain, Mexico, Colombia, and Argentina. As of March 30, 2013, the Company has a number of open tax years with various taxing jurisdictions that range from 2003 to 2012. The results of current tax audits and reviews related to open tax years have not been finalized, and management believes that the ultimate outcomes of these audits and reviews will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Note 13.  Special Charges, Net

As part of our business strategy, the Company incurs amounts related to corporate-level decisions or Board of Director actions. These actions are primarily associated with initiatives attributable to restructuring and realignment of manufacturing operations and management structures as well as the pursuit of certain transaction opportunities when applicable. In addition, the Company evaluates its long-lived assets for impairment whenever events or changes in circumstances including the aforementioned, indicate that the carrying amounts may not be recoverable. These amounts are included in Special charges, net in the Statement of Operations. A summary for each respective period is as follows:

16

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Restructuring and plant realignment costs
Internal redesign and restructure of global operations	$	1,543	$	747
Plant realignment costs	96		673
IS support initiative	7		277
Other restructure initiatives	—		50
Total restructuring and plant realignment costs	1,646		1,747
Acquisition and merger related costs
Blackstone acquisition costs	—		361
Total acquisition and merger related costs	—		361
Other special charges
Other charges	158		311
Total other special charges	158		311
Total special charges, net	$	1,804	$	2,419

Restructuring and Plant Realignment Costs

Internal redesign and restructuring of global operations

During 2012, the Company initiated the internal redesign and restructuring of its global operations for the purposes of realigning and repositioning the Company to consolidate the benefits of its global footprint, align resources and capabilities with future growth opportunities and provide for a more efficient structure to serve existing markets. During the three months ended March 30, 2013, the Company incurred $1.5 million associated with this initiative, of which $1.2 million related to professional consulting fees and $0.1 million related to employee separations. Costs related to employee relocation, recruitment and other administrative costs were $0.2 million. During the three months ended March 31, 2012, the Company incurred $0.7 million, which related to professional consulting fees.

Plant Realignment Costs

The Company incurs costs associated with ongoing restructuring initiatives intended to result in lower working capital levels and improve operating performance and profitability. Costs associated with these initiatives include improving manufacturing productivity, reducing headcount, realignment of management structures, reducing corporate costs and rationalizing certain assets, businesses and employee benefit programs. For the three months ended March 30, 2013 and March 31, 2012, the Company incurred costs of $0.1 million and $0.7 million, respectively, associated with plant realignment initiatives primarily in the Americas and Europe regions.

IS Support Initiative

During 2012, the Company launched an initiative to utilize a third-party service provider for its Information Systems support tactical functions, including: service desk; desktop/end-user computing; server administration; network services; data center operations; database and applications development; and maintenance. For the three months ended March 30, 2013 and March 31, 2012, the Company incurred less than $0.01 millionand $0.3 million, respectively, associated with this initiative, which consisted primarily of employee separation and severance expenses.

Other Restructuring Initiatives

The Company incurs costs associated with less significant ongoing restructuring initiatives resulting from the continuous evaluation of opportunities to optimize the manufacturing process. During the three months ended March 31, 2012, costs associated with these initiatives were $0.1 million.

The changes in the restructuring reserves were as follows:

17

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Beginning balance	$	6,278		$	1,100
Additions	188			1,747
Cash payments	(2,535		)	(1,533		)
Adjustments	(57		)	39
Ending balance	$	3,874		$	1,353

The Company accounts for its restructuring programs in accordance with ASC 712, "Compensation - Non-retirement Postemployment Benefits" ("ASC 712") and anticipates that the substantial majority of the remaining accrued liability will be paid by the end of 2013.

Acquisition and Merger Related Costs

Blackstone Acquisition Costs

As a result of the Merger on January 28, 2011, the Company incurred direct acquisition costs associated with the transaction including investment banking, legal, accounting and other fees for professional services. For the three months ended March 31, 2012, the Company incurred $0.4 million of costs associated with the Merger.

Other Special Charges

Other Charges

Other charges consist primarily of expenses related to the Company’s pursuit of other business opportunities. The Company reviews its business operations on an ongoing basis in light of current and anticipated market conditions and other factors and, from time to time, may undertake certain actions in order to optimize overall business, performance or competitive position. To the extent any such decisions are made, the Company would likely incur costs associated with such actions, which could be material.

Note 14.  Other Operating, Net

Transactions that are denominated in a currency other than an entity's functional currency are subject to changes in exchange rates with the resulting gains and losses recorded within current earnings. The Company includes these gains and losses related to receivables and payables as well as the impacts of other operating transactions as a component of Operating income (loss).

For the three months ended March 30, 2013, the Company recognized a loss of $0.3 million within Other operating, net. Amounts associated with foreign currency losses totaled $0.4 million and other miscellaneous income was $0.1 million. For the three months ended March 31, 2012, the Company recognized income of $0.4 million associated with foreign currency gains.

Note 15. Foreign Currency and Other, Net

Transactions that are denominated in a currency other than an entity's functional currency are subject to changes in exchange rates with the resulting gains and losses recorded within current earnings. The Company includes these gains and losses related to intercompany loans and debt as well as other non-operating activities as a component of Other income (expense).

For the three months ended March 30, 2013, the Company recognized a loss of $1.4 million within Foreign currency and other, net. Amounts associated with foreign currency losses totaled $1.0 million and other non-operating expenses were $0.4 million. For the three months ended March 31, 2012, the Company recognized income of $0.1 million. Amounts associated with foreign currency gains totaled $0.3 million, partially offset by other non-operating expenses of $0.2 million.

Note 16.  Commitments and Contingencies

The Company is involved from time to time in various litigations, claims and administrative proceedings arising out of the ordinary conduct of its business. Amounts recorded for identified contingent liabilities are estimates, which are reviewed periodically and adjusted to reflect additional information when it becomes available. Subject to the uncertainties inherent in estimating future costs for contingent liabilities, management believes that any liability which may result from these legal matters would not have a material adverse effect on the Company's business or financial condition.

18

Environmental

The Company is subject to a broad range of federal, foreign, state and local laws and regulations relating to pollution and protection of the environment. The Company believes that it is currently in substantial compliance with applicable environmental requirements and does not currently anticipate any material adverse effect on its operations, financial or competitive position as a result of its efforts to comply with environmental requirements. Some risk of environmental liability is inherent, however, in the nature of the Company’s business and, accordingly, there can be no assurance that material environmental liabilities will not arise.

Equipment Lease Agreement

In the third quarter of 2011, the Company's state-of-the-art spunmelt line in Waynesboro, Virginia commenced commercial production. The plant expansion increased capacity to meet demand for nonwoven materials in the hygiene and healthcare applications in the U.S. The line was principally funded by a seven year equipment lease with a capitalized cost of $53.6 million. From the commencement of the lease to its fourth anniversary date, the Company will make annual lease payments of $8.3 million. From the fourth anniversary date to the end of the lease term, the Company's annual lease payments may change, as defined in the lease agreement. The aggregate monthly lease payments under the agreement, subject to adjustment, are expected to approximate $58 million. The lease includes covenants, events of default and other provisions that requires us to maintain certain financial ratios and other requirements.

China Hygiene Expansion

In the second quarter of 2011, the Company entered into a firm purchase agreement to acquire a spunmelt line to be installed in Suzhou, China that will manufacture nonwoven products primarily for the hygiene market. The Company plans to fund the project using a combination of existing cash balances, internal cash flows and the Hygiene Facility. As of March 30, 2013, the estimated total remaining project costs related to the firm commitment to purchase equipment was $12.8 million. As a result of the firm commitment being denominated in Euros, we entered into a series of foreign exchange forward contracts with a third-party financial institution to purchase fixed amount of Euros on specified future dates that coincide with the payment amounts and the dates of the payments.

Note 17.  Segment Information

The Company is a leading global innovator, manufacturer and marketer of engineered materials, primarily focused on the production of nonwoven products. The Company operates through four segments, with the main source of revenue being the sales of primary and intermediate products to the hygiene, healthcare, wipes and industrial markets. The Company has one major customer that accounts for over 10% of its business, the loss of which would have a material adverse impact on reported financial results. Sales to this customer are reported within each of the the Nonwoven segments.

During 2012, the Company approved the internal redesign and restructuring of its global operations for the purposes of realigning and repositioning the Company to consolidate the benefits of its global footprint, align resources and capabilities with future growth opportunities and provide for a more efficient structure to serve existing markets. As part of the change, the Company eliminated the Latin America Nonwovens segment and merged it with the U.S. Nonwoven segment to create the Americas Nonwoven segment. The Company's segments are now as follows: Americas Nonwovens, Europe Nonwovens, Asia Nonwovens and Oriented Polymers segments. Segment information for all years has been revised to reflect the new structure.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies except that the segment results are prepared on a management basis that is consistent with the manner in which the Company desegregates financial information for internal review and decision making. Intercompany sales between the segments are eliminated.

Financial data by segment is as follows:

19

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Net sales
Americas Nonwovens	$	153,004		$	165,893
Europe Nonwovens	78,274			75,667
Asia Nonwovens	37,967			36,423
Oriented Polymers	17,837			17,188
Total	$	287,082		$	295,171
Operating income (loss)
Americas Nonwovens	$	11,474		$	19,289
Europe Nonwovens	3,292			3,647
Asia Nonwovens	4,553			4,011
Oriented Polymers	1,593			1,677
Unallocated Corporate	(9,692		)	(9,368		)
Eliminations	(36		)	161
Subtotal	11,184			19,417
Special charges, net	(1,804		)	(2,419		)
Total	$	9,380		$	16,998
Depreciation and amortization expense
Americas Nonwovens	$	8,317		$	8,337
Europe Nonwovens	3,059			2,695
Asia Nonwovens	3,389			3,317
Oriented Polymers	348			381
Unallocated Corporate	432			437
Subtotal	15,545			15,167
Amortization of loan acquisition costs	607			685
Total	$	16,152		$	15,852
Capital spending
Americas Nonwovens	$	818		$	640
Europe Nonwovens	548			2,243
Asia Nonwovens	12,559			9,709
Oriented Polymers	125			86
Corporate	267			634
Total	$	14,317		$	13,312

20

In thousands	March 30, 2013		December 29, 2012
Division assets
Americas Nonwovens	$	494,577	$	513,765
Europe Nonwovens	197,831		202,139
Asia Nonwovens	255,873		248,790
Oriented Polymers	28,626		25,329
Corporate	36,728		32,046
Total	$	1,013,635	$	1,022,069

Note 18.  Certain Relationships and Related Party Transactions

In connection with the Merger, Holdings entered into a shareholders agreement (the “Shareholders Agreement”) with Blackstone and certain members of the Company's management. The Shareholders Agreement governs certain matters relating to ownership of Holdings, including the election of directors of our parent companies, restrictions on the issuance or transfer of shares, including tag-along rights and drag-along rights, other special corporate governance provisions and registration rights (including customary indemnification provisions). As of March 30, 2013, the Board of Directors of the Company includes three Blackstone members, three outside members and the Company’s Chief Executive Officer. Furthermore, Blackstone has the power to designate all of the members of the Board of Directors of the Company and the right to remove any or all directors, with or without cause.

Management Services Agreement

Upon the completion of the Merger, the Company became subject to a management services agreement (“Management Services Agreement”) with Blackstone Management Partners V L.L.C. (“BMP”), an affiliate of Blackstone. Under the Management Services Agreement, BMP (including through its affiliates) has agreed to provide certain monitoring, advisory and consulting services for an annual non-refundable advisory fee, to be paid at the beginning of each fiscal year, equal to the greater of (i) $3.0 million or (ii) 2.0% of the Company’s consolidated EBITDA (as defined under the credit agreement governing our ABL Facility) for the immediately preceding fiscal year. The amount of such fee shall be initially paid based on the Company’s then most current estimate of the Company’s projected EBITDA amount for the fiscal year immediately preceding the date upon which the advisory fee is paid. After completion of the fiscal year to which the fee relates and following the availability of audited financial statements for such period, the parties will recalculate the amount of such fee based on the actual consolidated EBITDA for such period and the Company or BMP, as applicable, shall adjust such payment as necessary based on the recalculated amount. Based on the Company’s fiscal 2012 financial performance, the advisory fee for the fiscal year ended December 29, 2012 remained at $3.0 million. With respect to the fiscal 2013 advisory fee, the Company paid $3.0 million during the first quarter of 2013. These amounts are included in Selling, general and administrative expenses in the Consolidated Statements of Operations.

Other Relationships

Blackstone and its affiliates have ownership interests in a broad range of companies. We may enter into commercial transactions in the ordinary course of our business with some of these companies, including the sale of goods and services and the purchase of goods and services.

Note 19.  Financial Guarantees and Condensed Consolidating Financial Statements

Polymer’s Senior Secured Notes are fully and unconditionally guaranteed, jointly and severally on a senior secured basis, by each of Polymer’s 100% owned domestic subsidiaries (collectively, the “Guarantors”). As substantially all of Polymer’s operating income and cash flow is generated by its subsidiaries, funds necessary to meet Polymer’s debt service obligations may be provided, in part, by distributions or advances from its subsidiaries. Under certain circumstances, contractual and legal restrictions, as well as the financial condition and operating requirements of Polymer’s subsidiaries, could limit Polymer’s ability to obtain cash from its subsidiaries for the purpose of meeting its debt service obligations, including the payment of principal and interest on the Senior Secured Notes. Although holders of the Senior Secured Notes will be direct creditors of Polymer’s principal direct subsidiaries by virtue of the guarantees, Polymer has subsidiaries that are not included among the Guarantors (collectively, the “Non-Guarantors”), and such subsidiaries will not be obligated with respect to the Senior Secured Notes. As a result, the claims of creditors of the Non-Guarantors will effectively have priority with respect to the assets and earnings of such companies over the claims of creditors of Polymer, including the holders of the Senior Secured Notes.

The following Condensed Consolidating Financial Statements are presented to satisfy the disclosure requirements of Rule 3-10 of Regulation S-X. In accordance with Rule 3-10, the subsidiary guarantors are all 100% owned by PGI (the “Issuer”). The

21

guarantees on the Senior Secured Notes are full and unconditional and all guarantees are joint and several. The information presents Condensed Consolidating Balance Sheets as of March 30, 2013 and December 29, 2012 and Condensed Consolidating Statements of Operations and Condensed Consolidating Statements of Cash Flows for the three months ended March 30, 2013 and March 31, 2012 of (1) PGI (Issuer), (2) the Guarantors, (3) the Non-Guarantors and (4) consolidating eliminations to arrive at the information for the Company on a consolidated basis.

The Company has made changes to its presentation of certain intercompany activities between PGI (Issuer), the Guarantors, the Non-Guarantors and corresponding Eliminations within its Condensed Consolidating Financial Statements contained herein. Certain prior period intercompany activities included in this note disclosure for the Condensed Consolidating Balance Sheets, the Condensed Consolidating Statements of Operations and the Condensed Consolidating Statements of Cash Flows have been recast to correct the classification of certain intercompany transactions. Management has determined that the adjustments were not material to prior periods and the nature of the changes is not material to the overall presentation. Accordingly, prior period Condensed Consolidating Balance Sheets, the Condensed Consolidating Statements of Operations and Condensed Consolidating Statements of Cash Flows included herein are not comparable to presentation included in prior period disclosures.

22

Condensed Consolidating Balance Sheet

As of March 30, 2013

In thousands	PGI (Issuer)			Guarantors		Non-Guarantors			Eliminations			Consolidated
ASSETS
Current Assets:
Cash and cash equivalents	$	4,060		$	15,234	$	55,333		$	—		$	74,627
Accounts receivable, net	—			24,913		114,935			—			139,848
Inventories, net	(52		)	21,025		75,919			—			96,892
Deferred income taxes	—			613		3,806			(613		)	3,806
Other current assets	3,908			10,017		26,153			—			40,078
Total current assets	7,916			71,802		276,146			(613		)	355,251
Property, plant and equipment, net	38,212			96,687		343,059			—			477,958
Goodwill	—			20,718		59,994			—			80,712
Intangible assets, net	23,483			41,715		8,439			—			73,637
Net investment in and advances to (from) subsidiaries	644,908			756,142		(169,899		)	(1,231,151		)	—
Deferred income taxes	—			—		1,222			—			1,222
Other noncurrent assets	306			5,645		18,904			—			24,855
Total assets	$	714,825		$	992,709	$	537,865		$	(1,231,764	)	$	1,013,635
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term borrowings	$	1,411		$	—	$	—		$	—		$	1,411
Accounts payable and accrued liabilities	17,985			38,875		136,316			—			193,176
Income taxes payable	—			—		3,716			—			3,716
Deferred income taxes	331			—		14			134			479
Current portion of long-term debt	107			—		21,356			—			21,463
Total current liabilities	19,834			38,875		161,402			134			220,245
Long-term debt	560,019			—		23,180			—			583,199
Deferred income taxes	273			9,149		24,370			(747		)	33,045
Other noncurrent liabilities	5,164			14,935		27,512			—			47,611
Total liabilities	585,290			62,959		236,464			(613		)	884,100
Common stock	—			—		36,083			(36,083		)	—
Other shareholders’ equity	129,535			929,750		265,318			(1,195,068		)	129,535
Total shareholders' equity	129,535			929,750		301,401			(1,231,151		)	129,535
Total liabilities and shareholders' equity	$	714,825		$	992,709	$	537,865		$	(1,231,764	)	$	1,013,635

23

Condensed Consolidating Balance Sheet

As of December 29, 2012

In thousands	PGI (Issuer)		Guarantors		Non-Guarantors			Eliminations			Consolidated
ASSETS
Current Assets:
Cash and cash equivalents	$	486	$	28,285	$	69,108		$	—		$	97,879
Accounts receivable, net	—		22,350		109,219			—			131,569
Inventories, net	—		23,843		71,121			—			94,964
Deferred income taxes	—		613		3,832			(613		)	3,832
Other current assets	1,821		7,710		23,883			—			33,414
Total current assets	2,307		82,801		277,163			(613		)	361,658
Property, plant and equipment, net	27,711		99,660		351,798			—			479,169
Goodwill	—		20,718		59,890			—			80,608
Intangible assets, net	24,313		42,422		8,928			—			75,663
Net investment in and advances to (from) subsidiaries	679,818		723,861		(188,670		)	(1,215,009		)	—
Deferred income taxes	—		—		945			—			945
Other noncurrent assets	275		5,787		17,964			—			24,026
Total assets	$	734,424	$	975,249	$	528,018		$	(1,215,622	)	$	1,022,069
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term borrowings	$	813	$	—	$	—		$	—		$	813
Accounts payable and accrued liabilities	28,511		33,344		135,050			—			196,905
Income taxes payable	—		89		3,752			—			3,841
Deferred income taxes	331		—		14			134			479
Current portion of long-term debt	107		—		19,370			—			19,477
Total current liabilities	29,762		33,433		158,186			134			221,515
Long-term debt	560,043		—		19,356			—			579,399
Deferred income taxes	273		9,149		24,506			(747		)	33,181
Other noncurrent liabilities	5,144		15,540		28,088			—			48,772
Total liabilities	595,222		58,122		230,136			(613		)	882,867
Common stock	—		—		36,083			(36,083		)	—
Other shareholders’ equity	139,202		917,127		261,799			(1,178,926		)	139,202
Total shareholders' equity	139,202		917,127		297,882			(1,215,009		)	139,202
Total liabilities and shareholders' equity	$	734,424	$	975,249	$	528,018		$	(1,215,622	)	$	1,022,069

24

Condensed Consolidating Statement of Operations

For the Three Months Ended March 30, 2013

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net sales	$	—		$	93,012		$	199,529		$	(5,459	)	$	287,082
Cost of goods sold	(25		)	(81,846		)	(164,804		)	5,459			(241,216		)
Gross profit	(25		)	11,166			34,725			—			45,866
Selling, general and administrative expenses	(9,644		)	(5,760		)	(18,938		)	—			(34,342		)
Special charges, net	(1,354		)	(37		)	(413		)	—			(1,804		)
Other operating, net	2			(76		)	(266		)	—			(340		)
Operating income (loss)	(11,021		)	5,293			15,108			—			9,380
Other income (expense):
Interest expense	(10,228		)	3,101			(4,957		)	—			(12,084		)
Intercompany royalty and technical service fees	1,327			1,607			(2,934		)	—			—
Foreign currency and other, net	(2		)	(97		)	(1,321		)	—			(1,420		)
Equity in earnings of subsidiaries	11,524			3,817			—			(15,341		)	—
Income (loss) before income taxes	(8,400		)	13,721			5,896			(15,341		)	(4,124		)
Income tax (provision) benefit	2,173			(2,145		)	(2,131		)	—			(2,103		)
Net income (loss)	$	(6,227	)	$	11,576		$	3,765		$	(15,341	)	$	(6,227	)
Comprehensive income (loss)	$	(9,903	)	$	16,102		$	5,384		$	(21,486	)	$	(9,903	)

Condensed Consolidating Statement of Operations

For the Three Months Ended March 31, 2012

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net sales	$	—		$	95,414		$	204,541		$	(4,784	)	$	295,171
Cost of goods sold	17			(82,447		)	(164,338		)	4,784			(241,984		)
Gross profit	17			12,967			40,203			—			53,187
Selling, general and administrative expenses	(9,291		)	(5,917		)	(18,923		)	—			(34,131		)
Special charges, net	(1,478		)	(216		)	(725		)	—			(2,419		)
Other operating, net	—			103			258			—			361
Operating income (loss)	(10,752		)	6,937			20,813			—			16,998
Other income (expense):
Interest expense	(11,275		)	3,315			(4,888		)	—			(12,848		)
Intercompany royalty and technical service fees	1,490			1,811			(3,301		)	—			—
Foreign currency and other, net	(30		)	(163		)	255			—			62
Equity in earnings of subsidiaries	18,165			9,151			—			(27,316		)	—
Income (loss) before income taxes	(2,402		)	21,051			12,879			(27,316		)	4,212
Income tax (provision) benefit	2,137			(2,832		)	(3,782		)	—			(4,477		)
Net income (loss)	$	(265	)	$	18,219		$	9,097		$	(27,316	)	$	(265	)
Comprehensive income (loss)	$	4,558		$	24,380		$	12,228		$	(36,608	)	$	4,558

25

Condensed Consolidating Statement of Cash Flows

For the Three Months Ended March 30, 2013

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net cash provided by (used in) operating activities	$	(15,118	)	$	16,397		$	(15,990	)	$	—		$	(14,711	)
Investing activities:
Purchases of property, plant and equipment	(10,592		)	(682		)	(3,043		)	—			(14,317		)
Proceeds from the sale of assets	—			—			11			—			11
Acquisition of intangibles and other	(53		)	—			—			—			(53		)
Intercompany investing activities, net	5,766			(23,000		)	—			17,234			—
Net cash provided by (used in) investing activities	(4,879		)	(23,682		)	(3,032		)	17,234			(14,359		)
Financing activities:
Proceeds from long-term borrowings	—			—			6,666			—			6,666
Proceeds from short-term borrowings	1,446			—			—			—			1,446
Repayment of long-term borrowings	(27		)	—			(885		)	—			(912		)
Repayment of short-term borrowings	(848		)	—			—			—			(848		)
Intercompany financing activities, net	23,000			(5,766		)	—			(17,234		)	—
Net cash provided by (used in) financing activities	23,571			(5,766		)	5,781			(17,234		)	6,352
Effect of exchange rate changes on cash	—			—			(534		)	—			(534		)
Net change in cash and cash equivalents	3,574			(13,051		)	(13,775		)	—			(23,252		)
Cash and cash equivalents at beginning of period	486			28,285			69,108			—			97,879
Cash and cash equivalents at end of period	$	4,060		$	15,234		$	55,333		$	—		$	74,627

26

Condensed Consolidating Statement of Cash Flows

For the Three Months Ended March 31, 2012

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net cash provided by (used in) operating activities	$	(31,450	)	$	28,014		$	23,050		$	—		$	19,614
Investing activities:
Purchases of property, plant and equipment	(8,316		)	(623		)	(4,373		)	—			(13,312		)
Proceeds from the sale of assets	—			1,646			11			—			1,657
Acquisition of intangibles and other	(56		)	—			—			—			(56		)
Intercompany investing activities, net	15,771			(25,770		)	(8,781		)	18,780			—
Net cash provided by (used in) investing activities	7,399			(24,747		)	(13,143		)	18,780			(11,711		)
Financing activities:
Proceeds from long-term borrowings	—			—			24			—			24
Proceeds from short-term borrowings	1,436			—			5			—			1,441
Repayment of long-term borrowings	(22		)	—			(918		)	—			(940		)
Repayment of short-term borrowings	(72		)	—			(2,000		)	—			(2,072		)
Intercompany financing activities, net	25,770			(6,990		)	—			(18,780		)	—
Net cash provided by (used in) financing activities	27,112			(6,990		)	(2,889		)	(18,780		)	(1,547		)
Effect of exchange rate changes on cash	—			—			523			—			523
Net change in cash and cash equivalents	3,061			(3,723		)	7,541			—			6,879
Cash and cash equivalents at beginning of period	3,135			14,574			55,033			—			72,742
Cash and cash equivalents at end of period	$	6,196		$	10,851		$	62,574		$	—		$	79,621

27

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis provides information which management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. The discussion should be read in conjunction with the consolidated financial statements and notes thereto contained in Part 1,Item 1 of this report. It should be noted that our gross profit margins may not be comparable to other companies since some entities classify shipping and handling costs in cost of goods sold and others, including us, include such costs in selling, general and administrative expenses. Similarly, some entities, including us, include foreign currency gains and losses resulting from operating activities as a component of operating income, and some entities classify all foreign currency gains and losses outside of operating income.

The terms "Polymer Group," " PGI," "the Company," "we," "us," and "our" and similar terms in this report refer to Polymer Group, Inc. and its consolidated subsidiaries. The term "Parent" as used within this report refers to Scorpio Acquisition Corporation, a Delaware corporation that owns 100% of the issued and outstanding capital stock of Polymer Group, Inc. The term "Holdings" as used within this report refers to Scorpio Holdings Corporation, a Delaware corporation that owns 100% of the Parent.

Our Overview

We are a leading global innovator, manufacturer and marketer of engineered materials, focused primarily on the production of nonwoven products. Nonwovens are a high-performance and low-cost fabric-like alternative to traditional textiles, paper and other materials. They can be made with specific value-added characteristics including absorbency, tensile strength, softness and barrier properties, among others. Our nonwoven products are critical components used in consumer and industrial products, including hygiene, healthcare, wipes and industrial applications. Primary applications in each of our target markets are as follows:

•Hygiene:    Baby diapers, feminine hygiene products and adult incontinence products

•Healthcare:    Single-use surgical gowns and drapes, hospital apparel and infection control supplies

•Wipes:        Household, personal care and commercial cleaning wipes

•Industrial:    Filtration, cable wrap, house wrap, furniture and bedding, agriculture, landscape, industrial

packaging and other specialty areas

We have one of the largest global platforms in the industry, with a total of thirteen manufacturing and converting facilities located in nine countries throughout the world, including a significant presence in Asia and Latin America. Our manufacturing facilities are strategically located near many of our key customers in order to increase our effectiveness in addressing local and regional demand, as many of our products do not ship economically over long distances. We work closely with our customers, which include well-established multinational and regional consumer and industrial product manufacturers, to provide engineered solutions to meet increasing demand for more sophisticated products. We believe that we have one of the broadest and most advanced technology portfolios in the industry, and most importantly, one that is based on modern, sustainable manufacturing practices.

On January 28, 2011, pursuant to an Agreement and Plan of Merger, dated as of October 4, 2010, we were acquired by affiliates of the Blackstone Group ("Blackstone"), along with certain members of our management (the "Merger"), for an aggregate purchase price valued at $403.5 million. As a result, we became a privately-held company. The Merger was financed by $560.0 million in aggregate principal of debt financing as well as common equity capital. In addition, we repaid our existing outstanding debt.

Our Industry

We compete primarily in the global nonwovens market, which management estimates to have exceeded $25 billion in 2012. Nonwovens are broadly defined as engineered sheet or web structures, made from polymers and/or natural fibers, that are bonded together by entangling fiber or filaments mechanically, thermally or chemically. They are flat sheets that are made directly from separate fibers or from molten plastic or plastic film. By definition, they are not made by weaving or knitting and do not require converting the fibers to yarn.

Nonwovens can be created through several different manufacturing techniques. Principal technologies utilized in the industry today include:

• Spunmelt technology uses thermoplastic polymers that are melt-spun to manufacture continuous-filament fabrics.

28

• Carded technologies (chemical, thermal and spunlace) involve fibers laid on a conveyor belt, teased apart and consolidated into a web and then bonded with chemical adhesive, heat or high pressure water, respectively.

• Air-laid technology uses high-velocity air to condense fibers.

• Wet-laid technology drains fibers through a wire screen similar to papermaking.

The global nonwovens market has historically experienced stable growth and favorable pricing dynamics. However, since late 2010, several of our competitors announced an intent to install or installed additional capacity in excess of what we believe to be current market demand in the regions where we conduct business; specifically in the Americas, Europe and Asia. As additional nonwovens manufacturing capacity entered into commercial production, in excess of market demand, the short-term to mid-term excess supply created unfavorable market dynamics, resulting in a downward pressure on selling prices. As we look forward, we will be challenged by the fact that new nonwovens manufacturing capacity has either entered or will enter the regional markets in which we conduct business. As a result, we have taken a number of actions to refocus our global footprint and optimize our operations around disposable applications and high-growth markets.

Going forward, we believe the global nonwovens market will continue to be driven by:

• Increase in global demand for disposable products driven by the increase in sanitary standards;

• Increase in performance standards such as barrier properties, strength, softness and other attributes;

• Global economic development coupled with the development of new nonwoven applications and technologies; and

• Shift to materials and technology that deliver a lower total cost of use.

Our current global footprint, coupled with our access to capital, enables us to continue to realize cost synergies and greater growth from our core operations. In addition, we are investing in technology and new initiatives which we expect to help fuel our future growth. As a result, despite the current market environment, we believe we are well positioned to remain competitive within our markets as well as leverage our solid foundation across the company to drive future growth.

Recent Developments

On March 22, 2013, a wholly-owned subsidiary of the Company entered into an amendment to an existing Equipment Lease Agreement (the "Agreement') associated with our state-of-the-art spunmelt line in Waynesboro, Virginia, which commenced commercial production in the third quarter of 2011. The line was principally funded by a seven year equipment lease with a capitalized cost of $53.6 million. The amendment (i) amends the Total Leverage Ratio covenant in the Agreement to extend by one year each of the time periods in which the required Total Leverage Ratio “steps down” to a more restrictive ratio, (ii) amends the definition of Total Debt, which is used in the calculation of Total Leverage Ratio, to provide for the subtraction of the total amount of unrestricted cash from the aggregate principal amount of all indebtedness when calculating Total Debt, and (iii) removes our option to purchase the equipment on the second anniversary of the commencement date.

Results of Operations

We operate our business in four segments: Americas Nonwovens, Europe Nonwovens, Asia Nonwovens (collectively, the “Nonwovens Segments”) and Oriented Polymers. This reflects how the overall business is currently managed by our senior management and reviewed by the Board of Directors.

Gross Profit Drivers

Our net sales are driven principally by the following factors:

• Volumes sold, which are tied to our available production capacity and customer demand for our products;

• Prices, which are tied to the quality of our products, the overall supply and demand dynamics in our regional markets, and the cost of our raw material inputs, as changes in input costs have historically been passed through to customers through either contractual mechanisms or business practices. This can result in significant increases in total net sales during periods of sustained raw material cost increases as well as significant declines in net sales during periods of raw material cost declines; and

• Product mix, which is tied to demand from various markets and customers, along with the type of available capacity and technological capabilities of our facilities and equipment. Average selling prices can vary for different product types, which impacts our total revenue trends.

29

Our primary costs of goods sold (“COGS”) include:

• Raw material costs (primarily polypropylene resins, which generally comprise over 75% of our raw material purchases) represent approximately 60% to 70% of COGS. We purchase raw materials, including polypropylene resins, from a number of qualified vendors located in the regions in which we operate. Polypropylene is a petroleum-based commodity material and its price historically has exhibited volatility. As discussed in the revenue factors above, we have historically been able to mitigate volatility in polypropylene prices through changes in our selling prices to customers, enabling us to maintain a more stable gross profit per kilogram;

• Other variable costs include utilities (primarily electricity), direct labor, and variable overhead. Utility rates vary depending on the regional market and provider. In Asia, we have experienced a trend of increasing utility rates that we do not expect to stabilize in the near-term. Our focus on operating efficiencies and initiatives associated with sustainability has resulted in a general trend of lower kilowatts used per ton produced over the last three years. Labor generally represents less than 10% of COGS and varies by region. Historically, we have been able to mitigate wage rate inflation with operating initiatives resulting in higher productivity and improvements in throughput and yield; and

• Fixed overhead consists primarily of depreciation expense, which is impacted by our level of capital investments and structural costs related to our locations. We believe our strategically located manufacturing facilities provide sufficient scale to maintain competitive unit manufacturing costs.

The level of our revenue and COGS vary due to changes in raw material cost. As a result, our gross profit margin as a percent of net sales can vary significantly from period to period. As such, we believe total gross profit provides a clearer representation of our operating trends. Changes in raw material costs historically have not resulted in a significant sustained impact on gross profit, as we have been able to effectively mitigate changes in raw material costs through changes in our selling prices to customers in order to maintain a more steady gross profit per kilogram sold. However, we are exposed to short-term changes in raw material cost, which can have an impact on our gross profit.

In addition, our sales are impacted by our selling prices, which is influenced by the cost of our raw material inputs. Historically, changes in input costs have been passed through to customers either by contractual mechanisms or business practices. This can result in significant increases in total net sales during periods of sustained raw material cost increases as well as significant declines in net sales during periods of raw material cost declines. As a result, financial statement items that use percentage of net sales as an economic indicator are influenced by the changes in our selling prices. In general, average prices for polypropylene resin and other raw material costs modestly trended downward throughout 2012. However, we have seen significant increases during the first three months of 2013 and expect the trend to continue through mid-year.

Three Months Ended March 30, 2013 Compared to the Three Months Ended March 31, 2012

The following table sets forth the period change for each category of the Statement of Operations for the three months ended March 30, 2013 as compared to the three months ended March 31, 2012, as well as each category as a percentage of net sales:

30

										Percentage of Net Sales for the Respective Period End
In thousands	Three Months Ended March 31, 2013			Three Months Ended March 31, 2012			Period Change Favorable (Unfavorable)			March 31, 2013		March 31, 2012
Net sales	$	287,082		$	295,171		$	(8,089	)	100.0	%	100.0	%
Cost of goods sold:
Raw materials	(157,661		)	(158,857		)	1,196			54.9	%	53.8	%
Labor	(18,933		)	(19,534		)	601			6.6	%	6.6	%
Overhead	(64,622		)	(63,593		)	(1,029		)	22.5	%	21.5	%
Gross profit	45,866			53,187			(7,321		)	16.0	%	18.0	%
Selling, general and administrative expenses	(34,342		)	(34,131		)	(211		)	12.0	%	11.6	%
Special charges, net	(1,804		)	(2,419		)	615			0.6	%	0.8	%
Other operating, net	(340		)	361			(701		)	0.1	%	(0.1	)%
Operating income (loss)	9,380			16,998			(7,618		)	3.3	%	5.8	%
Other income (expense):
Interest expense	(12,084		)	(12,848		)	764			4.2	%	4.4	%
Foreign currency and other, net	(1,420		)	62			(1,482		)	0.5	%	—	%
Income (loss) before income taxes	(4,124		)	4,212			(8,336		)	(1.4	)%	1.4	%
Income tax (provision) benefit	(2,103		)	(4,477		)	2,374			0.7	%	1.5	%
Income (loss) from continuing operations	(6,227		)	(265		)	(5,962		)	(2.2	)%	(0.1	)%
Discontinued operations, net	—			—			—			—	%	—	%
Net income (loss)	(6,227		)	(265		)	(5,962		)	(2.2	)%	(0.1	)%
Less: Earnings attributable to noncontrolling interests	—			—			—			—	%	—	%
Net income (loss) attributable to Polymer Group, Inc	$	(6,227	)	$	(265	)	$	(5,962	)	(2.2	)%	(0.1	)%

Net Sales

Net sales for the three months ended March 30, 2013 were $287.1 million, a $8.1 million decrease compared with the three months ended March 31, 2012. A reconciliation presenting the components of the period change by each of our operating divisions is as follows:

	Nonwovens										Oriented Polymers			Total
In millions	Americas			Europe		Asia		Total
Beginning of period	$	165.9		$	75.7	$	36.4	$	278.0		$	17.2		$	295.2
Changes due to:
Volume	(5.4		)	1.1		1.3		(3.0		)	1.0			(2.0		)
Price/product mix	(7.5		)	1.0		0.2		(6.3		)	(0.3		)	(6.6		)
Currency translation	—			0.5		0.1		0.6			(0.1		)	0.5
Sub-total	(12.9		)	2.6		1.6		(8.7		)	0.6			(8.1		)
End of period	$	153.0		$	78.3	$	38.0	$	269.3		$	17.8		$	287.1

Nonwovens Segments:

Net sales for the three months ended March 30, 2013 were $269.3 million, a $8.7 million decrease compared with the three months ended March 31, 2012. The decrease in net sales was primarily driven by lower net selling prices of $7.5 million in the Americas. The pricing decrease, a result of raw material trends and a competitive pricing environment, was partially offset by higher net selling prices in Europe and Asia. Combined, these regions provided incremental growth of $1.2 million, which resulted from our passing through higher raw material costs associated with index-based selling agreements and market-based pricing trends. In addition, favorable foreign currency impacts of $0.6 million resulted in the higher translation of sales generated in foreign jurisdictions, particularly in Europe and Asia.

31

For the three months ended March 30, 2013, volumes decreased by $3.0 million compared with the three months ended March 31, 2012. The decrease in volume was primarily driven by reductions in the Americas, particularly in Latin America, a result of a competitive pricing environment in certain markets. However, the volume reduction was partially offset by increased sales of industrial and wipe products in the Americas as demand increased with the overall markets. In addition, incremental growth of $1.3 million in Asia was primarily driven by higher volumes sold in the Hygiene markets as well as Healthcare product sales from the new spunmelt line installed in 2011. Higher volumes in Europe of $1.1 million were due to the stabilization of underlying demand in our industrial markets as well as additional volume for consumer disposables, particularly wipes.

Oriented Polymers

Net sales for the three months ended March 30, 2013 were $17.8 million, a $0.6 million increase compared with the three months ended March 31, 2012. The increase was primarily driven by an increase in volume attributable to higher demand in the building products market, offset in part by lower demand in the industrial packaging and agriculture markets. However, the volume increase was partially offset by lower net selling prices of $0.3 million, which resulted from our passing through lower raw material cost associated with index-based selling agreements and market-based pricing trends. In addition, unfavorable foreign currency impacts of $0.1 million resulted in lower translation of sales generated in foreign jurisdictions.

Gross Profit

Gross profit for the three months ended March 30, 2013 was $45.9 million, a $7.3 million decrease compared with the three months ended March 31, 2012. As a result, gross profit as a percentage of sales decreased to 16.0% from 18.0%. The decrease in gross margin was primarily driven by lower net selling prices, the result of raw material trends and a competitive pricing environment in the Americas. In addition, our higher overall cost for the raw materials of resin and fibers, especially polypropylene resin, contributed to the decrease. As a percentage of net sales, the raw material component of cost of goods sold increased to 54.9% from 53.8%. Our overhead component increased by $1.0 million primarily associated with volume-related manufacturing inefficiencies, particularly in the Americas. As a percentage of net sales, our overhead component increased to 22.5% from 21.5%. The decrease in gross profit was partially offset by our labor component of cost of goods sold which reflects the positive benefits of our plant consolidation activity in the U.S. implemented during 2012. For the three months ended March 31, 2013, our labor component decreased $0.6 million compared with the three months ended March 31, 2012. As a percentage of net sales, labor remained at 6.6% for each respective period.

Operating Income

Operating income for the three months ended March 30, 2013 was $9.4 million, a $7.6 million decrease compared with the three months ended March 31, 2012. A reconciliation presenting the components of the period change by each of our operating divisions is as follows:

	Nonwovens
In millions	Americas			Europe			Asia			Total			Oriented Polymers			Corporate/ Other			Total
Beginning of period	$	19.3		$	3.6		$	4.0		$	26.9		$	1.7		$	(11.6	)	$	17.0
Changes due to:
Volume	(1.4		)	1.2			0.3			0.1			0.2			—			0.3
Price/product mix	(7.5		)	0.5			0.2			(6.8		)	(0.3		)	—			(7.1		)
Raw material cost	0.3			(1.0		)	(0.7		)	(1.4		)	0.7			(0.1		)	(0.8		)
Manufacturing costs	0.7			(0.1		)	0.9			1.5			(0.8		)	—			0.7
Currency translation	0.3			—			—			0.3			—			—			0.3
Depreciation and amortization	—			(0.3		)	(0.1		)	(0.4		)	—			—			(0.4		)
Special charges	—			—			—			—			—			0.6			0.6
All other	(0.2		)	(0.6		)	(0.1		)	(0.9		)	0.1			(0.4		)	(1.2		)
Sub-total	(7.8		)	(0.3		)	0.5			(7.6		)	(0.1		)	0.1			(7.6		)
End of period	$	11.5		$	3.3		$	4.5		$	19.3		$	1.6		$	(11.5	)	$	9.4

The amounts for acquisition and integration expenses as well as special charges have not been allocated to our reportable business divisions because our management does not evaluate such charges on a division-by-division basis. Division operating performance is measured and evaluated before such items.

32

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 30, 2013 were $34.3 million, a $0.2 million increase compared with the three months ended March 31, 2012. The increase in selling, general and administrative expenses was primarily driven by a $1.5 million increase in shipping and handling costs as activity between regions increased with the ramp up of certain new products. Other factors contributing to the increase included $0.5 million associated with our our utilization of a third-party provider for information system support as well as $0.4 million associated with the reimbursement of out-of-pocket expenses in connection with our management services agreement with Blackstone. These amounts were partially offset by cost reduction initiatives implemented during 2012 which reduced employee-related expenses such as salaries, benefits, short-term incentive compensation, travel and severance. Combined, these reductions totaled $1.4 million. Other reductions included $0.6 million related to research and development and $0.2 million related to favorable changes in foreign currency rates. As a result, selling, general and administrative expenses as a percentage of net sales increased to 12.0% for the three months ended March 30, 2013 from 11.6% for the three months ended March 31, 2012.

Special Charges, net

As part of our business strategy, we incur costs related to corporate-level decisions or Board of Director actions. These actions are primarily associated with initiatives attributable to restructuring and realignment of manufacturing operations and management structures as well as the pursuit of certain transaction opportunities when applicable. In addition, we evaluate our long-lived assets for impairment whenever events or changes in circumstances including the aforementioned, indicate that the carrying amounts may not be recoverable.

Special charges for the three months ended March 30, 2013 were $1.8 million and consisted of the following components:

• $1.5 million related to cost associated with our internal redesign and restructuring of global operations initiatives

• $0.1 million related to separation and severance expenses associated with our plant realignment cost initiatives

• $0.2 million related to other corporate initiatives

Special charges for the three months ended March 31, 2012 were $2.4 million and consisted of the following components:

• $0.7 million related to cost associated with our internal redesign and restructuring of global operations initiatives

• $0.7 million related to separation and severance expenses associated with our plant realignment cost initiatives

• $0.3 million related to separation and severance expenses associated with our IS support initiative

• $0.4 million related to professional fees and other transaction costs associated with the Merger

• $0.3 million related to other corporate initiatives

The amounts included in Special charges, net have not been allocated to our reportable business divisions because our management does not evaluate such charges on a division-by-division basis. Division operating performance is measured and evaluated before such items.

Other Operating, net

Other operating expense for the three months ended March 30, 2013 was $0.3 million. Amounts associated with foreign currency losses on operating assets and liabilities totaled $0.4 million. These losses were partially offset by $0.1 million of other operating income. For the three months ended March 31, 2012, other operating income totaled $0.4 million, all of which was associated with foreign currency gains.

Other Income (Expense)

Interest expense for the three months ended March 30, 2013 was $12.1 million, a $0.7 million decrease compared to the three months ended March 31, 2012. Average outstanding debt levels and weighted-average interest rates have been consistent over each of the respective periods, however, amounts associated with capitalized interest increased by $0.5 million.

Foreign currency and other, net for the three months ended March 30, 2013 was an expense of $1.4 million. Amounts associated with foreign currency losses on non-operating assets and liabilities totaled $1.0 million. In addition, we incurred $0.4 million of other non-operating expenses. For the three months ended March 31, 2012, other operating income totaled $0.1 million, primarily associated with $0.3 million foreign currency gains on non-operating assets and liabilities. These amounts were partially offset by other non-operating expenses.

Income Tax (Provision) Benefit

33

During the three months ended March 30, 2013, we recognized income tax provision of $2.1 million on consolidated pre-tax book loss from continuing operations of $4.1 million. The combination of our income tax provision and our recorded loss from operations before income taxes resulted in a negative 51.0% effective tax rate for the period. During the three months ended March 31, 2012, we recognized an income tax provision of $4.5 million on consolidated pre-tax book income from continuing operations of $4.2 million. Our income tax expense in 2013 and 2012 is different than such expense determined at the U.S. federal statutory rate due to losses in certain jurisdictions for which no income tax benefits are anticipated, foreign withholding taxes for which tax credits are not anticipated, changes in the amounts recorded for tax uncertainties, foreign taxes calculated at statutory rates different than the U.S. federal statutory rate, and the application of intraperiod tax allocation rules.

Liquidity and Capital Resources

The following table contains several key indicators to measure our financial condition and liquidity:

In millions	March 30, 2013			December 29, 2012
Balance Sheet Data:
Cash and cash equivalents	$	74.6		$	97.9
Operating working capital	43.6			29.6
Total assets	1,013.6			1,022.1
Total debt	606.1			599.7
Total shareholders’ equity	129.5			139.2
Debt-to-total capital	82.4		%	81.2		%

We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities. In doing so, we review and analyze our current cash on hand, the number of days our sales are outstanding, inventory turns, capital expenditure commitments and income tax rates. Our cash requirements primarily consist of the following:

•Debt service requirements

•Funding of working capital

•Funding of capital expenditures

Our primary sources of liquidity include cash balances on hand, cash flows from operations, cash inflows from the sale of certain accounts receivables through our factoring arrangements and borrowing availability under our existing credit facilities and our ABL facility. We expect our cash on hand and cash flow from operations (which may fluctuate due to short-term operational requirements), combined with the current borrowing availability under our existing credit facilities and our ABL Facility, to provide sufficient liquidity to fund our current obligations, projected working capital requirements and capital spending during the next twelve month period and our ongoing operations, projected working capital requirements and capital spending during the foreseeable future.

On January 28, 2011, pursuant to an Agreement and Plan of Merger, dated as of October 4, 2010, we were acquired by affiliates of Blackstone along with certain members of the Company's management for an aggregate purchase price of $403.5 million. As a result, we are significantly leveraged. Accordingly, our liquidity requirements are significant, primarily due to our debt service requirements. As of March 30, 2013, our total indebtedness was $606.1 million with a debt-to-capital ratio of 82.4%. Cash interest payments for the three months ended March 30, 2013 and March 31, 2012 amounted to $22.3 million and $23.5 million, respectively. As of March 30, 2013, we had an additional $18.6 million of availability under our ABL Facility. The availability under our ABL Facility is determined in accordance with a borrowing base which can decline due to various factors. Therefore, amounts under our ABL Facility may not be available when we need them.

We currently have multiple intercompany loan agreements, and in certain circumstances, management services agreements in place that allow us to repatriate foreign subsidiary cash balances to the U.S. without being subject to significant amounts of either foreign jurisdiction withholding taxes or adverse U.S. taxation. In addition, our U.S. legal entities have royalty arrangements, associated with our foreign subsidiaries’ use of U.S. legal entities intellectual property rights that allow us to repatriate foreign subsidiary cash balances, subject to foreign jurisdiction withholding tax requirements, ranging from 5% to 10%. Should we decide to permanently repatriate foreign jurisdiction earnings by means of a dividend, the repatriated cash would be subject to foreign jurisdiction withholding tax requirements, ranging from 5% to 10%. We believe that any such dividend activity and the related tax effect would not be material.

At March 30, 2013, we had $74.6 million of cash and cash equivalents on hand, of which $55.3 million was held by our subsidiaries outside of the U.S., the majority of which was available for repatriation through various intercompany arrangements.

34

In addition, our U.S. legal entities in the past have also borrowed cash, on a temporary basis, from our foreign subsidiaries to meet U.S. obligations via short-term intercompany loans. Our U.S. legal entities may in the future borrow from our foreign subsidiaries.

Our liquidity and our ability to fund our capital requirements is dependent on our future financial performance, which is subject to general economic, financial and other factors that are beyond our control and many of which are described under "Item 1A - Risk Factors" in our most recently filed Annual Report on Form 10-K. If those factors significantly change or other unexpected factors adversely affect us, our business may not generate sufficient cash flow from operations or we may not be able to obtain future financings to meet our liquidity needs. We anticipate that to the extent additional liquidity is necessary to fund our operations, it would be funded through borrowings under our ABL Facility, incurring other indebtedness, additional equity financings or a combination of these potential sources of liquidity. We may not be able to obtain this additional liquidity on terms acceptable to us or at all.

Cash Flows

The following table sets forth the major categories of cash flows:

In millions	Three Months Ended March 30, 2013			Three months Ended March 31, 2012
Cash Flow Data:
Net cash provided by (used in) operating activities	$	(14.7	)	$	19.6
Net cash provided by (used in) investing activities	(14.4		)	(11.7		)
Net cash provided by (used in) financing activities	6.4			(1.5		)
Total	$	(22.7	)	$	6.4

Operating Activities

Net cash used in operating activities for the three months ended March 30, 2013 was $14.7 million, of which working capital requirements used $23.0 million. The primary driver of the outflow related to a $9.9 million increase in accounts receivable, which resulted from our passing through higher raw material costs associated with index-based selling agreements and market-based pricing trends. At March 30, 2013, days sales outstanding was 44 days. Other current assets increased $6.4 million primarily due to the timing of prepaid items as well as the timing of payments from our factoring agents. In addition, inventory increased $3.2 million, primarily a result of the higher overall purchase price of raw materials. At March 30, 2013, inventory on hand was 37 days. Accounts payable and accruals decreased, which resulted in an outflow of $3.6 million. The decrease was primarily driven by the payment of interest on our Senior Secured Notes which was due during the current period. However, this amount was partially offset by the increase in trade accounts payable which was primarily driven by the timing of vendor purchases. As a result, accounts payable days was 73 days at March 30, 2013.

Net cash provided by operating activities for the three months ended March 31, 2012 was $19.6 million, of which $0.9 million was generated by changes in working capital. The primary driver of the inflow related to the reduction in inventory during the year due to the lower overall purchase price of raw materials and increased volumes sold during the period. The $5.8 million impact on net cash provided by operating activities reduced inventory on hand to 37 days at March 31, 2012 from 39 days at December 31, 2011. Accounts receivable provided $0.4 million during the three months ended March 31, 2012, keeping days sales outstanding at 44 days. These amounts were partially offset by an increase in other current assets and a decrease in accounts payable and accrued liabilities, which reduced cash provided by operating activities by $2.9 million and $2.4 million, respectively. The increase in other current assets was driven by our prepaid expense balances as well as the timing of payments from factoring agents. The reduction on our accounts payable and accrued liabilities was driven by the payment of interest on our Senior Secured Notes partially offset by higher prices paid for raw materials. Accounts payable days was 70 days at March 31, 2012.

As sales volume and raw material costs vary, inventory and accounts receivable balances are expected to rise and fall accordingly, which in turn, result in changes in our levels of working capital and cash flows going forward. In addition, we review our business on an ongoing basis relative to current and expected market conditions, attempting to match our production capacity and cost structure to the demands of the markets in which we participate, and strive to continuously streamline our manufacturing operations consistent with world-class standards. Accordingly, in the future we may decide to undertake certain restructuring efforts to improve our competitive position. To the extent further decisions are made to restructure our business, such actions could result in cash restructuring charges and asset impairment charges, which could be material. Cash tax payments are significantly influenced by, among other things, actual operating results in each of our tax jurisdictions, changes in tax law, changes in our tax structure and any resolutions of uncertain tax positions.

Investing Activities

35

Net cash used in investing activities for the three months ended March 30, 2013 was $14.4 million. The primary driver related to $14.3 million of property, plant and equipment expenditures associated with our manufacturing expansion project in China. In addition, other items included in our capital expenditures relates to machinery and equipment upgrades that extend the useful life and/or increased the functionality of the asset.

Net cash used in investing activities for the three months ended March 31, 2012 was $11.7 million. The primary driver related to $13.3 million of property, plant and equipment expenditures associated with our manufacturing expansion project in China. In addition, other items included in our capital expenditures relates to machinery and equipment upgrades that extend the useful life and/or increased the functionality of the asset. These amounts were partially offset by $1.7 million of proceeds recognized in the first quarter of 2012 associated with the sale of a former manufacturing facility in North Little Rock, Arkansas.

Financing Activities

Net cash provided by financing activities for the three months ended March 30, 2013 was $6.4 million. Proceeds from borrowings totaled $8.1 million and primarily related to our credit facility in China funding our manufacturing expansion project in China. Other proceeds were related to short-term facilities. These amounts were partially offset by repayments of $1.7 million.

Net cash used in financing activities for the three months ended March 31, 2012 was $1.5 million. Proceeds from borrowings totaled $1.5 million and primarily related to short-term credit facilities used to finance insurance premium payments. These amounts were more than offset by repayments of $3.0 million, of which $2.1 million related to short-term borrowing.

Indebtedness

The following table summarizes our outstanding debt at March 30, 2013:

In thousands	Matures	Interest Rate	Outstanding Balance
Senior Secured Notes	2019	7.75%	$	560,000
ABL Facility	2016	—	—
Argentine Facility	2016	3.19%	10,842
China credit facilities:
China Credit Facility — Healthcare	2013	5.42%	15,981
China Credit Facility — Hygiene	2015	5.48%	17,642
Capital lease obligations	2013 - 2014	3.20%	197
Total debt			604,662
Less: Current maturities	2013	2.46%	(21,463		)
Total long-term debt			$	583,199

Senior Secured Notes

In connection with the Merger, we issued $560.0 million of 7.75% Senior Secured Notes on January 28, 2011. The notes are due in 2019 and are fully and unconditionally guaranteed, jointly and severally on a senior secured basis, by each of the Polymer Group's wholly-owned domestic subsidiaries. Interest on the notes is paid semi-annually on February 1 and August 1.

The agreement governing the Senior Secured Notes, among other restrictions, limits our ability and the ability of our restricted subsidiaries to: (i) incur or guarantee additional debt or issue disqualified stock or preferred stock; (ii) pay dividends and make other distributions on, or redeem or repurchase, capital stock; (iii) make certain investments; (iv) repurchase stock; (v) incur certain liens; (vi) enter into transactions with affiliates; (vii) merge or consolidate; (viii) enter into agreements that restrict the ability of subsidiaries to make dividends or other payments to Polymer Group, Inc.; (ix) designate restricted subsidiaries as unrestricted subsidiaries; and (x) transfer or sell assets. However, subject to certain exceptions, the indenture permits us and our restricted subsidiaries to incur additional indebtedness, including senior indebtedness and secured indebtedness. The indenture also does not limit the amount of additional indebtedness that Parent or its parent entities may incur.

Under the agreement governing the Senior Secured Notes and under the credit agreement governing the senior secured asset-based revolving credit facility, our ability to engage in activities such as incurring additional indebtedness, making investments, refinancing certain indebtedness, paying dividends and entering into certain merger transactions is governed, in part, by our ability to satisfy tests based on Adjusted EBITDA as defined in the indenture.

ABL Facility

36

In connection with the Merger, we entered into a senior secured asset-based revolving credit facility (the "ABL Facility") to provide for borrowings not to exceed $50.0 million, subject to borrowing base availability. The ABL Facility provides borrowing capacity available for letters of credit and borrowings on a same-day basis. The ABL Facility is comprised of (i) a revolving tranche of up to $42.5 million (“Tranche 1”) and (ii) a first-in, last out revolving tranche of up to $7.5 million (“Tranche 2”). Provided that no default or event of default was then existing or would arise therefrom, we had the option to request that the ABL Facility be increased by an amount not to exceed $20.0 million, subject to certain rights of the administrative agent, swing line lender and issuing banks with respect to the lenders providing commitments for such increase. The facility was set to expire on January 28, 2015.

On October 5, 2012, we entered into an amended and restated ABL Facility. The amended and restated facility extended the maturity date to October 5, 2016 as well as made certain pricing and other changes to the original agreement. We maintain the option to request that the ABL Facility be increased by an amount not to exceed $20.0 million, subject to certain rights of the administrative agent, swing line lender and issuing banks with respect to the lenders providing commitments for such increase. As of March 30, 2013, we had no outstanding borrowings under the ABL Facility. Borrowing base availability was $29.6 million, however, outstanding letters of credit in the aggregate amount of $11.0 million left $18.6 million available for additional borrowings. The aforementioned letters of credit were primarily provided to certain administrative service providers and financial institutions. None of these letters of credit had been drawn on as of March 30, 2013.

Based on current borrowing base availability, the borrowings under the ABL Facility will bear interest at a rate per annum equal to, at our option, either (A) Adjusted London Interbank Offered Rate (“LIBOR”) (adjusted for statutory reserve requirements) plus (i) 2.00% in the case of Tranche 1 or (ii) 4.00% in the case of Tranche 2; or (B) the higher of (a) the administrative agent's Prime Rate and (b) the federal funds effective rate plus 0.5% (“ABR”) plus (x) 1.00% in the case of Tranche 1 or (y) 3.00% in the case of the Tranche 2.

The ABL Facility contains certain customary representations and warranties, affirmative covenants and events of default, including among other things payment defaults, breach of representations and warranties, covenant defaults, cross-defaults and cross acceleration to certain indebtedness, bankruptcy and insolvency defaults, certain events under ERISA, certain monetary judgment defaults, invalidity of guarantees or security interests, and change of control. If such an event of default occurs, the lenders under the ABL Facility would be entitled to take various actions, including the acceleration of amounts due under the ABL Facility and all actions permitted to be taken by a secured creditor.

Argentine Facility

In January 2007, our subsidiary in Argentina entered into an arrangement with banking institutions in Argentina in order to finance the installation of a new spunmelt line at its facility near Buenos Aires, Argentina. The maximum borrowings available under the facility, excluding any interest added to principal, were 33.5 million Argentine pesos with respect to an Argentine peso-denominated loan and $26.5 million with respect to a U.S. dollar-denominated loan. The loans are secured by pledges covering (i) the subsidiary's existing equipment lines; (ii) the outstanding stock of the subsidiary; and (iii) the new machinery and equipment being purchased, as well as a trust assignment agreement related to a portion of receivables due from certain major customers of the subsidiary.

The interest rate applicable to borrowings under these term loans is based on LIBOR plus 290 basis points for the U.S. dollar-denominated loan and Buenos Aires Interbanking Offered Rate plus 475 basis points for the Argentine peso-denominated loan. Principal and interest payments began in July 2008 with the loans maturing as follows: annual amounts of $3.5 million beginning in 2011 and continuing through 2015, and the remaining $1.7 million in 2016.

In connection with the Merger, we repaid and terminated the Argentine peso-denominated loans. In addition, the U.S. denominated loan was adjusted to reflect its fair value as of the date of the Merger. As a result, we recorded a contra-liability in Long-term debt and will amortize the balance over the remaining life of the facility. At March 30, 2013, the face amount of the outstanding indebtedness under the U.S. dollar-denominated loan was $11.2 million, with a carrying amount of $10.8 million and a weighted average interest rate of 3.19%.

China Credit Facility — Healthcare

In the third quarter of 2010, our subsidiary in China entered into a three-year U.S. dollar denominated construction loan agreement (the “Healthcare Facility”) with a banking institution in China to finance a portion of the installation of the new spunmelt line at its manufacturing facility in Suzhou, China. The three-year term of the agreement began with the date of the first draw down on the Healthcare Facility, which occurred in fourth quarter of 2010. The interest rate applicable to borrowings is based on three-month LIBOR plus an amount to be determined at the time of funding based on the lender's internal head office lending rate (400 basis points at the time the credit agreement was executed), but in no event would the interest rate be less than 1-year LIBOR plus 250 points.

37

The maximum borrowings available under the facility, excluding any interest added to principal, were $20.0 million. We repaid $4.0 million of the principle balance in the fourth quarter of 2012. As a result, the outstanding balance under the Healthcare Facility was $16.0 million at December 29, 2012, with a weighted average interest rate of 5.44%. As of March 30, 2013, the outstanding balance under the Healthcare Facility was $16.0 million with a weighted-average interest rate of 5.42%. The outstanding balance is scheduled to be repaid during 2013 using a combination of existing cash balances and cash generated from operations.

China Credit Facility — Hygiene

On July 1, 2012, our subsidiary in China entered into a three-year U.S. dollar denominated construction loan agreement (the “Hygiene Facility”) with a banking institution in China to finance a portion of the installation of a new spunmelt line at its manufacturing facility in Suzhou, China. The interest rate applicable to borrowings under the Hygiene Facility is based on three-month LIBOR plus an amount to be determined at the time of funding based on the lender's internal head office lending rate (520 basis points at the time the credit agreement was executed).

The maximum borrowings available under the facility, excluding any interest added to principal, were $25.0 million. At December 29, 2012, the outstanding balance under the Hygiene Facility was $11.0 million with a weighted average interest rate of 5.51%. As of March 30, 2013, the outstanding balance under the Hygiene Facility was $17.6 million with a weighted-average interest rate of 5.48%. In addition, we had $9.4 million of outstanding letters of credit that expired during the three months ended March 30, 2013. Our first payment on the outstanding principal is due in late 2013.

Other Subsidiary Indebtedness

We periodically enter into short-term credit facilities in order to finance various liquidity requirements. At March 30, 2013, outstanding amounts related to such facilities were $1.4 million, which are being used to finance insurance premium payments. The weighted average interest rate on these borrowings was 2.44%. At December 29, 2012, amounts outstanding under these facilities were $0.8 million at a weighted average interest rate of 2.46%. Borrowings are included in Short-term borrowings in the Consolidated Balance Sheets.

We also have documentary letters of credit not associated with the ABL Facility, Healthcare Facility or the Hygiene Facility. These letters of credit were primarily provided to certain raw material vendors and amounted to $5.9 and $6.9 million at March 30, 2013 and December 29, 2012, respectively. None of these letters of credit have been drawn on.

Factoring Agreements

In the ordinary course of business, we may utilize accounts receivable factoring arrangements with third-party financial institutions in order to accelerate its cash collections from product sales. These arrangements involve the ownership transfer of eligible U.S. and non-U.S. trade accounts receivable, without recourse or discount, to a third party financial institution in exchange for cash. The maximum amount of outstanding advances at any one time is $20.0 million under the U.S. based program and $49.7 million under the non-U.S. based program. At March 30, 2013, the net amount of trade accounts receivable sold to third-party financial institutions, and therefore excluded from our accounts receivable balance, was $54.8 million. Amounts due from the third-party financial institutions were $7.5 million at March 30, 2013. Factoring of our trade accounts receivable improves our cash conversion cycle. If we were to discontinue the use of these arrangements or if the amounts of receivables sold under these programs fluctuates significantly, we may experience short-term variability in our cash conversion cycle.

Covenant Compliance

We report our financial results in accordance with Generally Accepted Accounting Principles in the United States (“GAAP”). In addition, we present Adjusted EBITDA as a supplemental financial measure in order to provide a more complete understanding of the factors and trends affecting our business. Adjusted EBITDA is a non-GAAP financial measure that should be considered supplemental to, not a substitute for or superior to, the financial measure calculated in accordance with GAAP. It has limitations in that it does not reflect all of the costs associated with the operations of our business as determined in accordance with GAAP. In addition, this measure may not be comparable to non-GAAP financial measures reported by other companies. We believe that Adjusted EBITDA provides important supplemental information to both management and investors regarding financial and business trends used in assessing our financial condition as well as provides additional information to investors about the calculation of, and compliance with, certain financial covenants in the agreement governing the Senior Secured Notes and in our ABL Facility. As a result, one should not consider Adjusted EBITDA in isolation or as a substitute for our results reported under GAAP. We compensate for these limitations by analyzing results on a GAAP basis as well as on a non-GAAP basis, predominantly disclosing GAAP results and providing reconciliations from GAAP results to non-GAAP results.

The following table shows a reconciliation of Adjusted EBITDA from the most directly comparable GAAP measure, Net income (loss) in order to show the differences in these measures of operating performance:

38

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Net income (loss)	$	(6,227	)	$	(265	)
Interest expense, net	12,084			12,848
Income and franchise tax	2,121			4,494
Depreciation & amortization (a)	15,545			15,167
Purchase accounting adjustments(b)	—			262
Non-cash compensation (c)	236			204
Special charges, net (d)	1,804			2,419
Foreign currency and other non-operating, net (e)	1,840			(422		)
Severance and relocation expenses (f)	245			767
Unusual or non-recurring charges, net	100			106
Business optimization expense (g)	50			420
Management, monitoring and advisory fees (h)	1,155			750
Adjusted EBITDA	$	28,953		$	36,750

(a) Excludes amortization of loan acquisition costs that are included in interest expense.

(b) Reflects fair market value adjustments as a result of purchase accounting associated with the Merger, primarily related to the step-up in inventory value.

(c) Reflects non-cash compensation costs related to employee and director restricted stock, restricted stock units and stock options.

(d) Reflects costs associated with non-cash asset impairment charges, the restructuring and realignment of manufacturing operations and management organizational structures, pursuit of certain transaction opportunities and other charges included in Special charges, net.

(e) Reflects (gains) losses from foreign currency translation of intercompany loans, unrealized (gains) losses on interest rate and foreign currency hedging transactions, (gains) losses on sales of assets outside the ordinary course of business, factoring costs and certain other non-operating (gains) losses recorded in Foreign Currency and Other, net as well as (gains) losses from foreign currency transactions recorded in Other Operating, net.

(f) Reflects severance and relocation expenses not included under Special charges, net.

(g) Reflects costs incurred to improve IT and accounting functions, costs associated with establishing new facilities and certain other expenses.

(h) Reflects management, monitoring and advisory fees paid under the Sponsor management agreement.

Off Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Recent Accounting Standards

In February 2013, the Financial Accounting Standards Board issued Accounting Standards Update No. 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income" ("ASU 2013-02"), which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, ASU 2013-02 requires an entity to present, either on the face of the income statement or in the notes to the financial statements, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under Generally Accepted Accounting Principles ("GAAP") to be reclassified to net income in its entirety in the same reporting period. For other amounts, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income in the financial statements. ASU 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012. The adoption of this guidance concerns disclosure only and did not have an impact on our financial results.

Critical Accounting Policies and Practices

Management’s Discussion and Analysis of Financial Condition and Results of Operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of financial statements in conformity with those accounting principles requires management to use judgment in making estimates and assumptions based on the relevant information available at the end of each period. These estimates and assumptions have a significant effect on reported amounts of assets and liabilities, revenue and expenses as well as the disclosure of contingent assets and liabilities because they result primarily from the need to make estimates and assumptions on matters that are inherently uncertain. Actual results may differ from estimates.

39

Management believes there have been no significant changes during the quarter ended March 30, 2013, to the items that we disclosed as our critical accounting policies and estimates in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 29, 2012.

CAUTIONARY STATEMENT FOR FORWARD LOOKING STATEMENTS

From time to time, we may publish forward-looking statements relative to matters, including, without limitation, anticipated financial performance, business prospects, technological developments, new product introductions, cost savings, research and development activities and similar matters. Forward-looking statements are generally accompanied by words such as “anticipate”, “believe”, “estimate”, “expect”, “forecast”, “intend”, “may”, “plans”, “predict”, “project”, “schedule”, “seeks”, “should”, “target” or other words that convey the uncertainty of future events or outcomes. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements.

Various statements contained in this report, including those that express a belief, expectation or intention, as well as those that are not statements of historical fact are, or may be deemed to be, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements speak only as of the date of this report.

These forward-looking statements are based on current expectations and assumptions about future events. Although management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control. There can be no assurance that these events will occur or that our results will be as anticipated. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements.

Important factors that could cause actual results to differ materially from those discussed in such forward-looking statements include, among other things:

• general economic factors including, but not limited to, changes in interest rates, foreign currency translation rates, consumer confidence, trends in disposable income, changes in consumer demand for goods produced, and cyclical or other downturns;

• cost and availability of raw materials, labor and natural and other resources, and our ability to pass raw material cost increases along to customers;

• changes to selling prices to customers which are based, by contract, on an underlying raw material index;

• substantial debt levels and potential inability to maintain sufficient liquidity to finance our operations and make necessary capital expenditures;

• ability to meet existing debt covenants or obtain necessary waivers;

• achievement of objectives for strategic acquisitions and dispositions;

• ability to achieve successful or timely start-up of new or modified production lines;

• reliance on major customers and suppliers;

• domestic and foreign competition;

• information and technological advances;

• risks related to operations in foreign jurisdictions; and

• changes in environmental laws and regulations, including climate change-related legislation and regulation.

The risks described in the “Risk Factors” section of this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K filed for the fiscal year ended December 29, 2012 are not exhaustive. Other sections of this Form 10-Q describe additional factors that could adversely affect our business, financial condition or results of operations. New risk factors emerge from time to time and it is not possible for us to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. We undertake no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to fluctuations in currency exchange rates, interest rates and commodity prices which could impact our results of operations and financial condition. As a result, we employ a financial risk management program, whose objective is to seek a reduction in the potential negative earnings impact of changes in interest rates, foreign exchange rates and raw material

40

pricing arising in our business activities. To manage these exposures, we primarily use operational means. However, to manage certain of these exposures, we used derivative instruments as described below. Derivative instruments utilized by us in our hedging activities are viewed as risk management tools, involve little complexity and are not used for trading or speculative purposes. To minimize the risk of counterparty non-performance, agreements are made only through major financial institutions with significant experience in such derivative instruments.

Long-Term Debt and Interest Rate Market Risk

Our objective in managing exposure to interest rate changes is to manage the impact of interest rate changes on earnings and cash flows as well as to minimize our overall borrowing costs. To achieve these objectives, we may use financial instruments such as interest rate swaps, in order to manage our mix of floating and fixed-rate debt.

The majority of our long-term financing consists of $560.0 million of 7.75% fixed-rate, Senior Secured Notes due 2019. However, the remaining portion of our indebtedness does have variable interest rates, for which we have not hedged the risks attributable to fluctuations in interest rates. Hypothetically, a 1% change in the interest rates affecting our outstanding variable interest rate subsidiary indebtedness, as of March 30, 2013, would change our interest expense by approximately $0.4 million.

Foreign Currency Exchange Rate Risk

We have operations throughout the world that manufacture and sell their products in various international markets. As a result, we are exposed to movements in exchange rates of various currencies against the U.S. Dollar as well as against other currencies throughout the world. Such currency fluctuations have much less effect on our local operating results because we, to a significant extent, sell our products within the countries in which they are manufactured.

On June 30, 2011, we entered into a series of foreign exchange forward contracts with a third-party financial institution used to minimize foreign exchange risk on certain future cash commitments related to a new spunmelt line under construction in China. The contracts allow us to purchase fixed amounts of Euros on specified future dates, coinciding with the payment amounts and dates of equipment purchase contracts. At March 30, 2013, the remaining notional amount of these contracts was $12.8 million.

Raw Material and Commodity Risks

The primary raw materials used in the manufacture of most of our products are polypropylene resin, polyester fiber, polyethylene resin, and, to a lesser extent, rayon and tissue paper. The prices of polypropylene, polyethylene and polyester are a function of, among other things, manufacturing capacity, demand and the price of crude oil and natural gas liquids. In certain regions of the world, we may source certain key raw materials from a limited number of suppliers or on a sole source basis. In addition, to the extent that we cannot procure our raw material requirements from a local country supplier, we will import raw materials from outside refiners. We believe that the loss of any one or more of our suppliers would not have a long-term material adverse effect on us because other suppliers with whom we conduct business would be able to fulfill our long-term requirements. However, the loss of certain of our suppliers or the delay in the import of raw materials could, in the short-term, adversely affect our business until alternative supply arrangements are secured and the respective suppliers were qualified with our customers, or when importation delays of raw material are resolved. We have not historically experienced, and do not expect, any significant disruptions in the long-term supply of raw materials.

We have not historically hedged our exposure to raw material increases with synthetic financial instruments. However, we have certain customer contracts with price adjustment provisions which provide for index-based pass-through of changes in the underlying raw material costs, although there is often a delay between the time we incur the new raw material cost and the time that we are able to adjust the selling price to our customers. On a global basis, raw material costs continue to fluctuate in response to certain global economic factors, including the regional supply versus demand dynamics for the raw materials and the volatile price of oil.

In periods of rising raw material costs, to the extent we are not able to pass along price increases of raw materials, or to the extent any such price increases are delayed, our cost of goods sold would increase and our operating profit would correspondingly decrease. Based on budgeted purchase volumes for fiscal 2013, if the price of polypropylene was to rise $.01 per pound and we were not able to pass along any of such increase to our customers, we would realize a $6.1 million impact in our cost of goods sold. Significant increases in raw material prices that cannot be passed on to customers could have a material adverse effect on our results of operations and financial condition. In periods of declining raw material costs, if sales prices do not decrease at a corresponding rate, our cost of goods sold would decrease and our operating profit would correspondingly increase.

41

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to the Company's management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our Chief Executive Officer and the Chief Financial Officer, the Company has evaluated the effectiveness of its disclosure controls and procedures, as such item is defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report. Based on that evaluation, the Company's Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, as of the end of the period covered by this report, in ensuring that information required to be disclosed in reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported within the requisite time periods and is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in the Company's internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act during the three months ended March 30, 2013 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are engaged in the defense of certain claims and lawsuits arising out of the ordinary course and conduct of our business, the outcomes of which are not determinable at this time. We have insurance policies covering such potential losses where such coverage is cost effective. In our opinion, any liability that might be incurred by us upon the resolution of these claims and lawsuits will not, in the aggregate, have a material adverse effect on our financial condition or results of operations.

We are subject to a broad range of federal, foreign, state and local laws and regulations relating to pollution and protection of the environment. We believe that we are currently in substantial compliance with applicable environmental requirements and do not currently anticipate any material adverse effect on our operations, financial or competitive position as a result of our efforts to comply with environmental requirements. Some risk of environmental liability is inherent, however, in the nature of our business and, accordingly, there can be no assurance that material environmental liabilities will not arise.

ITEM 1A. RISK FACTORS

There have been no material changes to our risk factors contained in our Annual Report on Form 10-K for the fiscal year ended December 29, 2012.

ITEM 4. MINE SAFETY DISCLOSURE

Not Applicable.

ITEM 5. OTHER INFORMATION

Iran Related Disclosure

Under the Iran Threat Reduction and Syrian Human Rights Act of 2012, which added Section 13(r) of the Exchange Act, we are required to include certain disclosures in our periodic reports if we or any of our “affiliates” knowingly engaged in certain specified activities during the period covered by the report. Because the SEC defines the term “affiliate” broadly, it includes any entity controlled by us as well as any person or entity that controls us or is under common control with us (“control” is also defined broadly by the SEC). We are not presently aware that we have knowingly engaged in any transaction or dealing reportable under Section 13(r) of the Exchange Act during the three months ended March 30, 2013. Except as described below, we are not presently aware of any such reportable transactions or dealings by other such companies.

42

Blackstone informed us that Hilton Worldwide, Inc, Travelport Limited, SunGard Capital Corp., SunGard Capital Corp. II and Sungard Data Systems, Inc., each being companies that may be considered one of its affiliates, included a disclosure in their current report on Form 10-Q as required by Section 13(r) of the Exchange Act. We have no involvement in or control over the activities of these companies, any of their respective predecessor companies or any of their subsidiaries, and we have not independently verified or participated in the preparation of any of their disclosures.

ITEM 6. EXHIBITS

(a) Exhibits

Exhibits required in connection with this Quarterly Report on Form 10-Q are listed below.

Exhibit No.	Description
3.2	Bylaws of the Company, as amended on February 20, 2013.
10.1	Fourth Amendment to Equipment Lease Agreement, dated as of March 22, 2013, between Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor.
31.1	Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by the Chief Executive Officer
31.2	Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by the Chief Financial Officer
32.1	Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by the Chief Executive Officer
32.2	Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by the Chief Financial Officer
101	The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended March 30, 2013, formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Statement of Operations; (iii) Consolidated Statements of Changes in Stockholders' Equity; (iv) Consolidated Statements of Cash Flows; and (v) Notes to Consolidated Financial Statements.

43

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Signature	Title	Date
/s/ Veronica M. Hagen
Veronica M. Hagen	President and Chief Executive Officer and Director (Principal Executive Officer)	May 9, 2013
/s/ Dennis E. Norman
Dennis E. Norman	Executive Vice President & Chief Financial Officer (Principal Financial Officer)	May 9, 2013
/s/ James L. Anderson
James L. Anderson	Vice President & Chief Accounting Officer (Principal Accounting Officer)	May 9, 2013

44

EX-3.2

AMENDED AND RESTATED BY-LAWS

OF

POLYMER GROUP, INC.

A Delaware Corporation

February 20, 2013

ARTICLE I

OFFICES

Section 1. Registered Office.

The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware.

Section 2. Other Offices.

The Corporation may also have offices at such other places both within and without the State of Delaware as the Board of Directors may from time to time determine.

ARTICLE II

MEETING OF STOCKHOLDERS

Section 1. Place of Meetings.

Meetings of the stockholders for the election of directors or for any other purpose shall be held at such time and place, either within or without the State of Delaware, as shall be designated from time to time by the Board of Directors.

Section 2. Annual Meetings.

The Annual Meeting of Stockholders shall be held on such date and at such time as shall be designated from time to time by the Board of Directors, at which meeting the stockholders shall elect a Board of Directors and transact such other business as may properly be brought before the meeting.

Section 3. Special Meetings.

Special Meetings of stockholders for any purpose or purposes may be called at any time by the Chairman of the Board or the Board of Directors, but such Special Meetings may not be called by any other person or persons. Business transacted at any Special Meeting shall be limited to the purposes stated in the notice.

Section 4. Notice of Meetings.

Notice of an Annual Meeting or Special Meeting stating the place, date, and hour of the meeting and in the case of a Special Meeting, the purpose or purposes for which the meeting is called, shall be given by the Corporation either personally or by mail or by other lawful means not less than ten nor more than sixty days before the date of the meeting to each stockholder entitled to vote at such meeting.

Section 5. Quorum.

Except as otherwise provided by law or by the Certificate of Incorporation, the holders of a majority in voting power of the capital stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business. If, however, such quorum shall not be present or represented at any meeting of the stockholders, the stockholders entitled to vote

thereat, present in person or represented by proxy, shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting of the time, place, if any, thereof and the means of remote communications, if any, by which stockholders may be deemed present in person at such adjourned meeting, until a quorum shall be present or represented. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.

Section 6. Voting.

Except as otherwise provided by or pursuant to the provisions of the Certificate of Incorporation, each stockholder entitled to vote at any meeting of stockholders shall be entitled to one vote for each share of stock held by such stockholder which has voting power upon the matter in question. Each stockholder entitled to vote at a meeting of stockholders or to express consent to corporate action in writing without a meeting may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. A proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. A stockholder may revoke any proxy which is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary of the Corporation a revocation of the proxy or a new proxy bearing a later date. Voting at meetings of stockholders need not be by written ballot. At all meetings of stockholders for the election of directors a plurality of the votes cast shall be sufficient to elect. All other elections and questions shall, unless otherwise provided by the Certificate of Incorporation, these Bylaws, the rules or regulations of any stock exchange applicable to the Corporation, or applicable law or pursuant to any regulation applicable to the Corporation or its securities, be decided by the affirmative vote of the holders of a majority in voting power of the shares of stock of the Corporation which are present in person or by proxy and entitled to vote thereon.

Section 7. Action by Consent.

Any action required to be taken at any Annual or Special meeting of stockholders, or any action which may be taken at any Annual or Special meeting of such stockholders, may be taken without a meeting, without prior notice and without a vote, if a consent shall be given by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Prompt notice of the taking of the corporate action without a meeting by less than unanimous consent shall be given to those stockholders who have not consented and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if the record date for such meeting had been the date that consents given by a sufficient number of holders to take the action were delivered to the Corporation.

Section 8. List of Stockholders Entitled to Vote.

The Secretary shall prepare and make, at least ten (10) days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, as required by applicable law. Except as otherwise provided by law, the stock ledger shall be the only evidence as to who are the stockholders entitled to examine the stock ledger, the list of stockholders or the books of the Corporation, or to vote in person or by proxy at any meeting of stockholders.

Section 9. Organization.

At every meeting of stockholders, the Chairman of the Board, if there be one, shall be the chairman of the meeting or, in the case of vacancy in office or absence of the Chairman of the Board, one of the following officers present shall be the Chairman of the meeting in the order stated: the Vice Chairman of the Board, the Chief Executive Officer, the Chief Operating Officer, the President, any Vice President, or, in the absence of any of the foregoing, a Chairman chosen by the stockholders at the meeting shall act as Chairman, and the Secretary, or in his or her absence, an Assistant Secretary, or in the absence of both the Secretary and Assistant Secretaries, a person appointed by the chairman of the meeting, shall act as Secretary.

Section 10. Record Date.

In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or to express consent to corporate action without a meeting, or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors and which record date: (i) in the case of determination of stockholders entitled to vote at any meeting of stockholders or adjournment thereof, shall, unless otherwise required by law, not be more than sixty nor less than ten days before the date of such meeting; (ii) in the case of determination of stockholders entitled to express consent to corporate action without a meeting, shall not be more than ten days from the date upon which the resolution fixing the record date is adopted by the Board of Directors; and (iii) in the case of any other action, shall not be more than sixty days prior to such other action. If no record date is fixed: (a) the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held; (b) the record date for determining stockholders entitled to express consent to corporate action without a meeting when no prior action of the Board of Directors is required by law, shall be the first day on which a consent setting forth the action taken or proposed to be taken is delivered to the Corporation in accordance with applicable law, or, if prior action by the Board of Directors is required by law, shall be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior action; and (c) the record date for determining stockholders for any other purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.

Section 11. Conduct of Meetings.

The date and time of the opening and the closing of the polls for each matter upon which the stockholders will vote at a meeting shall be announced at the meeting by the chairman of the meeting. The Board of Directors may adopt by resolution such rules and regulations for the conduct of the meeting of stockholders as it shall deem appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the chairman of any meeting of stockholders shall have the right and authority to convene and to adjourn the meeting, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following: (i) the establishment of an agenda or order of business for the meeting; (ii) rules and procedures for maintaining order at the meeting and the safety of those present; (iii) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies or such other persons as the chairman of the meeting shall determine; (iv) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (v) limitations on the time allotted to questions or comments by participants. The chairman of any meeting of stockholders, in addition to making any other determinations that may be appropriate to the conduct of the meeting, shall, if the facts warrant, determine and declare to the meeting that a matter or business was not properly brought before the meeting and if such chairman should so determine, such person shall so declare to the meeting and any such matter or business not properly brought before the meeting shall not be transacted or considered. Unless and to the extent determined by the Board of Directors or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure.

ARTICLE III

DIRECTORS

Section 1. Number and Election of Directors.

The number of directors that shall constitute the Board of Directors shall be not less than one nor more than seven. The initial directors shall be determined by resolution of the sole incorporator of the Corporation. Thereafter, within the limits specified above, the number of directors shall be determined by the Board of Directors.

Each elected director shall hold office until the next Annual Meeting and until his successor is duly elected and qualified, or until his earlier resignation or removal.

Section 2. Vacancies.

Vacancies and newly created directorships resulting from any increase in the authorized number of directors may be filled by a majority vote of all directors then in office, even if less than a quorum, or by a sole remaining director, and the directors so chosen shall hold office until the next annual election and until their successors are duly elected and qualified, or until their earlier resignation or removal.

Section 3. Committees.

The Board of Directors may designate one or more committees, which committees shall, to the extent provided in the resolution of the Board of Directors establishing such a committee, have all authority and may exercise all the powers of the Board of Directors in the management of the business and affairs of the Corporation to the extent lawful under the General Corporation Law of the State of Delaware.

Section 4. Duties and Powers.

The business of the Corporation shall be managed by or under the direction of the Board of Directors which may exercise all such powers of the Corporation and do all such lawful acts and things as are not by statute or by the Certificate of Incorporation or by these Bylaws directed or required to be exercised or done by the stockholders.

Section 5. Meetings.

The Board of Directors of the Corporation may hold meetings, both regular and special, either within or without the State of Delaware. Regular meetings of the Board of Directors may be held without notice at such time and at such place as may from time to time be determined by the Board of Directors. Special meetings of the Board of Directors may be called by the President or any one director with one day's notice to each director, either personally or by mail, telephone, facsimile transmission or other means of electronic transmission.

Section 6. Quorum: Board Action.

Except as may be otherwise specifically provided by law, the Certificate of Incorporation or these Bylaws, at all meetings of the Board of Directors, a majority of the entire Board of Directors shall constitute a quorum for the transaction of business, and the vote of a majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors. If a quorum shall not be present at any meeting of the Board of Directors, the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting of the time, place, if any, thereof and the means of remote communications, if any, by which directors may be deemed present in person at such adjourned meeting, until a quorum shall be present.

Section 7. Actions of Board.

Unless otherwise provided by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all the members of the Board of Directors or committee, as the case may be, consent thereto in accordance with applicable law.

Section 8. Removal.

Unless otherwise restricted by the Certificate of Incorporation or these Bylaws, any director or the entire Board of Directors may be removed, with or without cause, by the holders of not less than eighty percent (80%) in voting power of outstanding shares of capital stock entitled to vote at an election of directors.

Section 9. Telephonic Meetings Permitted.

Members of the Board of Directors, or any committee designated by the Board of Directors, may participate in a meeting thereof by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this By-law shall constitute presence in person at such meeting.

ARTICLE IV

OFFICERS

The officers of the Corporation shall consist of a President, a Secretary, a Treasurer and such other additional officers with such titles as the Board of Directors shall determine, all of whom shall be chosen by and shall serve at the pleasure of the Board of Directors. Such officers shall have the usual powers and shall perform all the usual duties incident to their respective offices. All officers shall be subject to the supervision and direction of the Board of Directors. The authority, duties or responsibilities of any officer of the Corporation may be suspended by the President with or without cause. Any officer elected or appointed by the Board of Directors may be removed by the Board of Directors with or without cause.

ARTICLE V

NOTICES

Section 1. Notices.

Except as otherwise provided herein or permitted by applicablelaw, whenever notice is required by law, the Certificate of Incorporation or these Bylaws, to be given to any director, member of a committee or stockholder, such notice may be given by mail, addressed to such director, member of a committee or stockholder, at his address as it appears on the records of the Corporation, with postage thereon prepaid, and such notice shall be deemed to be given at the time when the same shall be deposited in the United States mail. Notice to directors may also be given personally or by telegram, telecopier, telephone or other means of electronic transmission.

Section 2. Waivers of Notice.

Whenever any notice is required by law, the Certificate of Incorporation or these Bylaws, to be given to any director, member of a committee or stockholder, a waiver thereof, given by the person entitled to notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened.

ARTICLE VI

GENERAL PROVISIONS

Section 1. Dividends.

Dividends upon the capital stock of the Corporation, subject to the provisions of the Certificate of Incorporation, may be declared by the Board of Directors at any regular or special meeting, and may be paid in cash, in property, or in shares of the capital stock. Before payment of any dividend, there may be set aside out of any funds of the Corporation available for dividends such sum or sums as the Board of Directors from time to time, in its absolute discretion, deems proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the Corporation, or for any proper purpose, and the Board of Directors may modify or abolish any such reserve.

Section 2. Fiscal Year.

The fiscal year of the Corporation shall be fixed by resolution of the Board of Directors.

Section 3. Corporate Seal.

The corporate seal shall have inscribed thereon the name of the Corporation, the year of its organization and the words "Corporate Seal, Delaware". The seal may be used by causing it or a facsimile thereof to be impressed or affixed or otherwise reproduced.

ARTICLE VII

AMENDMENTS

These Bylaws may be altered, amended or repealed, in whole or in part, or new Bylaws may be adopted by the majority vote of the Board of Directors.

Section 1. Entire Board of Directors.

As used in these Bylaws generally, the term "entire Board of Directors" means the total number of the directors which the Corporation would have if there were no vacancies or newly created directorships.

EX-10.1

Execution Version

FOURTH AMENDMENT
TO EQUIPMENT LEASE AGREEMENT

This FOURTH AMENDMENT, dated as of March 22, 2013 (this “Amendment”), to that certain Equipment Lease Agreement, dated as of June 24, 2010 (as amended through the date hereof, the “Equipment Lease Agreement”), between CHICOPEE, INC., a Delaware corporation (the “Lessee” or the “Company”), and GOSSAMER HOLDINGS, LLC, a Delaware limited liability company (the “Lessor”).

WITNESSETH:

WHEREAS, the Lessee and the Lessor have agreed to make certain amendments to the Equipment Lease Agreement on the terms and conditions contained herein;

NOW THEREFORE, the parties hereto hereby agree as follows:

1.Defined Terms.

Unless otherwise defined herein, terms defined in the Equipment Lease Agreement and used herein shall have the meanings given to them in the Equipment Lease Agreement.

2.    Amendments to Equipment Lease Agreement and Appendix I.

The Equipment Lease Agreement and Appendix I are hereby amended by:

(a) deleting the definition of “First EBO Date” in its entirety and all references to such defined term (including without limitation references in Sections 3(b) and Exhibit No. 1).

(b) deleting the definition of “First EBO Price” in its entirety and all references to such defined term (including without limitation references in Section 3(a), 3(b) and Exhibit No. 1).

(c) changing the defined term “Second EBO Date” and all references thereto (including without limitation references in Sections 3(b), 19(d) and Exhibit No. 1) to “EBO Date”.

(d) changing the defined term “Second EBO Price” and all references thereto (including without limitation references in Sections 3(a), 3(b), 19(d) and Exhibit No. 1) to “EBO Price”.

(e) deleting Section 19(c) in its entirety and inserting in lieu thereof the following:

“(c) Intentionally Omitted.”

3.    Amendments to Appendix II.

Appendix II of the Equipment Lease Agreement is hereby amended by:

(a) deleting the Total Leverage Ratio covenant in its entirety and inserting in lieu thereof the following:

“Total Leverage Ratio. The Total Leverage Ratio as of the end of any fiscal quarter of PGI for which financial statements are available shall not exceed (a) for the fiscal quarter ending April 2, 2011 and each fiscal quarter thereafter through the end of fiscal year 2013, 4.85 to 1.00, (b) from and after the end of fiscal year 2013 through the end of fiscal year 2014, 4.50 to 1.00, (c) from and after the end of fiscal year 2014 through the end of fiscal year 2015, 4.25 to 1.00, (d) from and after the end of fiscal year 2015 through the end of fiscal year 2016, 4.00 to 1.00 and (e) thereafter, 3.75 to 1.00.”

(b) deleting the definition of “Total Debt” in its entirety and inserting in lieu thereof the following:

‘“Total Debt” means as of any date of determination, (x) the aggregate principal amount of all Indebtedness (including, without limitation, all letters of credit, but excluding for all purposes

1

indebtedness attributable to the Site Lease), less (y) the total amount of unrestricted cash, in each case as listed on the balance sheet of PGI and its subsidiaries as of the most recent financial statement available and determined on a consolidated basis in accordance with generally accepted accounting principles.’

4.    Effectiveness.

This Amendment shall become effective as of the date (the “Amendment Effective Date”) on which the Lessor shall have received (i) counterparts hereof duly executed by the Company and the Lessor and (ii) evidence that the Company has paid all costs and expenses pursuant to Section 5 hereto.

5.    Cost and Expenses.

The Company hereby shall pay Lessor for all reasonable and documented out-of-pocket expenses incurred by Lessor in connection with the preparation, negotiation, execution and delivery of this Amendment, including but not limited to the reasonable and documented fees, charges and disbursements of attorneys for Lessor with respect thereto. The Company shall pay these expenses directly to Winston & Strawn LLP, Lessor’s legal counsel.

6.    Representations and Warranties.

The Lessee hereby represents and warrants that, on and as of the Amendment Effective Date, after giving effect to this Amendment:

(a)    The Lessee is in good standing under the laws of the state of its jurisdiction of incorporation.

(b) The Lessee is duly authorized to execute and deliver this Amendment and is duly authorized to perform its obligations hereunder.

(c) The execution, delivery and performance by the Lessee of this Amendment do not and will not (i) require any consent or approval of any federal, state, local or municipal governmental authority or any other entity or person, except where the failure to obtain any of the foregoing would not have a Material Adverse Effect or (ii)  (A) violate any judgment, order, law, regulation, or rule applicable to Lessee or any provision of Lessee’s charter or bylaws or (B) result in any breach of, constitute a default under or result in the creation of any lien, charge, security interest or other encumbrance (other than Permitted Liens) upon the Operative Documents or any Equipment pursuant to any indenture, mortgage, deed of trust, bank loan or credit agreements or other material instrument (other than the Equipment Lease Agreement) to which the Lessee is a party.

(d) This Amendment is the legal, valid and binding obligation of the Lessee, enforceable against the Lessee in accordance with its terms, subject to bankruptcy, insolvency and similar laws affecting enforceability of creditors’ rights generally and to general principals of equity.

(e) No Default has occurred and is continuing; and

(f) Each of the representations and warranties of the Lessee in the Equipment Lease Agreement is true and correct in all material respects, on and as of the Amendment Effective Date with the same effect as though made on and as of the Amendment Effective Date, except to the extent such representations and warranties expressly relate to an earlier date (in which case such representations and warranties were true and correct in all material respects as of such earlier date).

7.    Continuing Effect.

Except as expressly amended hereby, the Equipment Lease Agreement shall continue to be and shall remain in full force and effect in accordance with its terms. From and after the date hereof, all references in the Equipment Lease Agreement to “this Agreement”, “hereunder”, “hereof”, “herein”, or words of like import shall be to the Equipment Lease Agreement as amended hereby. This Amendment shall constitute an Operative Document for purposes of the Equipment Lease Agreement and the other Operative Documents.

2

8.    Counterparts.

This Amendment may be executed by one or more of the parties hereto on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Amendment by facsimile transmission or electronic transmission shall be effective as delivery of a manually executed counterpart hereof.

9.    Headings.

Section headings used in this Amendment are for convenience of reference only, are not part of this Amendment and are not to affect the constructions of, or to be taken into consideration in interpreting, this Amendment.

10.    GOVERNING LAW.

THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

[Signature page follows]

3

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered by their duly authorized officers as of the date first written above.

CHICOPEE, INC.

By:    /s/ Dennis E. Norman    

    Name: Dennis E. Norman

    Title: Chief Financial Officer

4

GOSSAMER HOLDINGS, LLC

BY: GENERAL ELECTRIC CREDIT CORPORATION OF TENNESSEE, its member

By:    /s/ Brian E. Miner________________

Name: Brian E. Miner

Title: Duly Authorized Signatory

BY: ING SPUNMELT HOLDINGS LLC, its member

By:    /s/ Jerry L. McDonald ____________

Name: Jerry L. McDonald

Title: Director

5

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Veronica M. Hagen, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Polymer Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	Polymer Group, Inc.
Date: May 9, 2013	By:	/s/ Veronica M. Hagen
		Veronica M. Hagen Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Dennis E. Norman, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Polymer Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	Polymer Group, Inc.
Date: May 9, 2013	By:	/s/ Dennis E. Norman
		Dennis E. Norman Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report on Form 10-Q of Polymer Group, Inc. (the “Company”) for the period ended March 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Veronica M. Hagen, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 9, 2013	By:	/s/ Veronica M. Hagen
		Veronica M. Hagen Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report on Form 10-Q of Polymer Group, Inc. (the “Company”) for the period ended March 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dennis E. Norman, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 9, 2013	By:	/s/ Dennis E. Norman
		Dennis E. Norman Chief Financial Officer

XML

Basis of Presentation (Details) (Parent Company, USD $) In Millions, unless otherwise specified	Jan. 28, 2011
Parent Company
Basis of Presentation [Line Items]
Aggregrate purchase price of company	$ 403.5
Portion financed by debt	$ 560.0

XML

Income Taxes Narrative (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Income Tax Holiday [Line Items]
Effective tax rate	(51.00%)	106.30%
Deferred tax liabilities	$ 28.5
Unrecognized tax benefits that would impact effective tax rate	24.2
Unrecognized tax benefits tax positions that could reasonably change in next 12 months	4.2
Other Noncurrent Liabilities
Income Tax Holiday [Line Items]
Total unrecognized tax benefit	24.2
Income tax interest and penalties	$ 11.4

XML

Debt Narrative (Details)													3 Months Ended									3 Months Ended	12 Months Ended		3 Months Ended		0 Months Ended
	Mar. 30, 2013 USD ($)	Dec. 29, 2012 USD ($)	Mar. 30, 2013 Letter of Credit USD ($)	Dec. 29, 2012 Letter of Credit USD ($)	Mar. 30, 2013 Short Term Credit Facility Argentina Subsidiary USD ($)	Dec. 29, 2012 Short Term Credit Facility Argentina Subsidiary	Mar. 30, 2013 Short Term Credit Facility Short-term Borrowings Argentina Subsidiary USD ($)	Dec. 29, 2012 Short Term Credit Facility Short-term Borrowings Argentina Subsidiary USD ($)	Mar. 30, 2013 Citibank, Morgan Stanley and Barclays Revolving Credit Facility USD ($)	Mar. 30, 2013 Citibank, Morgan Stanley and Barclays Revolving Tranche USD ($)	Mar. 30, 2013 Citibank, Morgan Stanley and Barclays Standby Letters of Credit USD ($)	Mar. 30, 2013 Citibank, Morgan Stanley and Barclays First-In, Last Out Revolving Tranche USD ($)	Oct. 02, 2010 CCB Suzhou Subsidiary - Healthcare USD ($)	Mar. 30, 2013 CCB Suzhou Subsidiary - Healthcare	Dec. 29, 2012 CCB Suzhou Subsidiary - Healthcare USD ($)	Mar. 30, 2013 CCB Suzhou subsidiary - Hygiene	Dec. 29, 2012 CCB Suzhou subsidiary - Hygiene	Mar. 30, 2013 Senior Notes 7.75% Senior secured notes USD ($)	Dec. 29, 2012 Senior Notes 7.75% Senior secured notes USD ($)	Jan. 28, 2011 Senior Notes 7.75% Senior secured notes	Jan. 31, 2007 Foreign Line of Credit Argentinan Pesos Loan Argentina Subsidiary ARS	Mar. 30, 2013 Foreign Line of Credit United States Dollar Loan Argentina Subsidiary USD ($)	Dec. 29, 2012 Foreign Line of Credit United States Dollar Loan Argentina Subsidiary USD ($)	Jan. 31, 2007 Foreign Line of Credit United States Dollar Loan Argentina Subsidiary USD ($)	Dec. 29, 2012 Foreign Line of Credit United States Dollar Loan Suzhou Subsidiary - Healthcare USD ($)	Mar. 30, 2013 Foreign Line of Credit United States Dollar Loan Suzhou Subsidiary - Healthcare USD ($)	Jul. 01, 2012 Foreign Line of Credit United States Dollar Loan Suzhou subsidiary - Hygiene	Mar. 30, 2013 Foreign Line of Credit United States Dollar Loan Suzhou subsidiary - Hygiene USD ($)	Dec. 29, 2012 Foreign Line of Credit United States Dollar Loan Suzhou subsidiary - Hygiene USD ($)	Jul. 02, 2012 Foreign Line of Credit United States Dollar Loan Suzhou subsidiary - Hygiene USD ($)	Mar. 30, 2013 LIBOR Citibank, Morgan Stanley and Barclays Revolving Tranche	Mar. 30, 2013 LIBOR Citibank, Morgan Stanley and Barclays First-In, Last Out Revolving Tranche	Jan. 31, 2007 LIBOR Foreign Line of Credit United States Dollar Loan Argentina Subsidiary	Dec. 29, 2012 LIBOR Foreign Line of Credit United States Dollar Loan Suzhou subsidiary - Hygiene	Mar. 30, 2013 Federal Fund Rate Citibank, Morgan Stanley and Barclays Revolving Credit Facility	Mar. 30, 2013 Alternative Base Rate Citibank, Morgan Stanley and Barclays Revolving Tranche	Mar. 30, 2013 Alternative Base Rate Citibank, Morgan Stanley and Barclays First-In, Last Out Revolving Tranche	Jan. 31, 2007 Buenos Aires Interbank Offered Rate Foreign Line of Credit Argentinan Pesos Loan Argentina Subsidiary	Oct. 02, 2010 Maximum LIBOR CCB Suzhou Subsidiary - Healthcare	Oct. 02, 2010 Minimum LIBOR CCB Suzhou Subsidiary - Healthcare
Debt Instrument [Line Items]
Fair value of long-term debt																		$ 649,000,000	$ 640,000,000
Carrying amount of long-term debt																		560,000,000	560,000,000			10,842,000	11,674,000
Interest on loan														5.42%	5.44%					7.75%
Maximum borrowing capacity									50,000,000	42,500,000.0		7,500,000.0	20,000,000								33,500,000			26,500,000						25,000,000
Maximum increase in maximum borrowing capacity									20,000,000
Amount outstanding			9,400,000		11,200,000				0		11,000,000				15,981,000											15,981,000		17,642,000	10,977,000
Borrowing base availability									29,600,000
Net availability under the ABL Facility									18,600,000
Basis spread on variable rate																															2.00%	4.00%	290.00%	520.00%	0.50%	1.00%	3.00%	475.00%	400.00%	250.00%
Repayments of long-term debt																						3,500,000	3,500,000		4,000,000
Due in 2013																						3,500,000
Due in 2014																						3,500,000
Due in 2015																						3,500,000
Due in 2016																						1,700,000
Weighted average interest, long-term debt					3.19%											5.48%	5.51%
Line of credit term													3 years														3 years
Short-term borrowings	1,411,000	813,000					1,400,000	800,000
Weighted average interest					2.44%	2.46%
Borrowings under the ABL Facility			$ 5,900,000	$ 6,900,000

XML

Schedule of Special Charges, Net (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Restructuring and plant realignment costs
Total restructuring and plant realignment costs	$ 188	$ 1,747
Other special charges
Total special charges, net	1,804	2,419
Special Charges Net
Restructuring and plant realignment costs
Internal redesign and restructure of global operations	1,543	747
Plant realignment costs	96	673
IS support initiative	7	277
Other restructure initiatives	0	50
Total restructuring and plant realignment costs	1,646	1,747
Acquisition and merger related costs
Blackstone acquisition costs	0	361
Total acquisition and merger related costs	0	361
Other special charges
Other charges	158	311
Total other special charges	158	311
Total special charges, net	$ 1,804	$ 2,419

XML

Accounts Payable and Accrued Liabilities (Details) (USD $) In Thousands, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Accounts payable and accrued liabilities
Accounts payable to vendors	$ 135,308	$ 127,969
Accrued salaries, wages, incentive compensation and other fringe benefits	23,344	21,759
Accrued interest	7,821	18,630
Other accrued expenses	26,703	28,547
Total	$ 193,176	$ 196,905

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 30, 2013

Fair Value Disclosures [Abstract]

Fair value of assets and liabilities

The following tables present the fair value and hierarchy levels for the Company's assets and liabilities, which are measured at fair value on a recurring basis as of the following periods:

In thousands	Level 1		Level 2			Level 3		March 30, 2013
Assets
Firm commitment	$	—	$	1,309		$	—	$	1,309
Liabilities
Hygiene contracts	—		(1,309		)	—		(1,309		)

In thousands	Level 1		Level 2			Level 3		December 29, 2012
Assets
Firm commitment	$	—	$	1,248		$	—	$	1,248
Liabilities
Hygiene contracts	—		(1,248		)	—		(1,248		)

XML

Special Charges, Net Narrative (Details) (USD $)	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 188,000	$ 1,747,000
Special Charges Net
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1,646,000	1,747,000
Plant realignment costs	96,000	673,000
IS support initiative (less than $0.01 million and $0.3 million for the 3 months ended March 30, 2013 and March 31, 2012, respectively)	7,000	277,000
Other restructure initiatives	0	50,000
Blackstone acquisition costs	0	361,000
Internal Redesign and Restructuring of Global Operations
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1,500,000
Severance costs	100,000
Internal Redesign and Restructuring of Global Operations | Consultant Fee
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1,200,000	700,000
Internal Redesign and Restructuring of Global Operations | Employee Relocation, Professional Fees and Other Administrative Cost
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 200,000

XML

Financial Guarantees and Condensed Consolidating Financial Statements

3 Months Ended

Mar. 30, 2013

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Financial Guarantees and Condensed Consolidating Financial Statements

Financial Guarantees and Condensed Consolidating Financial Statements

Polymer’s Senior Secured Notes are fully and unconditionally guaranteed, jointly and severally on a senior secured basis, by each of Polymer’s 100% owned domestic subsidiaries (collectively, the “Guarantors”). As substantially all of Polymer’s operating income and cash flow is generated by its subsidiaries, funds necessary to meet Polymer’s debt service obligations may be provided, in part, by distributions or advances from its subsidiaries. Under certain circumstances, contractual and legal restrictions, as well as the financial condition and operating requirements of Polymer’s subsidiaries, could limit Polymer’s ability to obtain cash from its subsidiaries for the purpose of meeting its debt service obligations, including the payment of principal and interest on the Senior Secured Notes. Although holders of the Senior Secured Notes will be direct creditors of Polymer’s principal direct subsidiaries by virtue of the guarantees, Polymer has subsidiaries that are not included among the Guarantors (collectively, the “Non-Guarantors”), and such subsidiaries will not be obligated with respect to the Senior Secured Notes. As a result, the claims of creditors of the Non-Guarantors will effectively have priority with respect to the assets and earnings of such companies over the claims of creditors of Polymer, including the holders of the Senior Secured Notes.

The following Condensed Consolidating Financial Statements are presented to satisfy the disclosure requirements of Rule 3-10 of Regulation S-X. In accordance with Rule 3-10, the subsidiary guarantors are all 100% owned by PGI (the “Issuer”). The guarantees on the Senior Secured Notes are full and unconditional and all guarantees are joint and several. The information presents Condensed Consolidating Balance Sheets as of March 30, 2013 and December 29, 2012 and Condensed Consolidating Statements of Operations and Condensed Consolidating Statements of Cash Flows for the three months ended March 30, 2013 and March 31, 2012 of (1) PGI (Issuer), (2) the Guarantors, (3) the Non-Guarantors and (4) consolidating eliminations to arrive at the information for the Company on a consolidated basis.

The Company has made changes to its presentation of certain intercompany activities between PGI (Issuer), the Guarantors, the Non-Guarantors and corresponding Eliminations within its Condensed Consolidating Financial Statements contained herein. Certain prior period intercompany activities included in this note disclosure for the Condensed Consolidating Balance Sheets, the Condensed Consolidating Statements of Operations and the Condensed Consolidating Statements of Cash Flows have been recast to correct the classification of certain intercompany transactions. Management has determined that the adjustments were not material to prior periods and the nature of the changes is not material to the overall presentation. Accordingly, prior period Condensed Consolidating Balance Sheets, the Condensed Consolidating Statements of Operations and Condensed Consolidating Statements of Cash Flows included herein are not comparable to presentation included in prior period disclosures.

Condensed Consolidating Balance Sheet

As of March 30, 2013

In thousands	PGI (Issuer)			Guarantors		Non-Guarantors			Eliminations			Consolidated
ASSETS
Current Assets:
Cash and cash equivalents	$	4,060		$	15,234	$	55,333		$	—		$	74,627
Accounts receivable, net	—			24,913		114,935			—			139,848
Inventories, net	(52		)	21,025		75,919			—			96,892
Deferred income taxes	—			613		3,806			(613		)	3,806
Other current assets	3,908			10,017		26,153			—			40,078
Total current assets	7,916			71,802		276,146			(613		)	355,251
Property, plant and equipment, net	38,212			96,687		343,059			—			477,958
Goodwill	—			20,718		59,994			—			80,712
Intangible assets, net	23,483			41,715		8,439			—			73,637
Net investment in and advances to (from) subsidiaries	644,908			756,142		(169,899		)	(1,231,151		)	—
Deferred income taxes	—			—		1,222			—			1,222
Other noncurrent assets	306			5,645		18,904			—			24,855
Total assets	$	714,825		$	992,709	$	537,865		$	(1,231,764	)	$	1,013,635
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term borrowings	$	1,411		$	—	$	—		$	—		$	1,411
Accounts payable and accrued liabilities	17,985			38,875		136,316			—			193,176
Income taxes payable	—			—		3,716			—			3,716
Deferred income taxes	331			—		14			134			479
Current portion of long-term debt	107			—		21,356			—			21,463
Total current liabilities	19,834			38,875		161,402			134			220,245
Long-term debt	560,019			—		23,180			—			583,199
Deferred income taxes	273			9,149		24,370			(747		)	33,045
Other noncurrent liabilities	5,164			14,935		27,512			—			47,611
Total liabilities	585,290			62,959		236,464			(613		)	884,100
Common stock	—			—		36,083			(36,083		)	—
Other shareholders’ equity	129,535			929,750		265,318			(1,195,068		)	129,535
Total shareholders' equity	129,535			929,750		301,401			(1,231,151		)	129,535
Total liabilities and shareholders' equity	$	714,825		$	992,709	$	537,865		$	(1,231,764	)	$	1,013,635

Condensed Consolidating Balance Sheet

As of December 29, 2012

In thousands	PGI (Issuer)		Guarantors		Non-Guarantors			Eliminations			Consolidated
ASSETS
Current Assets:
Cash and cash equivalents	$	486	$	28,285	$	69,108		$	—		$	97,879
Accounts receivable, net	—		22,350		109,219			—			131,569
Inventories, net	—		23,843		71,121			—			94,964
Deferred income taxes	—		613		3,832			(613		)	3,832
Other current assets	1,821		7,710		23,883			—			33,414
Total current assets	2,307		82,801		277,163			(613		)	361,658
Property, plant and equipment, net	27,711		99,660		351,798			—			479,169
Goodwill	—		20,718		59,890			—			80,608
Intangible assets, net	24,313		42,422		8,928			—			75,663
Net investment in and advances to (from) subsidiaries	679,818		723,861		(188,670		)	(1,215,009		)	—
Deferred income taxes	—		—		945			—			945
Other noncurrent assets	275		5,787		17,964			—			24,026
Total assets	$	734,424	$	975,249	$	528,018		$	(1,215,622	)	$	1,022,069
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term borrowings	$	813	$	—	$	—		$	—		$	813
Accounts payable and accrued liabilities	28,511		33,344		135,050			—			196,905
Income taxes payable	—		89		3,752			—			3,841
Deferred income taxes	331		—		14			134			479
Current portion of long-term debt	107		—		19,370			—			19,477
Total current liabilities	29,762		33,433		158,186			134			221,515
Long-term debt	560,043		—		19,356			—			579,399
Deferred income taxes	273		9,149		24,506			(747		)	33,181
Other noncurrent liabilities	5,144		15,540		28,088			—			48,772
Total liabilities	595,222		58,122		230,136			(613		)	882,867
Common stock	—		—		36,083			(36,083		)	—
Other shareholders’ equity	139,202		917,127		261,799			(1,178,926		)	139,202
Total shareholders' equity	139,202		917,127		297,882			(1,215,009		)	139,202
Total liabilities and shareholders' equity	$	734,424	$	975,249	$	528,018		$	(1,215,622	)	$	1,022,069

Condensed Consolidating Statement of Operations

For the Three Months Ended March 30, 2013

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net sales	$	—		$	93,012		$	199,529		$	(5,459	)	$	287,082
Cost of goods sold	(25		)	(81,846		)	(164,804		)	5,459			(241,216		)
Gross profit	(25		)	11,166			34,725			—			45,866
Selling, general and administrative expenses	(9,644		)	(5,760		)	(18,938		)	—			(34,342		)
Special charges, net	(1,354		)	(37		)	(413		)	—			(1,804		)
Other operating, net	2			(76		)	(266		)	—			(340		)
Operating income (loss)	(11,021		)	5,293			15,108			—			9,380
Other income (expense):
Interest expense	(10,228		)	3,101			(4,957		)	—			(12,084		)
Intercompany royalty and technical service fees	1,327			1,607			(2,934		)	—			—
Foreign currency and other, net	(2		)	(97		)	(1,321		)	—			(1,420		)
Equity in earnings of subsidiaries	11,524			3,817			—			(15,341		)	—
Income (loss) before income taxes	(8,400		)	13,721			5,896			(15,341		)	(4,124		)
Income tax (provision) benefit	2,173			(2,145		)	(2,131		)	—			(2,103		)
Net income (loss)	$	(6,227	)	$	11,576		$	3,765		$	(15,341	)	$	(6,227	)
Comprehensive income (loss)	$	(9,903	)	$	16,102		$	5,384		$	(21,486	)	$	(9,903	)

Condensed Consolidating Statement of Operations

For the Three Months Ended March 31, 2012

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net sales	$	—		$	95,414		$	204,541		$	(4,784	)	$	295,171
Cost of goods sold	17			(82,447		)	(164,338		)	4,784			(241,984		)
Gross profit	17			12,967			40,203			—			53,187
Selling, general and administrative expenses	(9,291		)	(5,917		)	(18,923		)	—			(34,131		)
Special charges, net	(1,478		)	(216		)	(725		)	—			(2,419		)
Other operating, net	—			103			258			—			361
Operating income (loss)	(10,752		)	6,937			20,813			—			16,998
Other income (expense):
Interest expense	(11,275		)	3,315			(4,888		)	—			(12,848		)
Intercompany royalty and technical service fees	1,490			1,811			(3,301		)	—			—
Foreign currency and other, net	(30		)	(163		)	255			—			62
Equity in earnings of subsidiaries	18,165			9,151			—			(27,316		)	—
Income (loss) before income taxes	(2,402		)	21,051			12,879			(27,316		)	4,212
Income tax (provision) benefit	2,137			(2,832		)	(3,782		)	—			(4,477		)
Net income (loss)	$	(265	)	$	18,219		$	9,097		$	(27,316	)	$	(265	)
Comprehensive income (loss)	$	4,558		$	24,380		$	12,228		$	(36,608	)	$	4,558

Condensed Consolidating Statement of Cash Flows

For the Three Months Ended March 30, 2013

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net cash provided by (used in) operating activities	$	(15,118	)	$	16,397		$	(15,990	)	$	—		$	(14,711	)
Investing activities:
Purchases of property, plant and equipment	(10,592		)	(682		)	(3,043		)	—			(14,317		)
Proceeds from the sale of assets	—			—			11			—			11
Acquisition of intangibles and other	(53		)	—			—			—			(53		)
Intercompany investing activities, net	5,766			(23,000		)	—			17,234			—
Net cash provided by (used in) investing activities	(4,879		)	(23,682		)	(3,032		)	17,234			(14,359		)
Financing activities:
Proceeds from long-term borrowings	—			—			6,666			—			6,666
Proceeds from short-term borrowings	1,446			—			—			—			1,446
Repayment of long-term borrowings	(27		)	—			(885		)	—			(912		)
Repayment of short-term borrowings	(848		)	—			—			—			(848		)
Intercompany financing activities, net	23,000			(5,766		)	—			(17,234		)	—
Net cash provided by (used in) financing activities	23,571			(5,766		)	5,781			(17,234		)	6,352
Effect of exchange rate changes on cash	—			—			(534		)	—			(534		)
Net change in cash and cash equivalents	3,574			(13,051		)	(13,775		)	—			(23,252		)
Cash and cash equivalents at beginning of period	486			28,285			69,108			—			97,879
Cash and cash equivalents at end of period	$	4,060		$	15,234		$	55,333		$	—		$	74,627

Condensed Consolidating Statement of Cash Flows

For the Three Months Ended March 31, 2012

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net cash provided by (used in) operating activities	$	(31,450	)	$	28,014		$	23,050		$	—		$	19,614
Investing activities:
Purchases of property, plant and equipment	(8,316		)	(623		)	(4,373		)	—			(13,312		)
Proceeds from the sale of assets	—			1,646			11			—			1,657
Acquisition of intangibles and other	(56		)	—			—			—			(56		)
Intercompany investing activities, net	15,771			(25,770		)	(8,781		)	18,780			—
Net cash provided by (used in) investing activities	7,399			(24,747		)	(13,143		)	18,780			(11,711		)
Financing activities:
Proceeds from long-term borrowings	—			—			24			—			24
Proceeds from short-term borrowings	1,436			—			5			—			1,441
Repayment of long-term borrowings	(22		)	—			(918		)	—			(940		)
Repayment of short-term borrowings	(72		)	—			(2,000		)	—			(2,072		)
Intercompany financing activities, net	25,770			(6,990		)	—			(18,780		)	—
Net cash provided by (used in) financing activities	27,112			(6,990		)	(2,889		)	(18,780		)	(1,547		)
Effect of exchange rate changes on cash	—			—			523			—			523
Net change in cash and cash equivalents	3,061			(3,723		)	7,541			—			6,879
Cash and cash equivalents at beginning of period	3,135			14,574			55,033			—			72,742
Cash and cash equivalents at end of period	$	6,196		$	10,851		$	62,574		$	—		$	79,621

XML

Derivatives Instruments Recognized on Consolidated Statement of Operations (Details) (Fair Value Hedge, Foreign Exchange Forward, Foreign Currency and Other, Net, USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Derivative Instruments, Gain (Loss) [Line Items]
(Gain) Loss recognized in income	$ 61	$ (1,373)
Hygiene contracts | Hygiene Line | Designated hedges:
Derivative Instruments, Gain (Loss) [Line Items]
(Gain) Loss recognized in income	61	(1,226)
Healthcare contracts | Healthcare Line | Undesignated hedges:
Derivative Instruments, Gain (Loss) [Line Items]
(Gain) Loss recognized in income	$ 0	$ (147)

XML

Inventories, Net (Details) (USD $) In Thousands, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Inventories
Raw materials and supplies	$ 42,438	$ 41,070
Work in process	14,493	14,299
Finished goods	39,961	39,595
Total	$ 96,892	$ 94,964

XML

Financial Guarantees and Condensed Consolidating Financial Statements (Tables)

3 Months Ended

Mar. 30, 2013

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Consolidating Balance Sheet

Condensed Consolidating Balance Sheet

As of March 30, 2013

In thousands	PGI (Issuer)			Guarantors		Non-Guarantors			Eliminations			Consolidated
ASSETS
Current Assets:
Cash and cash equivalents	$	4,060		$	15,234	$	55,333		$	—		$	74,627
Accounts receivable, net	—			24,913		114,935			—			139,848
Inventories, net	(52		)	21,025		75,919			—			96,892
Deferred income taxes	—			613		3,806			(613		)	3,806
Other current assets	3,908			10,017		26,153			—			40,078
Total current assets	7,916			71,802		276,146			(613		)	355,251
Property, plant and equipment, net	38,212			96,687		343,059			—			477,958
Goodwill	—			20,718		59,994			—			80,712
Intangible assets, net	23,483			41,715		8,439			—			73,637
Net investment in and advances to (from) subsidiaries	644,908			756,142		(169,899		)	(1,231,151		)	—
Deferred income taxes	—			—		1,222			—			1,222
Other noncurrent assets	306			5,645		18,904			—			24,855
Total assets	$	714,825		$	992,709	$	537,865		$	(1,231,764	)	$	1,013,635
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term borrowings	$	1,411		$	—	$	—		$	—		$	1,411
Accounts payable and accrued liabilities	17,985			38,875		136,316			—			193,176
Income taxes payable	—			—		3,716			—			3,716
Deferred income taxes	331			—		14			134			479
Current portion of long-term debt	107			—		21,356			—			21,463
Total current liabilities	19,834			38,875		161,402			134			220,245
Long-term debt	560,019			—		23,180			—			583,199
Deferred income taxes	273			9,149		24,370			(747		)	33,045
Other noncurrent liabilities	5,164			14,935		27,512			—			47,611
Total liabilities	585,290			62,959		236,464			(613		)	884,100
Common stock	—			—		36,083			(36,083		)	—
Other shareholders’ equity	129,535			929,750		265,318			(1,195,068		)	129,535
Total shareholders' equity	129,535			929,750		301,401			(1,231,151		)	129,535
Total liabilities and shareholders' equity	$	714,825		$	992,709	$	537,865		$	(1,231,764	)	$	1,013,635

Condensed Consolidating Balance Sheet

As of December 29, 2012

In thousands	PGI (Issuer)		Guarantors		Non-Guarantors			Eliminations			Consolidated
ASSETS
Current Assets:
Cash and cash equivalents	$	486	$	28,285	$	69,108		$	—		$	97,879
Accounts receivable, net	—		22,350		109,219			—			131,569
Inventories, net	—		23,843		71,121			—			94,964
Deferred income taxes	—		613		3,832			(613		)	3,832
Other current assets	1,821		7,710		23,883			—			33,414
Total current assets	2,307		82,801		277,163			(613		)	361,658
Property, plant and equipment, net	27,711		99,660		351,798			—			479,169
Goodwill	—		20,718		59,890			—			80,608
Intangible assets, net	24,313		42,422		8,928			—			75,663
Net investment in and advances to (from) subsidiaries	679,818		723,861		(188,670		)	(1,215,009		)	—
Deferred income taxes	—		—		945			—			945
Other noncurrent assets	275		5,787		17,964			—			24,026
Total assets	$	734,424	$	975,249	$	528,018		$	(1,215,622	)	$	1,022,069
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term borrowings	$	813	$	—	$	—		$	—		$	813
Accounts payable and accrued liabilities	28,511		33,344		135,050			—			196,905
Income taxes payable	—		89		3,752			—			3,841
Deferred income taxes	331		—		14			134			479
Current portion of long-term debt	107		—		19,370			—			19,477
Total current liabilities	29,762		33,433		158,186			134			221,515
Long-term debt	560,043		—		19,356			—			579,399
Deferred income taxes	273		9,149		24,506			(747		)	33,181
Other noncurrent liabilities	5,144		15,540		28,088			—			48,772
Total liabilities	595,222		58,122		230,136			(613		)	882,867
Common stock	—		—		36,083			(36,083		)	—
Other shareholders’ equity	139,202		917,127		261,799			(1,178,926		)	139,202
Total shareholders' equity	139,202		917,127		297,882			(1,215,009		)	139,202
Total liabilities and shareholders' equity	$	734,424	$	975,249	$	528,018		$	(1,215,622	)	$	1,022,069

Condensed Consolidating Statement of Operations

Condensed Consolidating Statement of Operations

For the Three Months Ended March 30, 2013

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net sales	$	—		$	93,012		$	199,529		$	(5,459	)	$	287,082
Cost of goods sold	(25		)	(81,846		)	(164,804		)	5,459			(241,216		)
Gross profit	(25		)	11,166			34,725			—			45,866
Selling, general and administrative expenses	(9,644		)	(5,760		)	(18,938		)	—			(34,342		)
Special charges, net	(1,354		)	(37		)	(413		)	—			(1,804		)
Other operating, net	2			(76		)	(266		)	—			(340		)
Operating income (loss)	(11,021		)	5,293			15,108			—			9,380
Other income (expense):
Interest expense	(10,228		)	3,101			(4,957		)	—			(12,084		)
Intercompany royalty and technical service fees	1,327			1,607			(2,934		)	—			—
Foreign currency and other, net	(2		)	(97		)	(1,321		)	—			(1,420		)
Equity in earnings of subsidiaries	11,524			3,817			—			(15,341		)	—
Income (loss) before income taxes	(8,400		)	13,721			5,896			(15,341		)	(4,124		)
Income tax (provision) benefit	2,173			(2,145		)	(2,131		)	—			(2,103		)
Net income (loss)	$	(6,227	)	$	11,576		$	3,765		$	(15,341	)	$	(6,227	)
Comprehensive income (loss)	$	(9,903	)	$	16,102		$	5,384		$	(21,486	)	$	(9,903	)

Condensed Consolidating Statement of Operations

For the Three Months Ended March 31, 2012

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net sales	$	—		$	95,414		$	204,541		$	(4,784	)	$	295,171
Cost of goods sold	17			(82,447		)	(164,338		)	4,784			(241,984		)
Gross profit	17			12,967			40,203			—			53,187
Selling, general and administrative expenses	(9,291		)	(5,917		)	(18,923		)	—			(34,131		)
Special charges, net	(1,478		)	(216		)	(725		)	—			(2,419		)
Other operating, net	—			103			258			—			361
Operating income (loss)	(10,752		)	6,937			20,813			—			16,998
Other income (expense):
Interest expense	(11,275		)	3,315			(4,888		)	—			(12,848		)
Intercompany royalty and technical service fees	1,490			1,811			(3,301		)	—			—
Foreign currency and other, net	(30		)	(163		)	255			—			62
Equity in earnings of subsidiaries	18,165			9,151			—			(27,316		)	—
Income (loss) before income taxes	(2,402		)	21,051			12,879			(27,316		)	4,212
Income tax (provision) benefit	2,137			(2,832		)	(3,782		)	—			(4,477		)
Net income (loss)	$	(265	)	$	18,219		$	9,097		$	(27,316	)	$	(265	)
Comprehensive income (loss)	$	4,558		$	24,380		$	12,228		$	(36,608	)	$	4,558

Condensed Consolidating Statement of Cash Flows

Condensed Consolidating Statement of Cash Flows

For the Three Months Ended March 30, 2013

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net cash provided by (used in) operating activities	$	(15,118	)	$	16,397		$	(15,990	)	$	—		$	(14,711	)
Investing activities:
Purchases of property, plant and equipment	(10,592		)	(682		)	(3,043		)	—			(14,317		)
Proceeds from the sale of assets	—			—			11			—			11
Acquisition of intangibles and other	(53		)	—			—			—			(53		)
Intercompany investing activities, net	5,766			(23,000		)	—			17,234			—
Net cash provided by (used in) investing activities	(4,879		)	(23,682		)	(3,032		)	17,234			(14,359		)
Financing activities:
Proceeds from long-term borrowings	—			—			6,666			—			6,666
Proceeds from short-term borrowings	1,446			—			—			—			1,446
Repayment of long-term borrowings	(27		)	—			(885		)	—			(912		)
Repayment of short-term borrowings	(848		)	—			—			—			(848		)
Intercompany financing activities, net	23,000			(5,766		)	—			(17,234		)	—
Net cash provided by (used in) financing activities	23,571			(5,766		)	5,781			(17,234		)	6,352
Effect of exchange rate changes on cash	—			—			(534		)	—			(534		)
Net change in cash and cash equivalents	3,574			(13,051		)	(13,775		)	—			(23,252		)
Cash and cash equivalents at beginning of period	486			28,285			69,108			—			97,879
Cash and cash equivalents at end of period	$	4,060		$	15,234		$	55,333		$	—		$	74,627

Condensed Consolidating Statement of Cash Flows

For the Three Months Ended March 31, 2012

In thousands	PGI (Issuer)			Guarantors			Non-Guarantors			Eliminations			Consolidated
Net cash provided by (used in) operating activities	$	(31,450	)	$	28,014		$	23,050		$	—		$	19,614
Investing activities:
Purchases of property, plant and equipment	(8,316		)	(623		)	(4,373		)	—			(13,312		)
Proceeds from the sale of assets	—			1,646			11			—			1,657
Acquisition of intangibles and other	(56		)	—			—			—			(56		)
Intercompany investing activities, net	15,771			(25,770		)	(8,781		)	18,780			—
Net cash provided by (used in) investing activities	7,399			(24,747		)	(13,143		)	18,780			(11,711		)
Financing activities:
Proceeds from long-term borrowings	—			—			24			—			24
Proceeds from short-term borrowings	1,436			—			5			—			1,441
Repayment of long-term borrowings	(22		)	—			(918		)	—			(940		)
Repayment of short-term borrowings	(72		)	—			(2,000		)	—			(2,072		)
Intercompany financing activities, net	25,770			(6,990		)	—			(18,780		)	—
Net cash provided by (used in) financing activities	27,112			(6,990		)	(2,889		)	(18,780		)	(1,547		)
Effect of exchange rate changes on cash	—			—			523			—			523
Net change in cash and cash equivalents	3,061			(3,723		)	7,541			—			6,879
Cash and cash equivalents at beginning of period	3,135			14,574			55,033			—			72,742
Cash and cash equivalents at end of period	$	6,196		$	10,851		$	62,574		$	—		$	79,621

XML

Pension and Postretirement Benefit Plans Net Periodic Benefit (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Pension Plans
Components of net periodic benefit cost:
Service cost	$ 844	$ 510
Interest cost	1,391	1,442
Return on plan assets	(1,884)	(1,616)
Curtailment / settlement (gain) loss	0	0
Transition costs and other	88	(16)
Net periodic benefit cost	439	320
Postretirement Benefit Plans
Components of net periodic benefit cost:
Service cost	15	18
Interest cost	46	54
Curtailment / settlement (gain) loss	0	0
Transition costs and other	9	6
Net periodic benefit cost	$ 70	$ 78

XML

Financial Guarantees and Condensed Consolidating Statement of Operations (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Condensed Consolidating Statement of Operations
Net sales	$ 287,082	$ 295,171
Cost of goods sold	(241,216)	(241,984)
Gross profit	45,866	53,187
Selling, general and administrative expenses	(34,342)	(34,131)
Special charges, net	(1,804)	(2,419)
Other operating, net	(340)	361
Operating income (loss)	9,380	16,998
Other income (expense):
Interest expense	(12,084)	(12,848)
Intercompany royalty and technical service fees	0	0
Foreign currency and other, net	(1,420)	62
Equity in earnings of subsidiaries	0	0
Income (loss) before income taxes	(4,124)	4,212
Income tax (provision) benefit	(2,103)	(4,477)
Net income (loss)	(6,227)	(265)
Other comprehensive income (loss)	(9,903)	4,558
PGI (Issuer)
Condensed Consolidating Statement of Operations
Net sales	0	0
Cost of goods sold	(25)	17
Gross profit	(25)	17
Selling, general and administrative expenses	(9,644)	(9,291)
Special charges, net	(1,354)	(1,478)
Other operating, net	2	0
Operating income (loss)	(11,021)	(10,752)
Other income (expense):
Interest expense	(10,228)	(11,275)
Intercompany royalty and technical service fees	1,327	1,490
Foreign currency and other, net	(2)	(30)
Equity in earnings of subsidiaries	11,524	18,165
Income (loss) before income taxes	(8,400)	(2,402)
Income tax (provision) benefit	2,173	2,137
Net income (loss)	(6,227)	(265)
Other comprehensive income (loss)	(9,903)	4,558
Guarantors
Condensed Consolidating Statement of Operations
Net sales	93,012	95,414
Cost of goods sold	(81,846)	(82,447)
Gross profit	11,166	12,967
Selling, general and administrative expenses	(5,760)	(5,917)
Special charges, net	(37)	(216)
Other operating, net	(76)	103
Operating income (loss)	5,293	6,937
Other income (expense):
Interest expense	3,101	3,315
Intercompany royalty and technical service fees	1,607	1,811
Foreign currency and other, net	(97)	(163)
Equity in earnings of subsidiaries	3,817	9,151
Income (loss) before income taxes	13,721	21,051
Income tax (provision) benefit	(2,145)	(2,832)
Net income (loss)	11,576	18,219
Other comprehensive income (loss)	16,102	24,380
Non-Guarantors
Condensed Consolidating Statement of Operations
Net sales	199,529	204,541
Cost of goods sold	(164,804)	(164,338)
Gross profit	34,725	40,203
Selling, general and administrative expenses	(18,938)	(18,923)
Special charges, net	(413)	(725)
Other operating, net	(266)	258
Operating income (loss)	15,108	20,813
Other income (expense):
Interest expense	(4,957)	(4,888)
Intercompany royalty and technical service fees	(2,934)	(3,301)
Foreign currency and other, net	(1,321)	255
Equity in earnings of subsidiaries	0	0
Income (loss) before income taxes	5,896	12,879
Income tax (provision) benefit	(2,131)	(3,782)
Net income (loss)	3,765	9,097
Other comprehensive income (loss)	5,384	12,228
Eliminations
Condensed Consolidating Statement of Operations
Net sales	(5,459)	(4,784)
Cost of goods sold	5,459	4,784
Gross profit	0	0
Selling, general and administrative expenses	0	0
Special charges, net	0	0
Other operating, net	0	0
Operating income (loss)	0	0
Other income (expense):
Interest expense	0	0
Intercompany royalty and technical service fees	0	0
Foreign currency and other, net	0	0
Equity in earnings of subsidiaries	(15,341)	(27,316)
Income (loss) before income taxes	(15,341)	(27,316)
Income tax (provision) benefit	0	0
Net income (loss)	(15,341)	(27,316)
Other comprehensive income (loss)	$ (21,486)	$ (36,608)

XML

Segment Information Narrative (Details)	3 Months Ended
	Mar. 30, 2013 segment
Segment Reporting Information [Line Items]
Number of operating segments	4
Customer Concentration Risk | Sales Revenue, Goods, Net
Segment Reporting Information [Line Items]
Number of major customers	1

XML

Schedule of Long-term Debt (Details) (USD $)	Mar. 30, 2013	Dec. 29, 2012
Long-term debt
Capital lease obligations	$ 197,000	$ 244,000
Total debt	604,662,000	598,876,000
Less: Current maturities	(21,463,000)	(19,477,000)
Total long-term debt	583,199,000	579,399,000
7.75% Senior secured notes | Senior Notes
Long-term debt
Carrying amount of long-term debt	560,000,000	560,000,000
ABL Facility | Line of Credit
Long-term debt
Carrying amount of long-term debt	0	0
United States Dollar Loan | Foreign Line of Credit | Argentina Subsidiary
Long-term debt
Carrying amount of long-term debt	10,842,000	11,674,000
United States Dollar Loan | Foreign Line of Credit | Suzhou Subsidiary - Healthcare
Long-term debt
Amount outstanding	15,981,000
United States Dollar Loan | Foreign Line of Credit | Suzhou subsidiary - Hygiene
Long-term debt
Amount outstanding	$ 17,642,000	$ 10,977,000

XML

Recent Accounting Pronouncements

3 Months Ended

Mar. 30, 2013

Accounting Policies [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update No. 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income" ("ASU 2013-02"), which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, ASU 2013-02 requires an entity to present, either on the face of the income statement or in the notes to the financial statements, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income in the financial statements. ASU 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012. The adoption of this guidance concerns disclosure only and did not have an impact on the Company's financial results. See Note 11 for additional information.

XML

Financial Data by Segment (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Net sales
Net sales	$ 287,082	$ 295,171
Operating income (loss)
Operating income (loss)	9,380	16,998
Special charges, net	(1,804)	(2,419)
Depreciation and amortization expense
Depreciation and amortization expense	16,152	15,852
Unallocated Corporate
Capital spending	14,317	13,312
Americas Nonwovens
Net sales
Net sales	153,004	165,893
Operating income (loss)
Operating income (loss)	11,474	19,289
Depreciation and amortization expense
Depreciation and amortization expense	8,317	8,337
Unallocated Corporate
Capital spending	818	640
Europe Nonwovens
Net sales
Net sales	78,274	75,667
Operating income (loss)
Operating income (loss)	3,292	3,647
Depreciation and amortization expense
Depreciation and amortization expense	3,059	2,695
Unallocated Corporate
Capital spending	548	2,243
Asia Nonwovens
Net sales
Net sales	37,967	36,423
Operating income (loss)
Operating income (loss)	4,553	4,011
Depreciation and amortization expense
Depreciation and amortization expense	3,389	3,317
Unallocated Corporate
Capital spending	12,559	9,709
Oriented Polymers
Net sales
Net sales	17,837	17,188
Operating income (loss)
Operating income (loss)	1,593	1,677
Depreciation and amortization expense
Depreciation and amortization expense	348	381
Unallocated Corporate
Capital spending	125	86
Unallocated Corporate
Operating income (loss)
Operating income (loss)	(9,692)	(9,368)
Depreciation and amortization expense
Depreciation and amortization expense	432	437
Unallocated Corporate
Capital spending	267	634
Eliminations
Operating income (loss)
Operating income (loss)	(36)	161
Subtotal
Operating income (loss)
Operating income (loss)	11,184	19,417
Depreciation and amortization expense
Depreciation and amortization expense	15,545	15,167
Unallocated Amount to Segment
Depreciation and amortization expense
Depreciation and amortization expense	$ 607	$ 685

XML

Inventories, Net Narrative (Details) (USD $) In Millions, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Inventory Disclosure [Abstract]
Obsolete and slow-moving inventories, net of reserves	$ 3.1	$ 3.3

XML

Intangible Assets (Tables)

3 Months Ended

Mar. 30, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived and Indefinite-Lived Intangible Assets

The following table sets forth the gross amount and accumulated amortization of the Company's intangible assets at March 30, 2013 and December 29, 2012:

In thousands	March 30, 2013			December 29, 2012
Technology	$	31,900		$	31,900
Customer relationships	16,896			16,869
Loan acquisition costs	19,472			19,472
Other	498			446
Total gross finite-lived intangible assets	68,766			68,687
Accumulated amortization	(18,629		)	(16,524		)
Total net finite-lived intangible assets	50,137			52,163
Tradenames (indefinite-lived)	23,500			23,500
Total	$	73,637		$	75,663

XML

Inventories Net (Tables)

3 Months Ended

Mar. 30, 2013

Inventory Disclosure [Abstract]

Inventories

At March 30, 2013 and December 29, 2012, the major classes of inventory were as follows:

In thousands	March 30, 2013		December 29, 2012
Raw materials and supplies	$	42,438	$	41,070
Work in process	14,493		14,299
Finished goods	39,961		39,595
Total	$	96,892	$	94,964

XML

Restructuring Reserve Rollforward (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Summary of components of accrued liability with respect to Company's business restructuring activities
Beginning balance	$ 6,278	$ 1,100
Additions	188	1,747
Cash payments	(2,535)	(1,533)
Adjustments	(57)	39
Ending balance	$ 3,874	$ 1,353

XML

Schedule of Finite and Indefinite-lived Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Goodwill [Line Items]
Total gross finite-lived intangible assets	$ 68,766	$ 68,687
Accumulated amortization	(18,629)	(16,524)
Total net finite-lived intangible assets	50,137	52,163
Total	73,637	75,663
Trade names
Goodwill [Line Items]
Tradenames (indefinite-lived)	23,500	23,500
Technology
Goodwill [Line Items]
Total gross finite-lived intangible assets	31,900	31,900
Customer relationships
Goodwill [Line Items]
Total gross finite-lived intangible assets	16,896	16,869
Loan acquisition costs
Goodwill [Line Items]
Total gross finite-lived intangible assets	19,472	19,472
Other intangibles, principally patents
Goodwill [Line Items]
Total gross finite-lived intangible assets	$ 498	$ 446

XML

Accounts Payable and Accrued Liabilities (Tables)

3 Months Ended

Mar. 30, 2013

Payables and Accruals [Abstract]

Accounts payable and accrued liabilities

Accounts payable and accrued liabilities consist of the following:

In thousands	March 30, 2013		December 29, 2012
Accounts payable to vendors	$	135,308	$	127,969
Accrued salaries, wages, incentive compensation and other fringe benefits	23,344		21,759
Accrued interest	7,821		18,630
Other accrued expenses	26,703		28,547
Total	$	193,176	$	196,905

XML

Debt (Tables)

3 Months Ended

Mar. 30, 2013

Debt Disclosure [Abstract]

Long-term debt

The following table presents the Company's long-term debt at March 30, 2013 and December 29, 2012:

In thousands	March 30, 2013			December 29, 2012
Senior Secured Notes	$	560,000		$	560,000
ABL Facility	—			—
Argentine Facility	10,842			11,674
China credit facilities:
China Credit Facility — Healthcare	15,981			15,981
China Credit Facility — Hygiene	17,642			10,977
Capital lease obligations	197			244
Total debt	604,662			598,876
Less: Current maturities	(21,463		)	(19,477		)
Total long-term debt	$	583,199		$	579,399

XML

Basis of Presentation

3 Months Ended

Mar. 30, 2013

Accounting Policies [Abstract]

Basis of Presentation

Description of Business

Polymer Group, Inc. (“Polymer” or “PGI”), a Delaware corporation, and its consolidated subsidiaries (the “Company”) is a leading global innovator, manufacturer and marketer of engineered materials, primarily focused on the production of nonwoven products. The Company has one of the largest global platforms in the industry, with a total of 13 manufacturing and converting facilities located in 9 countries throughout the world. The Company operates through 4 reportable segments, with the main sources of revenue being the sales of primary and intermediate products to the hygiene, healthcare, wipes and industrial markets.

Basis of Presentation

The accompanying consolidated financial statements reflect the consolidated operations of the Company and have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) as defined by the Financial Accounting Standards Board (“FASB”) within the FASB Accounting Standards Codification (“ASC”). In the opinion of management, the accompanying consolidated financial statements contain all adjustments, which include normal recurring adjustments, necessary to present fairly the consolidated results for the periods presented. The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Polymer Group, Inc. Annual Report on Form 10-K for the year ended December 29, 2012.

On January 28, 2011, pursuant to an Agreement and Plan of Merger, dated as of October 4, 2010, the Company was acquired by affiliates of the Blackstone Group (“Blackstone”), along with certain members of the Company's management (the "Merger"), for an aggregate purchase price valued at $403.5 million. As a result, the Company became a privately-held company. The Merger was financed by $560.0 million in aggregate principal of debt financing as well as common equity capital. In addition, the Company repaid its existing outstanding debt. Although the Company continues to operate as the same legal entity subsequent to the Merger and related change in control, a new entity was created for accounting purposes as of January 28, 2011. As a result, the purchase price was allocated to assets acquired and liabilities assumed based on their estimated fair market values at the date of acquisition. Under the guidance of the Securities and Exchange Commission ("SEC") Staff Accounting Bulletin Topic 5J, “New Basis of Accounting Required in Certain Circumstances,” push-down accounting is required when such transactions result in an entity being substantially wholly-owned. Therefore, the basis in shares of common stock of the Company has been "pushed down" to the Company from Scorpio Holdings Corporation, a Delaware corporation ("Holdings") that owns 100% of the issued and outstanding stock of Scorpio Acquisition Corporation, a Delaware corporation ("Parent") that owns 100% of the issued and outstanding common stock of the Company.

The Company's fiscal year is based on a 52 week period ending on the Saturday closest to each December 31. Therefore, the financial results of 53-week fiscal years, and the associated 14-week quarters, will not be comparable to the prior and subsequent 52-week fiscal years and the associated quarters having only 13 weeks. The three months ended March 30, 2013 and March 31, 2012 each contain operating results for 13 weeks.

XML

Derivative Instruments (Tables)

3 Months Ended

Mar. 30, 2013

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of aggregate notional amount and estimated fair value of derivative instruments

The following table presents the fair values of the Company's derivative instruments included within Accounts payable and accrued expenses on the Consolidated Balance Sheets as of March 30, 2013 and December 29, 2012:

	As of March 30, 2013					As of December 29, 2012
In thousands	Notional		Fair Value			Notional		Fair Value
Designated hedges:
Hygiene contracts	$	12,779	$	(1,309	)	$	22,554	$	(1,248	)
Undesignated hedges:
Healthcare contracts	—		—			—		—
Total	$	12,779	$	(1,309	)	$	22,554	$	(1,248	)

Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location

The following table represents the amount of (gain) or loss associated with derivatives designated as hedges affecting Foreign currency and other, net in the Consolidated Statement of Operations:

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Designated hedges:
Hygiene contracts	61		(1,226		)
Undesignated hedges:
Healthcare contracts	—		(147		)
Total	$	61	$	(1,373	)

XML

Accounts Receivable Factoring Agreements Narrative (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Receivables [Abstract]
Factoring agreement maximum outstanding amount	$ 20.0
Foreign Subsidiary Factoring agreement maximum outstanding amount	49.7
Sale of receivable under factoring agreement	101.8	88.8
Factoring fees	$ 0.3	$ 0.3

XML

Pension and Postretirement Benefit Plans Narrative (Details) (USD $)	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012	Mar. 30, 2013 Pension Plans	Mar. 31, 2012 Pension Plans	Dec. 29, 2012 Canadian Plans pension_plan	Mar. 30, 2013 Canadian Plans Special Charges Net	Dec. 29, 2012 Other Current Assets Canadian Plans
Defined Benefit Plan Disclosure [Line Items]
Number of liquidated pension plans					2
Current assets							$ 0
Curtailment / settlement (gain) loss			0	0		800,000
Contributions by employer			1,700,000
Employer contributions in 2013			5,300,000
Reclassed out of AOCI ($0.1 million for 3 months ended March 30, 2013 and less than $0.1 million in the three months ended March 31, 2012)	$ 100,000	$ 100,000

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Current assets:
Cash and cash equivalents	$ 74,627	$ 97,879
Accounts receivable, net	139,848	131,569
Inventories, net	96,892	94,964
Deferred income taxes	3,806	3,832
Other current assets	40,078	33,414
Total current assets	355,251	361,658
Property, plant and equipment, net of accumulated depreciation of $119,170 and $106,134, respectively	477,958	479,169
Goodwill	80,712	80,608
Intangible assets, net	73,637	75,663
Deferred income taxes	1,222	945
Other noncurrent assets	24,855	24,026
Total assets	1,013,635	1,022,069
Current liabilities:
Short-term borrowings	1,411	813
Accounts payable and accrued liabilities	193,176	196,905
Income taxes payable	3,716	3,841
Deferred income taxes	479	479
Current portion of long-term debt	21,463	19,477
Total current liabilities	220,245	221,515
Long-term debt	583,199	579,399
Deferred income taxes	33,045	33,181
Other noncurrent liabilities	47,611	48,772
Total liabilities	884,100	882,867
Commitments and contingencies
Shareholders’ equity:
Common stock — 1,000 shares issued and outstanding	0	0
Additional paid-in capital	256,416	256,180
Retained earnings (deficit)	(108,436)	(102,209)
Accumulated other comprehensive income (loss)	(18,445)	(14,769)
Total shareholders' equity	129,535	139,202
Total liabilities and shareholders' equity	$ 1,013,635	$ 1,022,069

XML

Intangible Assets Narrative (Details) (USD $)	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012	Dec. 29, 2012
Goodwill [Line Items]
Intangible assets, net	$ 73,637,000		$ 75,663,000
Amortization of intangible assets	2,100,000	2,100,000
Amortization in 2013			8,000,000
Amortization in 2014			7,000,000
Amortization of 2015			7,000,000
Amortization of 2016			7,000,000
Amortization of 2017			7,000,000
Interest Expense
Goodwill [Line Items]
Amortization of intangible assets	$ 600,000	$ 700,000

XML

Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Operating activities:
Net income (loss)	$ (6,227)	$ (265)
Adjustments for non-cash transactions:
Deferred income taxes	(28)	0
Depreciation and amortization expense	16,152	15,852
(Gain) loss on financial instruments	0	(147)
(Gain) loss on sale of assets, net	67	(6)
Non-cash compensation	236	204
Changes in operating assets and liabilities:
Accounts receivable	(9,884)	428
Inventories	(3,246)	5,756
Other current assets	(6,364)	(2,883)
Accounts payable and accrued liabilities	(3,534)	(2,381)
Other, net	(1,883)	3,056
Net cash provided by (used in) operating activities	(14,711)	19,614
Investing activities:
Purchases of property, plant and equipment	(14,317)	(13,312)
Proceeds from sale of assets	11	1,657
Acquisition of intangibles and other	(53)	(56)
Net cash provided by (used in) investing activities	(14,359)	(11,711)
Financing activities:
Proceeds from long-term borrowings	6,666	24
Proceeds from short-term borrowings	1,446	1,441
Repayment of long-term borrowings	(912)	(940)
Repayment of short-term borrowings	(848)	(2,072)
Net cash provided by (used in) financing activities	6,352	(1,547)
Effect of exchange rate changes on cash	(534)	523
Net change in cash and cash equivalents	(23,252)	6,879
Cash and cash equivalents - beginning of period	97,879	72,742
Cash and cash equivalents - end of period	74,627	79,621
Supplemental disclosures of cash flow information:
Cash payments for interest	22,300	23,537
Cash payments (receipts) for taxes, net	$ 3,435	$ 2,720

XML

Foreign Currency and Other, Net (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Component of Other Expense, Nonoperating [Line Items]
Foreign currency and other, net	$ (1,420)	$ 62
Foreign Currency Loss
Component of Other Expense, Nonoperating [Line Items]
Foreign currency and other, net	(1,000)	300
Other Non-Operating Expenses
Component of Other Expense, Nonoperating [Line Items]
Foreign currency and other, net	$ (400)	$ (200)

XML

Special Charges, Net (Tables)

3 Months Ended

Mar. 30, 2013

Special Charges, Net [Abstract]

Summary of special charges

These amounts are included in Special charges, net in the Statement of Operations. A summary for each respective period is as follows:

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Restructuring and plant realignment costs
Internal redesign and restructure of global operations	$	1,543	$	747
Plant realignment costs	96		673
IS support initiative	7		277
Other restructure initiatives	—		50
Total restructuring and plant realignment costs	1,646		1,747
Acquisition and merger related costs
Blackstone acquisition costs	—		361
Total acquisition and merger related costs	—		361
Other special charges
Other charges	158		311
Total other special charges	158		311
Total special charges, net	$	1,804	$	2,419

Summary of components of accrued liability with respect to Company's business restructuring activities

The changes in the restructuring reserves were as follows:

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Beginning balance	$	6,278		$	1,100
Additions	188			1,747
Cash payments	(2,535		)	(1,533		)
Adjustments	(57		)	39
Ending balance	$	3,874		$	1,353

XML

Financial Guarantees and Condensed Consolidating Financial Statements Narrative (Details)	Mar. 30, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Subsidiary guarantors are owned by PGI	100.00%

XML

Commitments and Contingencies

3 Months Ended

Mar. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

The Company is involved from time to time in various litigations, claims and administrative proceedings arising out of the ordinary conduct of its business. Amounts recorded for identified contingent liabilities are estimates, which are reviewed periodically and adjusted to reflect additional information when it becomes available. Subject to the uncertainties inherent in estimating future costs for contingent liabilities, management believes that any liability which may result from these legal matters would not have a material adverse effect on the Company's business or financial condition.

Environmental

The Company is subject to a broad range of federal, foreign, state and local laws and regulations relating to pollution and protection of the environment. The Company believes that it is currently in substantial compliance with applicable environmental requirements and does not currently anticipate any material adverse effect on its operations, financial or competitive position as a result of its efforts to comply with environmental requirements. Some risk of environmental liability is inherent, however, in the nature of the Company’s business and, accordingly, there can be no assurance that material environmental liabilities will not arise.

Equipment Lease Agreement

In the third quarter of 2011, the Company's state-of-the-art spunmelt line in Waynesboro, Virginia commenced commercial production. The plant expansion increased capacity to meet demand for nonwoven materials in the hygiene and healthcare applications in the U.S. The line was principally funded by a seven year equipment lease with a capitalized cost of $53.6 million. From the commencement of the lease to its fourth anniversary date, the Company will make annual lease payments of $8.3 million. From the fourth anniversary date to the end of the lease term, the Company's annual lease payments may change, as defined in the lease agreement. The aggregate monthly lease payments under the agreement, subject to adjustment, are expected to approximate $58 million. The lease includes covenants, events of default and other provisions that requires us to maintain certain financial ratios and other requirements.

China Hygiene Expansion

In the second quarter of 2011, the Company entered into a firm purchase agreement to acquire a spunmelt line to be installed in Suzhou, China that will manufacture nonwoven products primarily for the hygiene market. The Company plans to fund the project using a combination of existing cash balances, internal cash flows and the Hygiene Facility. As of March 30, 2013, the estimated total remaining project costs related to the firm commitment to purchase equipment was $12.8 million. As a result of the firm commitment being denominated in Euros, we entered into a series of foreign exchange forward contracts with a third-party financial institution to purchase fixed amount of Euros on specified future dates that coincide with the payment amounts and the dates of the payments.

XML

Segment Information (Tables)

3 Months Ended

Mar. 30, 2013

Segment Reporting [Abstract]

Financial data by segment

Financial data by segment is as follows:

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Net sales
Americas Nonwovens	$	153,004		$	165,893
Europe Nonwovens	78,274			75,667
Asia Nonwovens	37,967			36,423
Oriented Polymers	17,837			17,188
Total	$	287,082		$	295,171
Operating income (loss)
Americas Nonwovens	$	11,474		$	19,289
Europe Nonwovens	3,292			3,647
Asia Nonwovens	4,553			4,011
Oriented Polymers	1,593			1,677
Unallocated Corporate	(9,692		)	(9,368		)
Eliminations	(36		)	161
Subtotal	11,184			19,417
Special charges, net	(1,804		)	(2,419		)
Total	$	9,380		$	16,998
Depreciation and amortization expense
Americas Nonwovens	$	8,317		$	8,337
Europe Nonwovens	3,059			2,695
Asia Nonwovens	3,389			3,317
Oriented Polymers	348			381
Unallocated Corporate	432			437
Subtotal	15,545			15,167
Amortization of loan acquisition costs	607			685
Total	$	16,152		$	15,852
Capital spending
Americas Nonwovens	$	818		$	640
Europe Nonwovens	548			2,243
Asia Nonwovens	12,559			9,709
Oriented Polymers	125			86
Corporate	267			634
Total	$	14,317		$	13,312

Division Assets

In thousands	March 30, 2013		December 29, 2012
Division assets
Americas Nonwovens	$	494,577	$	513,765
Europe Nonwovens	197,831		202,139
Asia Nonwovens	255,873		248,790
Oriented Polymers	28,626		25,329
Corporate	36,728		32,046
Total	$	1,013,635	$	1,022,069

XML

Certain Relationships and Related Party Transactions

3 Months Ended

Mar. 30, 2013

Related Party Transactions [Abstract]

Certain Relationships and Related Party Transactions

Certain Relationships and Related Party Transactions

In connection with the Merger, Holdings entered into a shareholders agreement (the “Shareholders Agreement”) with Blackstone and certain members of the Company's management. The Shareholders Agreement governs certain matters relating to ownership of Holdings, including the election of directors of our parent companies, restrictions on the issuance or transfer of shares, including tag-along rights and drag-along rights, other special corporate governance provisions and registration rights (including customary indemnification provisions). As of March 30, 2013, the Board of Directors of the Company includes three Blackstone members, three outside members and the Company’s Chief Executive Officer. Furthermore, Blackstone has the power to designate all of the members of the Board of Directors of the Company and the right to remove any or all directors, with or without cause.

Management Services Agreement

Upon the completion of the Merger, the Company became subject to a management services agreement (“Management Services Agreement”) with Blackstone Management Partners V L.L.C. (“BMP”), an affiliate of Blackstone. Under the Management Services Agreement, BMP (including through its affiliates) has agreed to provide certain monitoring, advisory and consulting services for an annual non-refundable advisory fee, to be paid at the beginning of each fiscal year, equal to the greater of (i) $3.0 million or (ii) 2.0% of the Company’s consolidated EBITDA (as defined under the credit agreement governing our ABL Facility) for the immediately preceding fiscal year. The amount of such fee shall be initially paid based on the Company’s then most current estimate of the Company’s projected EBITDA amount for the fiscal year immediately preceding the date upon which the advisory fee is paid. After completion of the fiscal year to which the fee relates and following the availability of audited financial statements for such period, the parties will recalculate the amount of such fee based on the actual consolidated EBITDA for such period and the Company or BMP, as applicable, shall adjust such payment as necessary based on the recalculated amount. Based on the Company’s fiscal 2012 financial performance, the advisory fee for the fiscal year ended December 29, 2012 remained at $3.0 million. With respect to the fiscal 2013 advisory fee, the Company paid $3.0 million during the first quarter of 2013. These amounts are included in Selling, general and administrative expenses in the Consolidated Statements of Operations.

Other Relationships

Blackstone and its affiliates have ownership interests in a broad range of companies. We may enter into commercial transactions in the ordinary course of our business with some of these companies, including the sale of goods and services and the purchase of goods and services.

XML

Financial Guarantees and Condensed Consolidating Statement of Cash Flows (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Operating activities:
Net cash (used in) provided by operating activities	$ (14,711)	$ 19,614
Investing activities:
Purchases of property, plant and equipment	(14,317)	(13,312)
Proceeds from sale of assets	11	1,657
Acquisition of intangibles and other	(53)	(56)
Intercompany investing activities, net	0	0
Net cash provided by (used in) investing activities	(14,359)	(11,711)
Financing activities:
Proceeds from long-term borrowings	6,666	24
Proceeds from short-term borrowings	1,446	1,441
Repayment of long-term borrowings	(912)	(940)
Repayment of short-term borrowings	(848)	(2,072)
Intercompany financing activities, net	0	0
Net cash provided by (used in) financing activities	6,352	(1,547)
Effect of exchange rate changes on cash	(534)	523
Net change in cash and cash equivalents	(23,252)	6,879
Cash and cash equivalents - beginning of period	97,879	72,742
Cash and cash equivalents - end of period	74,627	79,621
PGI (Issuer)
Operating activities:
Net cash (used in) provided by operating activities	(15,118)	(31,450)
Investing activities:
Purchases of property, plant and equipment	(10,592)	(8,316)
Proceeds from sale of assets	0	0
Acquisition of intangibles and other	(53)	(56)
Intercompany investing activities, net	5,766	15,771
Net cash provided by (used in) investing activities	(4,879)	7,399
Financing activities:
Proceeds from long-term borrowings	0	0
Proceeds from short-term borrowings	1,446	1,436
Repayment of long-term borrowings	(27)	(22)
Repayment of short-term borrowings	(848)	(72)
Intercompany financing activities, net	23,000	25,770
Net cash provided by (used in) financing activities	23,571	27,112
Effect of exchange rate changes on cash	0	0
Net change in cash and cash equivalents	3,574	3,061
Cash and cash equivalents - beginning of period	486	3,135
Cash and cash equivalents - end of period	4,060	6,196
Guarantors
Operating activities:
Net cash (used in) provided by operating activities	16,397	28,014
Investing activities:
Purchases of property, plant and equipment	(682)	(623)
Proceeds from sale of assets	0	1,646
Acquisition of intangibles and other	0	0
Intercompany investing activities, net	(23,000)	(25,770)
Net cash provided by (used in) investing activities	(23,682)	(24,747)
Financing activities:
Proceeds from long-term borrowings	0	0
Proceeds from short-term borrowings	0	0
Repayment of long-term borrowings	0	0
Repayment of short-term borrowings	0	0
Intercompany financing activities, net	(5,766)	(6,990)
Net cash provided by (used in) financing activities	(5,766)	(6,990)
Effect of exchange rate changes on cash	0	0
Net change in cash and cash equivalents	(13,051)	(3,723)
Cash and cash equivalents - beginning of period	28,285	14,574
Cash and cash equivalents - end of period	15,234	10,851
Non-Guarantors
Operating activities:
Net cash (used in) provided by operating activities	(15,990)	23,050
Investing activities:
Purchases of property, plant and equipment	(3,043)	(4,373)
Proceeds from sale of assets	11	11
Acquisition of intangibles and other	0	0
Intercompany investing activities, net	0	(8,781)
Net cash provided by (used in) investing activities	(3,032)	(13,143)
Financing activities:
Proceeds from long-term borrowings	6,666	24
Proceeds from short-term borrowings	0	5
Repayment of long-term borrowings	(885)	(918)
Repayment of short-term borrowings	0	(2,000)
Intercompany financing activities, net	0	0
Net cash provided by (used in) financing activities	5,781	(2,889)
Effect of exchange rate changes on cash	(534)	523
Net change in cash and cash equivalents	(13,775)	7,541
Cash and cash equivalents - beginning of period	69,108	55,033
Cash and cash equivalents - end of period	55,333	62,574
Eliminations
Operating activities:
Net cash (used in) provided by operating activities	0	0
Investing activities:
Purchases of property, plant and equipment	0	0
Proceeds from sale of assets	0	0
Acquisition of intangibles and other	0	0
Intercompany investing activities, net	17,234	18,780
Net cash provided by (used in) investing activities	17,234	18,780
Financing activities:
Proceeds from long-term borrowings	0	0
Proceeds from short-term borrowings	0	0
Repayment of long-term borrowings	0	0
Repayment of short-term borrowings	0	0
Intercompany financing activities, net	(17,234)	(18,780)
Net cash provided by (used in) financing activities	(17,234)	(18,780)
Effect of exchange rate changes on cash	0	0
Net change in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	$ 0	$ 0

XML

Description of Business

3 Months Ended

Mar. 30, 2013

Accounting Policies [Abstract]

Business Description

Description of Business

Polymer Group, Inc. (“Polymer” or “PGI”), a Delaware corporation, and its consolidated subsidiaries (the “Company”) is a leading global innovator, manufacturer and marketer of engineered materials, primarily focused on the production of nonwoven products. The Company has one of the largest global platforms in the industry, with a total of 13 manufacturing and converting facilities located in 9 countries throughout the world. The Company operates through 4 reportable segments, with the main sources of revenue being the sales of primary and intermediate products to the hygiene, healthcare, wipes and industrial markets.

Basis of Presentation

The accompanying consolidated financial statements reflect the consolidated operations of the Company and have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) as defined by the Financial Accounting Standards Board (“FASB”) within the FASB Accounting Standards Codification (“ASC”). In the opinion of management, the accompanying consolidated financial statements contain all adjustments, which include normal recurring adjustments, necessary to present fairly the consolidated results for the periods presented. The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Polymer Group, Inc. Annual Report on Form 10-K for the year ended December 29, 2012.

On January 28, 2011, pursuant to an Agreement and Plan of Merger, dated as of October 4, 2010, the Company was acquired by affiliates of the Blackstone Group (“Blackstone”), along with certain members of the Company's management (the "Merger"), for an aggregate purchase price valued at $403.5 million. As a result, the Company became a privately-held company. The Merger was financed by $560.0 million in aggregate principal of debt financing as well as common equity capital. In addition, the Company repaid its existing outstanding debt. Although the Company continues to operate as the same legal entity subsequent to the Merger and related change in control, a new entity was created for accounting purposes as of January 28, 2011. As a result, the purchase price was allocated to assets acquired and liabilities assumed based on their estimated fair market values at the date of acquisition. Under the guidance of the Securities and Exchange Commission ("SEC") Staff Accounting Bulletin Topic 5J, “New Basis of Accounting Required in Certain Circumstances,” push-down accounting is required when such transactions result in an entity being substantially wholly-owned. Therefore, the basis in shares of common stock of the Company has been "pushed down" to the Company from Scorpio Holdings Corporation, a Delaware corporation ("Holdings") that owns 100% of the issued and outstanding stock of Scorpio Acquisition Corporation, a Delaware corporation ("Parent") that owns 100% of the issued and outstanding common stock of the Company.

The Company's fiscal year is based on a 52 week period ending on the Saturday closest to each December 31. Therefore, the financial results of 53-week fiscal years, and the associated 14-week quarters, will not be comparable to the prior and subsequent 52-week fiscal years and the associated quarters having only 13 weeks. The three months ended March 30, 2013 and March 31, 2012 each contain operating results for 13 weeks.

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Statement of Financial Position [Abstract]
Accumulated depreciation	$ 119,170	$ 106,134
Common stock, shares issued	1,000	1,000
Common stock, shares outstanding	1,000	1,000

XML

Pension and Postretirement Benefit Plans

3 Months Ended

Mar. 30, 2013

Compensation and Retirement Disclosure [Abstract]

Pension and Postretirement Benefit Plans

Pension and Postretirement Benefit Plans

The Company and its subsidiaries sponsor multiple defined benefit plans that cover certain employees. Postretirement benefit plans, other than pensions, provide healthcare benefits for certain eligible employees. Benefits are primarily based on years of service and the employee’s compensation.

Pension Plans

The Company has both funded and unfunded pension benefit plans. It is the Company’s policy to fund such plans in accordance with applicable laws and regulations in order to ensure adequate funds are available in the plans to make benefit payments to plan participants and beneficiaries when required.

The components of the Company's pension related costs for the following periods are as follows:

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Service cost	$	844		$	510
Interest cost	1,391			1,442
Return on plan assets	(1,884		)	(1,616		)
Curtailment / settlement (gain) loss	—			—
Net amortization of:
Transition costs and other	88			(16		)
Net periodic benefit cost	$	439		$	320

During the fourth quarter of 2012, the Company completed the liquidation of two pension plans related to its former Dominion Textile, Inc. business in Canada. All pension benefits legally owed to plan participants were fully paid from plan assets by the end of 2012. Excess plan assets left in the trust after all participants were paid was $0.3 million and is reported within Other current assets in the Company's Consolidated Balance Sheet at December 29, 2012. The surplus was received by the Company in the first quarter of 2013. As a result of the liquidation of these plans during 2012, the Company recognized a settlement loss of $0.8 million within Special charges, net in the Company's Consolidated Statement of Operations.

The Company’s practice is to fund amounts for its qualified pension plans at least sufficient to meet the minimum requirements set forth in applicable employee benefit laws and local tax laws. In addition, the Company manages these plans to ensure that all present and future benefit obligations are met as they come due. During the three months ended March 30, 2013, employer contributions totaled $1.7 million. Full year contributions are expected to approximate $5.3 million.

Postretirement Plans

The Company sponsors several non-U.S. postretirement plans that provide healthcare benefits to cover certain eligible employees. These plans have no plan assets, but instead are funded by the Company on a pay-as-you-go basis in the form of direct benefit payments.

The components of the Company's postretirement related costs for the following periods are as follows:

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Service cost	$	15	$	18
Interest cost	46		54
Curtailment / settlement (gain) loss	—		—
Net amortization of:
Transition costs and other	9		6
Net periodic benefit cost	$	70	$	78

For the three months ended March 30, 2013 and March 31, 2012, reclassifications out of accumulated other comprehensive income (loss) totaled $0.1 million and less than $0.1 million, respectively. These amounts related to net actuarial gains/losses included in the computation of net periodic benefit cost for both pension and postretirement benefit plans.

Defined Contribution Plans

The Company sponsors several defined contribution plans through its domestic subsidiaries covering employees who meet certain service requirements.  The Company makes matching contributions to the plans based upon a percentage of the employee's contribution in the case of its 401(k) plans and makes safe harbor contributions based on the employee's eligibility to participate in the plan.  In the case of the non-qualified Executive Retirement Plan, the Company does not make any contributions.

XML

Document and Entity Information	3 Months Ended
	Mar. 30, 2013	May 03, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	POLYMER GROUP INC
Entity Central Index Key	0000927417
Document Type	10-Q
Document Period End Date	Mar. 30, 2013
Amendment Flag	false
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-28
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		1,000

XML

Income Taxes

3 Months Ended

Mar. 30, 2013

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company accounts for its provision for income taxes in accordance with ASC 740, "Income Taxes," which requires an estimate of the annual effective tax rate for the full year to be applied to the respective interim period, taking into account year-to-date amounts and projected results for the full year. For the three months ended March 30, 2013, the combination of the Company's income tax provision and recorded loss from operations before income taxes resulted in a negative 51.0% effective tax rate for the period. For the three months ended March 31, 2012, the effective tax rate was 106.3%. The effective tax rate for the three months ended March 30, 2013 is different than the Company's statutory tax rate primarily due to losses in certain jurisdictions for which no income tax benefits are anticipated, foreign withholding taxes for which tax credits are not anticipated, changes in the amounts of tax uncertainties and foreign taxes calculated at statutory rates different than the U.S. statutory rate.

Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax reporting purposes and (b) operating loss and tax credit carryforwards. A valuation allowance is recorded when, based on the weight of the evidence, it is more likely than not that some portion, or all, of the deferred tax asset will not be realized. The realization of the deferred tax asset depends on the ability to generate sufficient taxable income of the appropriate character in the future and in the appropriate taxing jurisdiction. At March 30, 2013, the Company has a net deferred tax liability of $28.5 million.

At March 30, 2013, the Company had unrecognized tax benefits of $24.2 million, of which $11.4 million relates to accrued interest and penalties. These amounts are included within Other noncurrent liabilities within the accompanying consolidated balance sheet. The total amount of unrecognized tax benefits that, if recognized, would affect the Company's effective tax rate is $24.2 million as of March 30, 2013. Included in the balance as of March 30, 2013 is $4.2 million related to tax positions for which it is reasonably possible that the total amounts could significantly change during the next twelve months. This amount is comprised of items which relate to the lapse of statute of limitations or the settlement of issues. The Company recognizes interest and/or penalties related to income taxes as a component of income tax expense.

Management judgment is required in determining tax provisions and evaluating tax positions. Although management believes its tax positions and related provisions reflected in the consolidated financial statements are fully supportable, it recognizes that these tax positions and related provisions may be challenged by various tax authorities. These tax positions and related provisions are reviewed on an ongoing basis and are adjusted as additional facts and information become available, including progress on tax audits, changes in interpretations of tax laws, developments in case law and closing of statute of limitations. The Company’s tax provision includes the impact of recording reserves and any changes thereto.

The major jurisdictions where the Company files income tax returns include the United States, Canada, China, the Netherlands, France, Germany, Spain, Mexico, Colombia, and Argentina. As of March 30, 2013, the Company has a number of open tax years with various taxing jurisdictions that range from 2003 to 2012. The results of current tax audits and reviews related to open tax years have not been finalized, and management believes that the ultimate outcomes of these audits and reviews will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

XML

Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Income Statement [Abstract]
Net sales	$ 287,082	$ 295,171
Cost of goods sold	(241,216)	(241,984)
Gross profit	45,866	53,187
Selling, general and administrative expenses	(34,342)	(34,131)
Special charges, net	(1,804)	(2,419)
Other operating, net	(340)	361
Operating income (loss)	9,380	16,998
Other income (expense):
Interest expense	(12,084)	(12,848)
Foreign currency and other, net	(1,420)	62
Income (loss) before income taxes	(4,124)	4,212
Income tax (provision) benefit	(2,103)	(4,477)
Net income (loss)	(6,227)	(265)
Other comprehensive income (loss):
Currency translation	(3,772)	4,823
Employee postretirement benefits, net of tax	96	0
Other comprehensive income (loss)	(3,676)	4,823
Other comprehensive income (loss)	$ (9,903)	$ 4,558

XML

Intangible Assets

3 Months Ended

Mar. 30, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangible Assets

Indefinite-lived intangible assets are tested and reviewed annually for impairment during the fourth quarter or whenever there is a significant change in events or circumstances that indicate that the fair value of the asset may be less than the carrying amount of the asset. All other intangible assets with finite useful lives are being amortized on a straight-line basis over their estimated useful lives.

The following table sets forth the gross amount and accumulated amortization of the Company's intangible assets at March 30, 2013 and December 29, 2012:

In thousands	March 30, 2013			December 29, 2012
Technology	$	31,900		$	31,900
Customer relationships	16,896			16,869
Loan acquisition costs	19,472			19,472
Other	498			446
Total gross finite-lived intangible assets	68,766			68,687
Accumulated amortization	(18,629		)	(16,524		)
Total net finite-lived intangible assets	50,137			52,163
Tradenames (indefinite-lived)	23,500			23,500
Total	$	73,637		$	75,663

As of March 30, 2013, the Company had recorded intangible assets of $73.6 million. Included in this amount are loan acquisition costs incurred in association with the Merger. These expenditures represent the cost of obtaining financings that are capitalized in the balance sheet and amortized over the term of the loans to which such costs relate.

Amortization of intangible assets was $2.1 million and $2.1 million for the three months ended March 30, 2013 and March 31, 2012, respectively, of which $0.6 million and $0.7 million were charged to Interest expense, respectively, related to the amortization of loan acquisition costs. Estimated amortization expense on existing intangible assets for each of the next five years, including fiscal year 2013, is expected to approximate $8 million in 2013, $7 million in 2014, $7 million in 2015, $7 million in 2016 and $7 million in 2017.

XML

Inventories, Net

3 Months Ended

Mar. 30, 2013

Inventory Disclosure [Abstract]

Inventories, Net

Inventories, Net

At March 30, 2013 and December 29, 2012, the major classes of inventory were as follows:

In thousands	March 30, 2013		December 29, 2012
Raw materials and supplies	$	42,438	$	41,070
Work in process	14,493		14,299
Finished goods	39,961		39,595
Total	$	96,892	$	94,964

Inventories are stated at the lower of cost, determined on the first-in, first-out ("FIFO") method, or fair market value. The Company performs periodic assessments to determine the existence of obsolete, slow-moving and non-saleable inventories and records necessary provisions to reduce such inventories to net realizable value. Reserve balances, primarily related to obsolete and slow-moving inventories, were $3.1 million and $3.3 million at March 30, 2013 and December 29, 2012, respectively.

XML

Segment Information

3 Months Ended

Mar. 30, 2013

Segment Reporting [Abstract]

Segment Information

Segment Information

The Company is a leading global innovator, manufacturer and marketer of engineered materials, primarily focused on the production of nonwoven products. The Company operates through four segments, with the main source of revenue being the sales of primary and intermediate products to the hygiene, healthcare, wipes and industrial markets. The Company has one major customer that accounts for over 10% of its business, the loss of which would have a material adverse impact on reported financial results. Sales to this customer are reported within each of the the Nonwoven segments.

During 2012, the Company approved the internal redesign and restructuring of its global operations for the purposes of realigning and repositioning the Company to consolidate the benefits of its global footprint, align resources and capabilities with future growth opportunities and provide for a more efficient structure to serve existing markets. As part of the change, the Company eliminated the Latin America Nonwovens segment and merged it with the U.S. Nonwoven segment to create the Americas Nonwoven segment. The Company's segments are now as follows: Americas Nonwovens, Europe Nonwovens, Asia Nonwovens and Oriented Polymers segments. Segment information for all years has been revised to reflect the new structure.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies except that the segment results are prepared on a management basis that is consistent with the manner in which the Company desegregates financial information for internal review and decision making. Intercompany sales between the segments are eliminated.

Financial data by segment is as follows:

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Net sales
Americas Nonwovens	$	153,004		$	165,893
Europe Nonwovens	78,274			75,667
Asia Nonwovens	37,967			36,423
Oriented Polymers	17,837			17,188
Total	$	287,082		$	295,171
Operating income (loss)
Americas Nonwovens	$	11,474		$	19,289
Europe Nonwovens	3,292			3,647
Asia Nonwovens	4,553			4,011
Oriented Polymers	1,593			1,677
Unallocated Corporate	(9,692		)	(9,368		)
Eliminations	(36		)	161
Subtotal	11,184			19,417
Special charges, net	(1,804		)	(2,419		)
Total	$	9,380		$	16,998
Depreciation and amortization expense
Americas Nonwovens	$	8,317		$	8,337
Europe Nonwovens	3,059			2,695
Asia Nonwovens	3,389			3,317
Oriented Polymers	348			381
Unallocated Corporate	432			437
Subtotal	15,545			15,167
Amortization of loan acquisition costs	607			685
Total	$	16,152		$	15,852
Capital spending
Americas Nonwovens	$	818		$	640
Europe Nonwovens	548			2,243
Asia Nonwovens	12,559			9,709
Oriented Polymers	125			86
Corporate	267			634
Total	$	14,317		$	13,312

In thousands	March 30, 2013		December 29, 2012
Division assets
Americas Nonwovens	$	494,577	$	513,765
Europe Nonwovens	197,831		202,139
Asia Nonwovens	255,873		248,790
Oriented Polymers	28,626		25,329
Corporate	36,728		32,046
Total	$	1,013,635	$	1,022,069

XML

Special Charges, Net

3 Months Ended

Mar. 30, 2013

Special Charges, Net [Abstract]

Special Charges, Net

Special Charges, Net

As part of our business strategy, the Company incurs amounts related to corporate-level decisions or Board of Director actions. These actions are primarily associated with initiatives attributable to restructuring and realignment of manufacturing operations and management structures as well as the pursuit of certain transaction opportunities when applicable. In addition, the Company evaluates its long-lived assets for impairment whenever events or changes in circumstances including the aforementioned, indicate that the carrying amounts may not be recoverable. These amounts are included in Special charges, net in the Statement of Operations. A summary for each respective period is as follows:

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Restructuring and plant realignment costs
Internal redesign and restructure of global operations	$	1,543	$	747
Plant realignment costs	96		673
IS support initiative	7		277
Other restructure initiatives	—		50
Total restructuring and plant realignment costs	1,646		1,747
Acquisition and merger related costs
Blackstone acquisition costs	—		361
Total acquisition and merger related costs	—		361
Other special charges
Other charges	158		311
Total other special charges	158		311
Total special charges, net	$	1,804	$	2,419

Restructuring and Plant Realignment Costs

Internal redesign and restructuring of global operations

During 2012, the Company initiated the internal redesign and restructuring of its global operations for the purposes of realigning and repositioning the Company to consolidate the benefits of its global footprint, align resources and capabilities with future growth opportunities and provide for a more efficient structure to serve existing markets. During the three months ended March 30, 2013, the Company incurred $1.5 million associated with this initiative, of which $1.2 million related to professional consulting fees and $0.1 million related to employee separations. Costs related to employee relocation, recruitment and other administrative costs were $0.2 million. During the three months ended March 31, 2012, the Company incurred $0.7 million, which related to professional consulting fees.

Plant Realignment Costs

The Company incurs costs associated with ongoing restructuring initiatives intended to result in lower working capital levels and improve operating performance and profitability. Costs associated with these initiatives include improving manufacturing productivity, reducing headcount, realignment of management structures, reducing corporate costs and rationalizing certain assets, businesses and employee benefit programs. For the three months ended March 30, 2013 and March 31, 2012, the Company incurred costs of $0.1 million and $0.7 million, respectively, associated with plant realignment initiatives primarily in the Americas and Europe regions.

IS Support Initiative

During 2012, the Company launched an initiative to utilize a third-party service provider for its Information Systems support tactical functions, including: service desk; desktop/end-user computing; server administration; network services; data center operations; database and applications development; and maintenance. For the three months ended March 30, 2013 and March 31, 2012, the Company incurred less than $0.01 millionand $0.3 million, respectively, associated with this initiative, which consisted primarily of employee separation and severance expenses.

Other Restructuring Initiatives

The Company incurs costs associated with less significant ongoing restructuring initiatives resulting from the continuous evaluation of opportunities to optimize the manufacturing process. During the three months ended March 31, 2012, costs associated with these initiatives were $0.1 million.

The changes in the restructuring reserves were as follows:

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Beginning balance	$	6,278		$	1,100
Additions	188			1,747
Cash payments	(2,535		)	(1,533		)
Adjustments	(57		)	39
Ending balance	$	3,874		$	1,353

The Company accounts for its restructuring programs in accordance with ASC 712, "Compensation - Non-retirement Postemployment Benefits" ("ASC 712") and anticipates that the substantial majority of the remaining accrued liability will be paid by the end of 2013.

Acquisition and Merger Related Costs

Blackstone Acquisition Costs

As a result of the Merger on January 28, 2011, the Company incurred direct acquisition costs associated with the transaction including investment banking, legal, accounting and other fees for professional services. For the three months ended March 31, 2012, the Company incurred $0.4 million of costs associated with the Merger.

Other Special Charges

Other Charges

Other charges consist primarily of expenses related to the Company’s pursuit of other business opportunities. The Company reviews its business operations on an ongoing basis in light of current and anticipated market conditions and other factors and, from time to time, may undertake certain actions in order to optimize overall business, performance or competitive position. To the extent any such decisions are made, the Company would likely incur costs associated with such actions, which could be material.

XML

Derivatives Instruments

3 Months Ended

Mar. 30, 2013

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives Instruments

Derivative Instruments

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. These fluctuations can increase the cost of financing, investing and operating the business. The Company uses derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes.

All derivatives are recognized on the Consolidated Balance Sheet at their fair value as either assets or liabilities. On the date the derivative contract is entered into, the Company designates the derivative as (1) a hedge of the fair value of a recognized asset or liability (fair value hedge), (2) a hedge of a forecasted transaction or the variability of cash flow to be paid (cash flow hedge), or (3) an undesignated instrument. Changes in the fair value of a derivative that is designated as a fair value hedge and determined to be highly effective are recorded in current earnings, along with the gain or loss on the recognized hedged asset or liability that is attributable to the hedged risk. Changes in the fair value of a derivative that is designated as a cash flow hedge and considered highly effective are recorded in Accumulated other comprehensive income (loss) until they are reclassified to earnings in the same period or periods during which the hedged transaction affects earnings. Changes in the fair value of undesignated derivative instruments and the ineffective portion of designated derivative instruments are reported in current earnings.

The Company formally documents all relationships between hedging instruments and hedged items, as well as the risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives that are designated as fair value hedges to specific assets and liabilities on the Consolidated Balance Sheet and linking cash flow hedges to specific forecasted transactions or variability of cash flow to be paid.

The Company also formally assesses, both at the hedge's inception and on an ongoing basis, whether the designated derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flow of hedged items. When a derivative is determined not to be highly effective as a hedge or the underlying hedged transaction is no longer probable, hedge accounting is discontinued prospectively, in accordance with current accounting standards.

The following table presents the fair values of the Company's derivative instruments included within Accounts payable and accrued expenses on the Consolidated Balance Sheets as of March 30, 2013 and December 29, 2012:

	As of March 30, 2013					As of December 29, 2012
In thousands	Notional		Fair Value			Notional		Fair Value
Designated hedges:
Hygiene contracts	$	12,779	$	(1,309	)	$	22,554	$	(1,248	)
Undesignated hedges:
Healthcare contracts	—		—			—		—
Total	$	12,779	$	(1,309	)	$	22,554	$	(1,248	)

Hygiene Contracts

On June 30, 2011, the Company entered into a series of foreign exchange forward contracts with a third-party financial institution used to minimize foreign exchange risk on certain future cash commitments related to the new hygiene line under construction in China (the "Hygiene Contracts"). The contracts allow the Company to purchase fixed amount of Euros on specified future dates, coinciding with the payment amounts and dates of equipment purchase contracts. The Hygiene Contracts qualify for hedge accounting treatment and are considered a fair value hedge; therefore, changes in the fair value of each contract is recorded in Foreign currency and other, net along with the gain or loss on the recognized hedged asset or liability that is attributable to the hedged risk. Since inception, the Company amended the equipment purchase contract on the hygiene line to which the Hygiene Contracts are linked. However, the Company modified the notional amounts of the Hygiene Contracts to synchronize with the underlying updated contract payments. As a result, the Hygiene Contracts remain highly effective and continue to qualify for hedge accounting treatment.

Healthcare Contracts

In January 2011, the Company entered into a series of foreign exchange forward contracts with a third-party financial institution used to minimize foreign exchange risk on certain future cash commitments related to the new healthcare line under construction in China (the "Healthcare Contracts"). The contracts allowed the Company to purchase fixed amount of Euros on specified future dates, coinciding with the payment amounts and dates of equipment purchase contracts. The Healthcare Contracts qualified for hedge accounting treatment and were considered a fair value hedge; therefore, changes in the fair value of each contract was recorded in Foreign currency and other, net along with the gain or loss on the recognized hedged asset or liability that was attributable to the hedged risk.

In July 2011, the Company completed commercial acceptance of the new healthcare line under construction in China and recorded a liability for the remaining balance due. As a result, the Company removed the hedge designation of the Healthcare Contracts and will continue to recognize changes in the fair value of the contracts in current earnings as an undesignated hedge. However, changes in the fair value of the hedged asset that is attributable to the hedged risk has been capitalized in the cost base of the healthcare line and no longer recognized in current earnings. During the first quarter of 2012, the Company remitted the final payment on the healthcare line and simultaneously fulfilled its obligations under the Healthcare Contracts.

The following table represents the amount of (gain) or loss associated with derivatives designated as hedges affecting Foreign currency and other, net in the Consolidated Statement of Operations:

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Designated hedges:
Hygiene contracts	61		(1,226		)
Undesignated hedges:
Healthcare contracts	—		(147		)
Total	$	61	$	(1,373	)

Gains and losses associated with the Company's designated fair value hedges are materially offset within Foreign currency and other, net by the changes in the fair value of the underlying transactions. However, once the hedge is undesignated, the fair value of the underlying transaction is no longer recognized in earnings.

XML

Commitments and Contingencies Narrative (Details) (USD $) In Millions, unless otherwise specified			3 Months Ended
	Oct. 01, 2011	Jul. 02, 2011 Firm Commitment to Purchase Equipment	Oct. 01, 2011 Equipment
Capital Leased Assets [Line Items]
Capital Lease, Term			7 years
Capital lease assets	$ 53.6
Capital lease annual payment	8.3
Purchase commitment		$ 12.8

XML

Accounts Payable and Accrued Liabilities

3 Months Ended

Mar. 30, 2013

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consist of the following:

In thousands	March 30, 2013		December 29, 2012
Accounts payable to vendors	$	135,308	$	127,969
Accrued salaries, wages, incentive compensation and other fringe benefits	23,344		21,759
Accrued interest	7,821		18,630
Other accrued expenses	26,703		28,547
Total	$	193,176	$	196,905

XML

Debt

3 Months Ended

Mar. 30, 2013

Debt Disclosure [Abstract]

Debt

Debt

The following table presents the Company's long-term debt at March 30, 2013 and December 29, 2012:

In thousands	March 30, 2013			December 29, 2012
Senior Secured Notes	$	560,000		$	560,000
ABL Facility	—			—
Argentine Facility	10,842			11,674
China credit facilities:
China Credit Facility — Healthcare	15,981			15,981
China Credit Facility — Hygiene	17,642			10,977
Capital lease obligations	197			244
Total debt	604,662			598,876
Less: Current maturities	(21,463		)	(19,477		)
Total long-term debt	$	583,199		$	579,399

The fair value of the Company's long-term debt was $649.0 million at March 30, 2013 and $640.0 million at December 29, 2012. The fair value of long-term debt is based upon quoted market prices in inactive markets or on available rates for debt with similar terms and maturities (Level 2).

Senior Secured Notes

In connection with the Merger, the Company issued $560.0 million of 7.75% Senior Secured Notes on January 28, 2011. The notes are due in 2019 and are fully and unconditionally guaranteed, jointly and severally on a senior secured basis, by each of the Polymer Group's wholly-owned domestic subsidiaries. Interest on the notes is paid semi-annually on February 1 and August 1.

The agreement governing the Senior Secured Notes, among other restrictions, limits the Company's ability and the ability of the Company's restricted subsidiaries to: (i) incur or guarantee additional debt or issue disqualified stock or preferred stock; (ii) pay dividends and make other distributions on, or redeem or repurchase, capital stock; (iii) make certain investments; (iv) repurchase stock; (v) incur certain liens; (vi) enter into transactions with affiliates; (vii) merge or consolidate; (viii) enter into agreements that restrict the ability of subsidiaries to make dividends or other payments to Polymer Group, Inc.; (ix) designate restricted subsidiaries as unrestricted subsidiaries; and (x) transfer or sell assets. However, subject to certain exceptions, the indenture permits the Company and its restricted subsidiaries to incur additional indebtedness, including senior indebtedness and secured indebtedness. The indenture also does not limit the amount of additional indebtedness that Parent or its parent entities may incur.

Under the agreement governing the Senior Secured Notes and under the credit agreement governing the senior secured asset-based revolving credit facility, the Company's ability to engage in activities such as incurring additional indebtedness, making investments, refinancing certain indebtedness, paying dividends and entering into certain merger transactions is governed, in part, by the Company's ability to satisfy tests based on Adjusted EBITDA as defined in the indenture.

ABL Facility

In connection with the Merger, the Company entered into a senior secured asset-based revolving credit facility (the "ABL Facility") to provide for borrowings not to exceed $50.0 million, subject to borrowing base availability. The ABL Facility provides borrowing capacity available for letters of credit and borrowings on a same-day basis. The ABL Facility is comprised of (i) a revolving tranche of up to $42.5 million (“Tranche 1”) and (ii) a first-in, last out revolving tranche of up to $7.5 million (“Tranche 2”). Provided that no default or event of default was then existing or would arise therefrom, the Company had the option to request that the ABL Facility be increased by an amount not to exceed $20.0 million, subject to certain rights of the administrative agent, swing line lender and issuing banks with respect to the lenders providing commitments for such increase. The facility was set to expire on January 28, 2015.

On October 5, 2012, the Company entered into an amended and restated ABL Facility. The amended and restated facility extended the maturity date to October 5, 2016 as well as made certain pricing and other changes to the original agreement. The Company maintained the option to request that the ABL Facility be increased by an amount not to exceed $20.0 million, subject to certain rights of the administrative agent, swing line lender and issuing banks with respect to the lenders providing commitments for such increase. As of March 30, 2013, the Company had no outstanding borrowings under the ABL Facility. Borrowing base availability was $29.6 million, however, outstanding letters of credit in the aggregate amount of $11.0 million left $18.6 million available for additional borrowings. The aforementioned letters of credit were primarily provided to certain administrative service providers and financial institutions. None of these letters of credit had been drawn on as of March 30, 2013.

Based on current borrowing base availability, the borrowings under the ABL Facility will bear interest at a rate per annum equal to, at our option, either (A) Adjusted London Interbank Offered Rate (“LIBOR”) (adjusted for statutory reserve requirements) plus (i) 2.00% in the case of Tranche 1 or (ii) 4.00% in the case of Tranche 2; or (B) the higher of (a) the administrative agent's Prime Rate and (b) the federal funds effective rate plus 0.5% (“ABR”) plus (x) 1.00% in the case of Tranche 1 or (y) 3.00% in the case of the Tranche 2.

The ABL Facility contains certain customary representations and warranties, affirmative covenants and events of default, including among other things payment defaults, breach of representations and warranties, covenant defaults, cross-defaults and cross acceleration to certain indebtedness, bankruptcy and insolvency defaults, certain events under ERISA, certain monetary judgment defaults, invalidity of guarantees or security interests, and change of control. If such an event of default occurs, the lenders under the ABL Facility would be entitled to take various actions, including the acceleration of amounts due under the ABL Facility and all actions permitted to be taken by a secured creditor.

Argentine Facility

In January 2007, the Company's subsidiary in Argentina entered into an arrangement with banking institutions in Argentina in order to finance the installation of a new spunmelt line at its facility near Buenos Aires, Argentina. The maximum borrowings available under the facility, excluding any interest added to principal, were 33.5 million Argentine pesos with respect to an Argentine peso-denominated loan and $26.5 million with respect to a U.S. dollar-denominated loan. The loans are secured by pledges covering (i) the subsidiary's existing equipment lines; (ii) the outstanding stock of the subsidiary; and (iii) the new machinery and equipment being purchased, as well as a trust assignment agreement related to a portion of receivables due from certain major customers of the subsidiary.

The interest rate applicable to borrowings under these term loans is based on LIBOR plus 290 basis points for the U.S. dollar-denominated loan and Buenos Aires Interbanking Offered Rate plus 475 basis points for the Argentine peso-denominated loan. Principal and interest payments began in July 2008 with the loans maturing as follows: annual amounts of $3.5 million beginning in 2011 and continuing through 2015, and the remaining $1.7 million in 2016.

In connection with the Merger, the Company repaid and terminated the Argentine peso-denominated loan. In addition, the U.S. denominated loan was adjusted to reflect its fair value as of the date of the Merger. As a result, the Company recorded a contra-liability in Long-term debt and will amortize the balance over the remaining life of the facility. At March 30, 2013, the face amount of the outstanding indebtedness under the U.S. dollar-denominated loan was $11.2 million, with a carrying amount of $10.8 million and a weighted average interest rate of 3.19%.

China Credit Facility — Healthcare

In the third quarter of 2010, the Company's subsidiary in China entered into a three-year U.S. dollar denominated construction loan agreement (the “Healthcare Facility”) with a banking institution in China to finance a portion of the installation of the new spunmelt line at its manufacturing facility in Suzhou, China. The three-year term of the agreement began with the date of the first draw down on the Healthcare Facility, which occurred in fourth quarter of 2010. The interest rate applicable to borrowings is based on three-month LIBOR plus an amount to be determined at the time of funding based on the lender's internal head office lending rate (400 basis points at the time the credit agreement was executed), but in no event would the interest rate be less than 1-year LIBOR plus 250 points.

The maximum borrowings available under the facility, excluding any interest added to principal, were $20.0 million. The Company repaid $4.0 million of the principal balance in the fourth quarter of 2012. As a result, the outstanding balance under the Healthcare Facility was $16.0 million at December 29, 2012, with a weighted average interest rate of 5.44%. As of March 30, 2013, the outstanding balance under the Healthcare Facility was $16.0 million with a weighted-average interest rate of 5.42%. The outstanding balance is scheduled to be repaid during 2013 using a combination of existing cash balances and cash generated from operations.

China Credit Facility — Hygiene

On July 1, 2012, the Company's subsidiary in China entered into a three-year U.S. dollar denominated construction loan agreement (the “Hygiene Facility”) with a banking institution in China to finance a portion of the installation of a new spunmelt line at its manufacturing facility in Suzhou, China. The interest rate applicable to borrowings under the Hygiene Facility is based on three-month LIBOR plus an amount to be determined at the time of funding based on the lender's internal head office lending rate (520 basis points at the time the credit agreement was executed).

The maximum borrowings available under the facility, excluding any interest added to principal, were $25.0 million. As of December 29, 2012, the outstanding balance under the Hygiene Facility was $11.0 million with a weighted-average interest rate of 5.51%. As of March 30, 2013, the outstanding balance under the Hygiene Facility was $17.6 million with a weighted average interest rate of 5.48%. In addition, the Company had $9.4 million of outstanding letters of credit that expired during the three months ended March 30, 2013. The Company's first payment on the outstanding principal is due in late 2013.

Other Indebtedness

The Company periodically enters into short-term credit facilities in order to finance various liquidity requirements. At March 30, 2013, outstanding amounts related to such facilities were $1.4 million, which are being used to finance insurance premium payments. The weighted average interest rate on these borrowings was 2.44%. At December 29, 2012, amounts outstanding under these facilities was $0.8 million at a weighted average interest rate of 2.46%. Borrowings are included in Short-term borrowings in the Consolidated Balance Sheets.

The Company also has documentary letters of credit not associated with the ABL Facility, Healthcare Facility or the Hygiene Facility. These letters of credit were primarily provided to certain raw material vendors and amounted to $5.9 million and $6.9 million at March 30, 2013 and December 29, 2012, respectively. None of these letters of credit have been drawn upon.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 30, 2013

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The accounting standard for fair value measurements establishes a framework for measuring fair value that is based on the inputs market participants use to determine the fair value of an asset or liability and establishes a fair value hierarchy to prioritize those inputs. The fair value hierarchy is comprised of three levels that are described below:

Level 1 — Inputs based on quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs other than Level 1 quoted prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 — Unobservable inputs based on little or no market activity and that are significant to the fair value of the assets and liabilities, therefore requiring an entity to develop its own assumptions.

The fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions regarding what a third party would use in pricing an asset or liability based on the best information available under the circumstances. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The following tables present the fair value and hierarchy levels for the Company's assets and liabilities, which are measured at fair value on a recurring basis as of the following periods:

In thousands	Level 1		Level 2			Level 3		March 30, 2013
Assets
Firm commitment	$	—	$	1,309		$	—	$	1,309
Liabilities
Hygiene contracts	—		(1,309		)	—		(1,309		)

In thousands	Level 1		Level 2			Level 3		December 29, 2012
Assets
Firm commitment	$	—	$	1,248		$	—	$	1,248
Liabilities
Hygiene contracts	—		(1,248		)	—		(1,248		)

ASC 820 "Fair Value Measurements and Disclosures" (ASC 820) defines fair value as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company determines fair value of its financial assets and liabilities using the following methodologies:

• Firm Commitment — Assets recognized associated with an unrecognized firm commitment to purchase equipment. The fair value of the assets is based upon indicative price information obtained from a third-party financial institution that is the counterparty to the transaction.

• Derivative instruments — These instruments consist of foreign forward exchange contracts. The fair value is based upon indicative price information obtained from a third-party financial institution that is the counterparty to the transaction.

The fair values of cash and cash equivalents, accounts receivable, inventories, short-term borrowings and accounts payable and accrued liabilities approximate their carrying values due to the short-term nature of these instruments. The methodologies used by the Company to determine the fair value of its financial assets and liabilities at March 30, 2013 are the same as those used at December 29, 2012. As a result, there have been no transfers between Level 1 and Level 2 categories.

XML

Certain Relationships and Related Party Transactions (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Mar. 30, 2013	Dec. 29, 2012
Related Party Transaction [Line Items]
Number of related party members in board of directors	3
Number of outside members in board of directors	3
Number of CEOs in board of directors	1
Non refundable advisory fees receivable each year if it is more than specified percentage of EBITDA	$ 3.0
Percentage of non refundable advisory fees receivable each year if it is more than specified amount	2.00%
Selling, general and administrative expenses
Related Party Transaction [Line Items]
Advisory fee	$ 3.0	$ 3.0

XML

Financial Guarantees and Condensed Consolidating Balance Sheet (Details) (USD $) In Thousands, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012	Mar. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 74,627	$ 97,879	$ 79,621	$ 72,742
Accounts receivable, net	139,848	131,569
Inventories, net	96,892	94,964
Deferred income taxes	3,806	3,832
Other current assets	40,078	33,414
Total current assets	355,251	361,658
Property, plant and equipment, net	477,958	479,169
Goodwill	80,712	80,608
Intangible assets, net	73,637	75,663
Net investment in and advances to (from) subsidiaries	0	0
Deferred income taxes	1,222	945
Other noncurrent assets	24,855	24,026
Total assets	1,013,635	1,022,069
Current liabilities:
Short-term borrowings	1,411	813
Accounts payable and accrued liabilities	193,176	196,905
Income taxes payable	3,716	3,841
Deferred income taxes	479	479
Current portion of long-term debt	21,463	19,477
Total current liabilities	220,245	221,515
Long-term debt	583,199	579,399
Deferred income taxes	33,045	33,181
Other noncurrent liabilities	47,611	48,772
Total liabilities	884,100	882,867
Common stock	0	0
Other shareholders’ equity	129,535	139,202
Total shareholders' equity	129,535	139,202
Total liabilities and shareholders' equity	1,013,635	1,022,069
PGI (Issuer)
Current assets:
Cash and cash equivalents	4,060	486	6,196	3,135
Accounts receivable, net	0	0
Inventories, net	(52)	0
Deferred income taxes	0	0
Other current assets	3,908	1,821
Total current assets	7,916	2,307
Property, plant and equipment, net	38,212	27,711
Goodwill	0	0
Intangible assets, net	23,483	24,313
Net investment in and advances to (from) subsidiaries	644,908	679,818
Deferred income taxes	0	0
Other noncurrent assets	306	275
Total assets	714,825	734,424
Current liabilities:
Short-term borrowings	1,411	813
Accounts payable and accrued liabilities	17,985	28,511
Income taxes payable	0	0
Deferred income taxes	331	331
Current portion of long-term debt	107	107
Total current liabilities	19,834	29,762
Long-term debt	560,019	560,043
Deferred income taxes	273	273
Other noncurrent liabilities	5,164	5,144
Total liabilities	585,290	595,222
Common stock	0	0
Other shareholders’ equity	129,535	139,202
Total shareholders' equity	129,535	139,202
Total liabilities and shareholders' equity	714,825	734,424
Guarantors
Current assets:
Cash and cash equivalents	15,234	28,285	10,851	14,574
Accounts receivable, net	24,913	22,350
Inventories, net	21,025	23,843
Deferred income taxes	613	613
Other current assets	10,017	7,710
Total current assets	71,802	82,801
Property, plant and equipment, net	96,687	99,660
Goodwill	20,718	20,718
Intangible assets, net	41,715	42,422
Net investment in and advances to (from) subsidiaries	756,142	723,861
Deferred income taxes	0	0
Other noncurrent assets	5,645	5,787
Total assets	992,709	975,249
Current liabilities:
Short-term borrowings	0	0
Accounts payable and accrued liabilities	38,875	33,344
Income taxes payable	0	89
Deferred income taxes	0	0
Current portion of long-term debt	0	0
Total current liabilities	38,875	33,433
Long-term debt	0	0
Deferred income taxes	9,149	9,149
Other noncurrent liabilities	14,935	15,540
Total liabilities	62,959	58,122
Common stock	0	0
Other shareholders’ equity	929,750	917,127
Total shareholders' equity	929,750	917,127
Total liabilities and shareholders' equity	992,709	975,249
Non-Guarantors
Current assets:
Cash and cash equivalents	55,333	69,108	62,574	55,033
Accounts receivable, net	114,935	109,219
Inventories, net	75,919	71,121
Deferred income taxes	3,806	3,832
Other current assets	26,153	23,883
Total current assets	276,146	277,163
Property, plant and equipment, net	343,059	351,798
Goodwill	59,994	59,890
Intangible assets, net	8,439	8,928
Net investment in and advances to (from) subsidiaries	(169,899)	(188,670)
Deferred income taxes	1,222	945
Other noncurrent assets	18,904	17,964
Total assets	537,865	528,018
Current liabilities:
Short-term borrowings	0	0
Accounts payable and accrued liabilities	136,316	135,050
Income taxes payable	3,716	3,752
Deferred income taxes	14	14
Current portion of long-term debt	21,356	19,370
Total current liabilities	161,402	158,186
Long-term debt	23,180	19,356
Deferred income taxes	24,370	24,506
Other noncurrent liabilities	27,512	28,088
Total liabilities	236,464	230,136
Common stock	36,083	36,083
Other shareholders’ equity	265,318	261,799
Total shareholders' equity	301,401	297,882
Total liabilities and shareholders' equity	537,865	528,018
Eliminations
Current assets:
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Inventories, net	0	0
Deferred income taxes	(613)	(613)
Other current assets	0	0
Total current assets	(613)	(613)
Property, plant and equipment, net	0	0
Goodwill	0	0
Intangible assets, net	0	0
Net investment in and advances to (from) subsidiaries	(1,231,151)	(1,215,009)
Deferred income taxes	0	0
Other noncurrent assets	0	0
Total assets	(1,231,764)	(1,215,622)
Current liabilities:
Short-term borrowings	0	0
Accounts payable and accrued liabilities	0	0
Income taxes payable	0	0
Deferred income taxes	134	134
Current portion of long-term debt	0	0
Total current liabilities	134	134
Long-term debt	0	0
Deferred income taxes	(747)	(747)
Other noncurrent liabilities	0	0
Total liabilities	(613)	(613)
Common stock	(36,083)	(36,083)
Other shareholders’ equity	(1,195,068)	(1,178,926)
Total shareholders' equity	(1,231,151)	(1,215,009)
Total liabilities and shareholders' equity	$ (1,231,764)	$ (1,215,622)

XML

Division Assets (Detail) (USD $) In Thousands, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Segment Reporting Information [Line Items]
Total assets	$ 1,013,635	$ 1,022,069
Americas Nonwovens
Segment Reporting Information [Line Items]
Total assets	494,577	513,765
Europe Nonwovens
Segment Reporting Information [Line Items]
Total assets	197,831	202,139
Asia Nonwovens
Segment Reporting Information [Line Items]
Total assets	255,873	248,790
Oriented Polymers
Segment Reporting Information [Line Items]
Total assets	28,626	25,329
Unallocated Corporate
Segment Reporting Information [Line Items]
Total assets	$ 36,728	$ 32,046

XML

Pension and Postretirement Benefit Plans (Tables)

3 Months Ended

Mar. 30, 2013

Pension Plans

Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]

Components of net periodic benefit costs

The components of the Company's pension related costs for the following periods are as follows:

In thousands	Three Months Ended March 30, 2013			Three Months Ended March 31, 2012
Service cost	$	844		$	510
Interest cost	1,391			1,442
Return on plan assets	(1,884		)	(1,616		)
Curtailment / settlement (gain) loss	—			—
Net amortization of:
Transition costs and other	88			(16		)
Net periodic benefit cost	$	439		$	320

Postretirement Benefit Plans

Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]

Components of net periodic benefit costs

The components of the Company's postretirement related costs for the following periods are as follows:

In thousands	Three Months Ended March 30, 2013		Three Months Ended March 31, 2012
Service cost	$	15	$	18
Interest cost	46		54
Curtailment / settlement (gain) loss	—		—
Net amortization of:
Transition costs and other	9		6
Net periodic benefit cost	$	70	$	78

XML

Fair Value of Financial Instruments (Details) (Fair Value, Measurements, Recurring, USD $)	Mar. 30, 2013	Dec. 29, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	$ 1,309,000	$ 1,248,000
Fair Value, Transfers Between Level 1 and Level 2, Description and Policy [Abstract]
Fair value assets Level 1 to Level 2 transfers	0
Fair value assets Level 2 to Level 1 transfers	0
Fair value liabilities Level 1 to Level 2 transfers	0
Fair value liabilities Level 2 to Level 1 transfers	0
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	1,309,000	1,248,000
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	0	0
Hygiene contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities	(1,309,000)	(1,248,000)
Hygiene contracts | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities	0	0
Hygiene contracts | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities	(1,309,000)	(1,248,000)
Hygiene contracts | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities	$ 0	$ 0

XML

Foreign Currency and Other, Net

3 Months Ended

Mar. 30, 2013

Foreign Currency [Abstract]

Foreign Currency and Other, Net

Foreign Currency and Other, Net

Transactions that are denominated in a currency other than an entity's functional currency are subject to changes in exchange rates with the resulting gains and losses recorded within current earnings. The Company includes these gains and losses related to intercompany loans and debt as well as other non-operating activities as a component of Other income (expense).

For the three months ended March 30, 2013, the Company recognized a loss of $1.4 million within Foreign currency and other, net. Amounts associated with foreign currency losses totaled $1.0 million and other non-operating expenses were $0.4 million. For the three months ended March 31, 2012, the Company recognized income of $0.1 million. Amounts associated with foreign currency gains totaled $0.3 million, partially offset by other non-operating expenses of $0.2 million.

XML

Basis of Presentation (Policies)

3 Months Ended

Mar. 30, 2013

Accounting Policies [Abstract]

Basis of Presentation

The accompanying consolidated financial statements reflect the consolidated operations of the Company and have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) as defined by the Financial Accounting Standards Board (“FASB”) within the FASB Accounting Standards Codification (“ASC”). In the opinion of management, the accompanying consolidated financial statements contain all adjustments, which include normal recurring adjustments, necessary to present fairly the consolidated results for the periods presented. The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Polymer Group, Inc. Annual Report on Form 10-K for the year ended December 29, 2012.

Fiscal Period

The Company's fiscal year is based on a 52 week period ending on the Saturday closest to each December 31. Therefore, the financial results of 53-week fiscal years, and the associated 14-week quarters, will not be comparable to the prior and subsequent 52-week fiscal years and the associated quarters having only 13 weeks. The three months ended March 30, 2013 and March 31, 2012 each contain operating results for 13 weeks.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update No. 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income" ("ASU 2013-02"), which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, ASU 2013-02 requires an entity to present, either on the face of the income statement or in the notes to the financial statements, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income in the financial statements. ASU 2013-02 is effective prospectively for reporting periods beginning after December 15, 2012. The adoption of this guidance concerns disclosure only and did not have an impact on the Company's financial results. See Note 11 for additional information.

XML

Derivatives Instruments Fair Value (Details) (Foreign Currency Hedge, Accounts payable and accrued liabilities, Foreign Exchange Forward, USD $) In Thousands, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Summary of aggregate notional amount and estimated fair value of derivative instruments
Notional	$ 12,779	$ 22,554
Fair Value	(1,309)	(1,248)
Hygiene Line | Designated hedges:
Summary of aggregate notional amount and estimated fair value of derivative instruments
Notional	12,779	22,554
Fair Value	(1,309)	(1,248)
Healthcare Line | Undesignated hedges:
Summary of aggregate notional amount and estimated fair value of derivative instruments
Notional	0	0
Fair Value	$ 0	$ 0

XML

Accounts Receivable Factoring Agreements Schedule (Details) (USD $) In Thousands, unless otherwise specified	Mar. 30, 2013	Dec. 29, 2012
Receivables [Abstract]
Trade receivables sold to financial institutions	$ 54,844	$ 48,767
Amounts received from financial institutions	47,314	41,937
Amounts due from financial institutions	$ 7,530	$ 6,830

XML

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) (USD $) In Thousands, unless otherwise specified	Total USD ($)	Total Equity USD ($)	Common Stock	Additional Paid-in Capital USD ($)	Retained Deficit USD ($)	Accumulated Other Comprehensive Income (Loss) USD ($)
Balance -- beginning of period at Dec. 29, 2012	$ 139,202	$ 139,202		$ 256,180	$ (102,209)	$ (14,769)
Balance -- beginning of period, shares at Dec. 29, 2012			1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(6,227)	(6,227)			(6,227)
Share-based compensation		236		236
Employee postretirement benefits, net of tax	96	96				96
Currency translation	(3,772)	(3,772)				(3,772)
Balance -- end of period at Mar. 30, 2013	$ 129,535	$ 129,535		$ 256,416	$ (108,436)	$ (18,445)
Balance -- end of period, shares at Mar. 30, 2013			1

XML

Accounts Receivable Factoring Agreements

3 Months Ended

Mar. 30, 2013

Receivables [Abstract]

Accounts Receivable Factoring Agreements

Accounts Receivable Factoring Agreements

In the ordinary course of business, the Company may utilize accounts receivable factoring agreements with third-party financial institutions in order to accelerate its cash collections from product sales. In addition, these agreements provide the Company with the ability to limit credit exposure to potential bad debts, better management of costs relate to collections as well as enable customers to extend their credit terms. These agreements involve the ownership transfer of eligible trade accounts receivable, without recourse or discount, to a third party financial institution in exchange for cash.

The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheet. Receivables are considered sold when they are transferred beyond the reach of the Company and its creditors, the purchaser has the right to pledge or exchange the receivables, and the Company has surrendered control over the transferred receivables. In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold. Amounts due from financial institutions are recorded with Other current assets in the Consolidated Balance Sheet.

The Company has a U.S. based program where certain U.S. based receivables are sold to an unrelated third-party financial institution. Under the current terms of the U.S. agreement, the maximum amount of outstanding advances at any one time is $20.0 million, which limitation is subject to change based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. In addition, the Company's subsidiaries in Mexico, Colombia, Spain and the Netherlands have entered into factoring agreements to sell certain receivables to unrelated third-party financial institutions. Under the terms of the non-U.S. agreements, the maximum amount of outstanding advances at any one time is $49.7 million, which limitation is subject to change based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold.

The following is a summary of receivables sold to the third-party financial institutions that existed at the following balance sheet dates:

In thousands	March 30, 2013		December 29, 2012
Trade receivables sold to financial institutions	$	54,844	$	48,767
Amounts received from financial institutions	47,314		41,937
Amounts due from financial institutions	$	7,530	$	6,830

The Company sold $101.8 million and $88.8 million of receivables under the terms of the factoring agreements during the three months ended March 30, 2013 and March 31, 2012, respectively. The increase is primarily related to the inclusion of the Netherlands, which entered into a factoring agreement in March 2012. The Company pays a factoring fee associated with the sale of receivables based on the dollar of the receivables sold. Amounts incurred were $0.3 million and $0.3 million during the three months ended March 30, 2013 and March 31, 2012, respectively.

XML

Other Operating, Net (Details) (USD $)	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Other Income and Expenses [Abstract]
Other operating income (loss)	$ (340,000)	$ 361,000
Other operating income (loss), associated with foreign currency gains (losses)	(400,000)
Other operating income	$ 100,000

XML

Accounts Receivable Factoring Agreements (Tables)

3 Months Ended

Mar. 30, 2013

Receivables [Abstract]

Schedule of Accounts Receivable Factoring Agreements to Third Parties

The following is a summary of receivables sold to the third-party financial institutions that existed at the following balance sheet dates:

In thousands	March 30, 2013		December 29, 2012
Trade receivables sold to financial institutions	$	54,844	$	48,767
Amounts received from financial institutions	47,314		41,937
Amounts due from financial institutions	$	7,530	$	6,830

XML

Description of Business Narrative (Details)	3 Months Ended
	Mar. 30, 2013 business_segment manufacturing_and_converting_facility Country
Accounting Policies [Abstract]
Number of manufacturing and converting facilities	13
Number of countries in which entity operates	9
Number of business segments	4

XML

Other Operating, Net

3 Months Ended

Mar. 30, 2013

Other Income and Expenses [Abstract]

Other Operating, Net

Other Operating, Net

Transactions that are denominated in a currency other than an entity's functional currency are subject to changes in exchange rates with the resulting gains and losses recorded within current earnings. The Company includes these gains and losses related to receivables and payables as well as the impacts of other operating transactions as a component of Operating income (loss).

For the three months ended March 30, 2013, the Company recognized a loss of $0.3 million within Other operating, net. Amounts associated with foreign currency losses totaled $0.4 million and other miscellaneous income was $0.1 million. For the three months ended March 31, 2012, the Company recognized income of $0.4 million associated with foreign currency gains.